Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,chloride channel activity (GO:0005254),-0.5711553315343587,-2.0305976600362494,0.0,0.023404694706408755,0.015,21/59,13.96%,SLC26A7;CLIC4;GABRG3;ANO1;ANO4;CLCN3;GABRA2;GABRB3;GLRA1;GABRB1;GABRG2;TTYH2;GLRA2;CLIC1;GABRB2;CLCN5;GABRA3;ANO3;ANO2;CFTR;SLC1A4
prerank,metalloendopeptidase activity (GO:0004222),0.6537686115098369,2.0116762674962354,0.0,0.00913713996615551,0.008,19/76,8.79%,ADAMTS6;ADAMTS12;ADAMTSL3;TRABD2B;THSD4;ADAMTS10;ADAMTS5;ADAM33;ADAMTS2;ADAMTSL2;MMP2;MMP19;MMP11;MMEL1;ADAMTS9;SPRTN;PMPCB;EEF1AKMT4-ECE2;ECE2
prerank,anion channel activity (GO:0005253),-0.5308968573649973,-1.9211638328636864,0.0,0.0836717835754113,0.124,22/61,13.96%,SLC26A7;LRRC8C;CLIC4;GABRG3;ANO1;LRRC8D;ANO4;CLCN3;GABRA2;GABRB3;GLRA1;GABRB1;GABRG2;GLRA2;CLIC1;GABRB2;CLCN5;GABRA3;ANO3;ANO2;CFTR;SLC1A4
prerank,metallopeptidase activity (GO:0008237),0.6001191268424108,1.8984717213825812,0.0,0.06258940876816525,0.111,21/113,8.79%,PAPPA;ADAMTS6;ADAMTS12;ADAMTSL3;TRABD2B;THSD4;ADAMTS10;ADAMTS5;ADAM33;ADAMTS2;ADAMTSL2;MMP2;MMP19;MMP11;MMEL1;ADAMTS9;SPRTN;DPEP1;PMPCB;EEF1AKMT4-ECE2;ECE2
prerank,chloride transmembrane transporter activity (GO:0015108),-0.6869856936684421,-1.873576346083051,0.0,0.10805167389458709,0.219,7/16,14.00%,SLC26A7;SLC26A2;SLC1A1;SLC4A8;SLC26A6;CFTR;SLC12A5
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.6974079527754576,-1.865755267963187,0.0,0.07021408411922628,0.235,6/16,5.92%,PTPRB;PTPRG;PTPRE;PTPRD;PTPRK;PTPRT
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.6974079527754576,-1.865755267963187,0.0,0.07021408411922628,0.235,6/16,5.92%,PTPRB;PTPRG;PTPRE;PTPRD;PTPRK;PTPRT
prerank,retinoid binding (GO:0005501),0.7604195345691337,1.8443968534331565,0.0,0.11604167757017497,0.291,5/22,6.06%,RBP4;CYP26B1;NR2F2;RBP1;ALDH1A2
prerank,transmitter-gated ion channel activity (GO:0022824),-0.5968670295332011,-1.8411457941441687,0.0,0.08074619673711021,0.311,14/29,9.66%,GRID2;GRIA4;GABRG3;GRIK1;GRIK2;GABRA2;GABRB3;GABRB1;GABRG2;GLRA2;GABRB2;GRIA2;GABRA3;GRID1
prerank,glutamate receptor activity (GO:0008066),-0.6572278552195856,-1.8089753754515423,0.0,0.10030583445603754,0.405,10/19,10.96%,GRM7;GRID2;GRM3;GRIA4;GRIK1;GRIK2;GRM5;GRIA2;GRID1;GRM8
prerank,protease binding (GO:0002020),0.5792385882977609,1.8034790222780415,0.0,0.17840265783918635,0.493,37/99,14.41%,CCBE1;COL1A2;COL1A1;TIMP3;SERPINE1;BCL2;ITGA3;CFLAR;ATP9A;STIM1;INSL3;RFFL;LDLR;BFAR;CST3;DERL1;BDKRB2;DERL3;CD28;POLG;TIMP2;RNF139;SLC2A13;PRKN;ITGB3;ITGAV;LONP2;ADAMTSL4;SELENOS;RIPK2;NOL3;TRIP4;PTEN;COL3A1;ADRM1;RIOK3;AMFR
prerank,platelet-derived growth factor binding (GO:0048407),0.8486476406337777,1.7995367666072128,0.0017482517482517483,0.15350395143141257,0.514,5/11,3.56%,COL1A2;COL1A1;COL5A1;PDGFRA;PDGFRB
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.6557186246339554,-1.7779709933194987,0.015306122448979591,0.12345976457630618,0.519,6/15,13.10%,SLC26A7;SLC26A2;SLC39A8;SLC4A8;SLC26A6;CFTR
prerank,ligand-gated ion channel activity (GO:0015276),-0.5581984603891459,-1.7736402819849921,0.0,0.11481303014310516,0.535,10/30,9.66%,GRID2;GRIA4;GRIK1;GRIK2;GRIN2A;GABRB1;GRIN2B;GRIN3A;GRIA2;GRID1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.7851386911200955,1.7655024105650972,0.00510204081632653,0.21517964620296226,0.699,5/15,8.58%,ALDH1A1;ALDH1A2;ALDH1L1;ALDH7A1;ALDH2
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.8005667503804499,1.7641866623632865,0.008741258741258742,0.1888777361575289,0.708,5/13,8.58%,ALDH1A1;ALDH1A2;ALDH1L1;ALDH7A1;ALDH2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.7375911629199114,1.7585777807643426,0.009852216748768473,0.17931637183580187,0.737,6/18,5.69%,LTBP1;TGFBR3;BMPR1A;TGFBR1;ACVR1;ENG
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.8068928748916386,1.7575710375156348,0.012195121951219513,0.1615243298461491,0.742,6/12,5.69%,LTBP1;TGFBR3;BMPR1A;TGFBR1;ACVR1;ENG
prerank,ligand-gated channel activity (GO:0022834),-0.5624124340118746,-1.74883725724001,0.0,0.13773662834721553,0.638,10/29,9.66%,GRID2;GRIA4;GRIK1;GRIK2;GRIN2A;GABRB1;GRIN2B;GRIN3A;GRIA2;GRID1
prerank,insulin-like growth factor receptor binding (GO:0005159),0.7942946385449523,1.7450643622030593,0.005434782608695652,0.16958531777184627,0.794,4/12,3.29%,IGF1;IGF2;PIK3R1;GNAS
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.6686204199858059,-1.7440050884566212,0.002403846153846154,0.1309599053799508,0.653,4/14,5.44%,KCNJ2;KCNJ3;KCND3;KCNQ1
prerank,ligand-gated anion channel activity (GO:0099095),-0.6430612732736689,-1.7339926143549562,0.0,0.13369931851036002,0.692,13/17,23.06%,GABRG3;GABRA2;GABRB3;GLRA1;GABRB1;GABRG2;GLRA2;GABRB2;GABRA3;CFTR;GABRA4;GABRG1;GLRA3
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.6360172355647519,-1.725222406138148,0.007556675062972292,0.1358372473537339,0.726,8/17,8.47%,GRIA4;PTK2B;GRIK1;GRIK2;GRIN2A;GRIN2B;GRIN3A;GRIA2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.7059348005019536,-1.72441867625952,0.007058823529411765,0.1277227625406878,0.73,4/11,11.84%,PPP1R1A;PPP1R14C;PPP1R14B;PPP1R14A
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.5790774525163471,1.7156788338972584,0.009589041095890411,0.23133577096130087,0.908,20/60,10.17%,EPHA3;NRP1;EPHA7;DDR2;FGFR1;EPHA4;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;AXL;MUSK;ROR1;NTRK3;EGFR;EPHB2;IGF2R;RYK
prerank,anion transmembrane transporter activity (GO:0008509),-0.6838357037028151,-1.7049515210108959,0.011990407673860911,0.1448750602326702,0.788,4/12,4.23%,ABCG2;SLCO2B1;SLC22A6;SLC39A8
prerank,retinoic acid binding (GO:0001972),0.7965341201268668,1.701740525544247,0.003436426116838488,0.2509667777370713,0.941,2/12,1.88%,CYP26B1;NR2F2
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.7251594975987535,1.6968329091666545,0.013559322033898305,0.23045172300353647,0.951,4/17,2.61%,EPHA3;EPHA7;EPHA4;EPHA8
prerank,ephrin receptor activity (GO:0005003),0.7251594975987535,1.6968329091666545,0.013559322033898305,0.23045172300353647,0.951,4/17,2.61%,EPHA3;EPHA7;EPHA4;EPHA8
prerank,amino acid binding (GO:0016597),-0.5421562656539454,-1.69637928175729,0.009174311926605505,0.1478152750051628,0.816,9/31,7.48%,GRM7;NOS3;GLRA1;GLRA2;DDAH1;NOS1;DDAH2;GRIN2B;GRIN3A
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.7824008425187491,1.6885812361447954,0.012089810017271158,0.23756563912004328,0.964,3/11,4.72%,ITPR1;TRPA1;RASA3
prerank,phospholipase activator activity (GO:0016004),0.7968536219369586,1.6883690440156978,0.01618705035971223,0.22340307217250222,0.964,3/10,6.31%,PDPK1;ARHGAP6;SRC
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6927429429352913,-1.686682873709521,0.006818181818181818,0.1529565636401184,0.851,7/12,9.47%,GABRG3;GABRA2;GABRB3;GABRB1;GABRG2;GABRB2;GABRA3
prerank,lipase activator activity (GO:0060229),0.7965906264974304,1.6834706963161379,0.0162748643761302,0.22224749270619432,0.969,3/10,6.31%,PDPK1;ARHGAP6;SRC
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5343540211159299,-1.6762934821842275,0.005555555555555556,0.1609072761065602,0.886,8/28,9.66%,GRID2;GABRG3;GRIK1;GRIK2;GABRA2;GABRG2;GABRA3;GRID1
prerank,BMP binding (GO:0036122),0.776984637230556,1.6674297767594748,0.015410958904109588,0.2519820155110887,0.984,2/11,5.69%,GREM2;ENG
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.7491598983221115,1.6620758122410166,0.013179571663920923,0.2522812434865885,0.989,2/14,0.18%,SLC7A11;SLC1A3
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.705780360944446,1.6592878988646858,0.022336769759450172,0.24702257898501423,0.989,6/18,9.92%,ALDH1A1;AKR1B1;ALDH1A2;ALDH2;ALDH18A1;AKR1B10
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.6597973975384663,-1.6538092938285953,0.017456359102244388,0.1890237054051802,0.939,7/13,18.89%,SH3BP4;CCDC88A;GDI1;ARHGDIA;ARHGDIB;GPSM2;ITGB1BP1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.5984760249140776,-1.6491922435229207,0.015424164524421594,0.18758862807186616,0.946,8/19,9.66%,GRID2;GABRG3;GRIK1;GRIK2;GABRA2;GABRG2;GABRA3;GRID1
prerank,calcium:sodium antiporter activity (GO:0005432),0.7758257586676484,1.6403311499299935,0.03767123287671233,0.2849917465634219,0.995,5/10,6.52%,SLC24A3;SLC8A1;SLC8A3;SLC24A1;SLC24A5
prerank,glycerophospholipid flippase activity (GO:0140333),-0.6691851035226427,-1.6381414956035858,0.01327433628318584,0.1978253957327407,0.958,4/11,7.23%,ATP8A1;ATP8B1;ATP11C;ATP11A
prerank,endopeptidase inhibitor activity (GO:0004866),0.5402806473819691,1.6355095508901554,0.0037546933667083854,0.28466344240013575,0.996,16/82,7.13%,COL4A3;TIMP3;AHSG;SERPINE1;SERPING1;RECK;FETUB;CAST;SERPIND1;WFDC3;TFPI;SERPINF1;CST3;SERPINH1;CRB2;TIMP2
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.6805910158367713,-1.622611284153436,0.015730337078651686,0.2151636138350532,0.974,3/11,5.44%,KCNJ3;KCND3;KCNQ1
prerank,transforming growth factor beta binding (GO:0050431),0.6409603160495604,1.6170089682680042,0.03937007874015748,0.3277452379164476,0.999,7/23,6.87%,LTBP1;TGFBR3;TGFBR1;TWSG1;ACVR1;ENG;LTBP3
prerank,phospholipid transfer activity (GO:0120014),-0.5519535682928729,-1.6148878233506083,0.015873015873015872,0.2182233382517112,0.98,7/21,8.99%,PITPNC1;CERT1;PLTP;PITPNA;TNFAIP8L3;PLEKHA3;OSBPL2
prerank,anion:anion antiporter activity (GO:0015301),-0.5815600191653254,-1.6140432131552311,0.02894736842105263,0.2105447327964021,0.98,5/17,13.83%,SLC26A7;SLC26A2;SLC26A6;SLC25A4;SLC25A11
prerank,voltage-gated chloride channel activity (GO:0005247),-0.6702141591511848,-1.612756774936736,0.018691588785046728,0.20441660356577404,0.981,5/10,21.21%,ANO1;CLCN3;CLCN5;ANO6;CLCN4
prerank,cation:chloride symporter activity (GO:0015377),-0.6770412010186235,-1.6101348100440676,0.023752969121140142,0.2004702119660473,0.982,5/10,17.73%,SLC12A2;SLC12A7;SLC12A6;SLC12A5;SLC12A8
prerank,metallocarboxypeptidase activity (GO:0004181),0.637002514351634,1.6080669521558482,0.016717325227963525,0.3424143202316777,0.999,7/26,11.70%,CPXM2;AEBP1;VASH2;CPXM1;AGBL2;PEPD;CPA2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.6473691563171955,-1.597942973557718,0.02358490566037736,0.2125926435832129,0.986,8/12,13.22%,PDE4D;PDE3B;PDE4B;PDE8A;PDE2A;PDE8B;PDE7A;PDE4C
prerank,poly(U) RNA binding (GO:0008266),0.6506336843774548,1.5957546868817956,0.029079159935379646,0.36676479824148217,0.999,3/20,1.36%,RBMS1;ATXN1;RBMS3
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.6010494546977134,-1.5943728338519805,0.024271844660194174,0.21151992840916914,0.99,8/15,12.99%,HS3ST1;HS3ST3A1;NDST3;HS3ST4;HS6ST3;HS3ST5;HS6ST2;HS3ST2
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.6128577150975116,-1.5939203621496385,0.022004889975550123,0.20515425497824502,0.99,5/14,13.83%,SLC26A7;SLC26A2;SLC25A30;SLC26A6;SLC25A11
prerank,diacylglycerol kinase activity (GO:0004143),-0.675649800057692,-1.59259053574784,0.01366742596810934,0.19995410844175215,0.99,7/11,20.81%,DGKB;DGKH;DGKK;DGKG;DGKQ;DGKZ;DGKI
prerank,alanine transmembrane transporter activity (GO:0022858),-0.6437932173993047,-1.5912213642589648,0.02962962962962963,0.19554244932128606,0.991,5/12,13.96%,SLC6A6;SLC38A5;SLC36A4;SLC3A2;SLC1A4
prerank,acid-thiol ligase activity (GO:0016878),0.7289950299477832,1.59056171829478,0.025295109612141653,0.3694567402468957,0.999,7/13,15.44%,SLC27A5;ACSL1;ACSS3;AASDH;ACSF3;ACSS2;AACS
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.7321933923829474,1.5848935252562808,0.03395585738539898,0.3761455952734018,1.0,6/13,15.58%,BMP6;CDH5;SRC;BMP2;BMP4;BMP5
prerank,E-box binding (GO:0070888),0.5942009415970935,1.5820286619314285,0.021865889212827987,0.3715879028379029,1.0,6/34,6.05%,TCF4;MITF;ZEB1;ASCL1;NEUROD1;ATOH8
prerank,GABA-A receptor activity (GO:0004890),-0.5803350399567191,-1.5771557394483284,0.037037037037037035,0.2111542300543815,0.993,7/18,9.47%,GABRG3;GABRA2;GABRB3;GABRB1;GABRG2;GABRB2;GABRA3
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.5325695586443017,1.5741211861826159,0.03125,0.3846105778167597,1.0,18/60,8.62%,EPHA3;EPHA7;DDR2;FGFR1;EPHA4;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;ACVR1;AXL;MUSK;ROR1;NTRK3;EGFR;EPHB2
prerank,GABA receptor activity (GO:0016917),-0.5531261004428957,-1.572473004353931,0.023316062176165803,0.2125926435832129,0.993,7/21,9.47%,GABRG3;GABRA2;GABRB3;GABRB1;GABRG2;GABRB2;GABRA3
prerank,mannose binding (GO:0005537),0.7206507406150278,1.5694908617518353,0.04194630872483222,0.3866533062344807,1.0,3/12,5.96%,LMAN2L;LMAN1;COLEC11
prerank,5'-nucleotidase activity (GO:0008253),-0.6101120511808011,-1.5659345317692703,0.041666666666666664,0.21704412473325532,0.995,5/13,19.08%,NT5E;NT5C2;NT5C1A;NT5C;ACP3
prerank,poly-pyrimidine tract binding (GO:0008187),0.622360457409997,1.5637389378419915,0.03475513428120063,0.3927496453194264,1.0,3/23,1.36%,RBMS1;ATXN1;RBMS3
prerank,CoA-ligase activity (GO:0016405),0.7094156071331256,1.5617139466425125,0.04047217537942664,0.38678655619232044,1.0,6/14,15.44%,SLC27A5;ACSL1;ACSS3;ACSF3;ACSS2;AACS
prerank,BMP receptor binding (GO:0070700),0.7322031539989257,1.558562880995661,0.039792387543252594,0.384562839363436,1.0,6/12,15.58%,BMP6;CDH5;SRC;BMP2;BMP4;BMP5
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.6674008084782571,-1.557677462329844,0.04535637149028078,0.22371544611511573,0.996,4/10,11.81%,DPP10;FAP;PRCP;DPP6
prerank,acylglycerol lipase activity (GO:0047372),-0.629526724674646,-1.5567683350845596,0.04772727272727273,0.2187038694232196,0.996,3/11,5.02%,MGLL;ABHD2;LIPE
prerank,translation elongation factor activity (GO:0003746),-0.6070751979677017,-1.556462357593679,0.02743142144638404,0.21323574555487546,0.997,7/14,13.99%,EEF2;GTPBP1;EIF5A;EIF5AL1;GFM2;EEF1A1;EEF1B2
prerank,phosphatidylglycerol binding (GO:1901611),-0.6027699375971969,-1.553653627584421,0.037209302325581395,0.21187407839485822,0.997,3/13,3.60%,PITPNC1;PLTP;PITPNA
prerank,wide pore channel activity (GO:0022829),0.6121233447095741,1.5526876827511462,0.042748091603053436,0.3907202293174557,1.0,4/23,7.00%,GJA1;GJB6;GJB2;PANX1
prerank,semaphorin receptor activity (GO:0017154),0.7208473239747631,1.5482698567503501,0.05385996409335727,0.39349745917103435,1.0,2/11,0.18%,NRP1;PLXNA2
prerank,gap junction channel activity (GO:0005243),0.6173519510860483,1.5450839452929999,0.04375,0.3921863521028749,1.0,4/22,7.00%,GJA1;GJB6;GJB2;PANX1
prerank,muscle alpha-actinin binding (GO:0051371),0.6776439061186428,1.5376858530162087,0.05802047781569966,0.4044048759074666,1.0,4/15,4.65%,PDLIM5;PDLIM2;PALLD;SYNPO2
prerank,alpha-actinin binding (GO:0051393),0.6178995904603674,1.5364728209351823,0.04739336492890995,0.397537723843287,1.0,6/24,6.66%,PDLIM5;DAG1;PDLIM2;PALLD;SYNPO2;CACNA1C
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.5481112794482836,-1.5335145654137456,0.04155124653739612,0.24031820500465095,0.999,7/19,12.77%,EFNA5;AFAP1L2;NRG3;GRM5;DGKQ;PAK2;ERBB3
prerank,NAD binding (GO:0051287),0.594607463481085,1.5302845331913655,0.03881987577639751,0.4062513000336834,1.0,5/26,8.58%,ALDH1A1;CRYL1;SIRT2;NNT;ALDH2
prerank,receptor ligand activity (GO:0048018),0.45417003324942573,1.529932461188112,0.003205128205128205,0.3970772600792031,1.0,28/245,7.08%,IGF1;GREM2;EPHA7;BMP6;IGF2;GDNF;AREG;TGFA;SEMA3D;IL34;IL17D;EPGN;WNT8B;INHBE;WNT4;GAS6;SEMA5A;WNT6;CSF1;APOA1;ENDOU;NTF3;VIP;FAM3B;CCL4;WNT5B;IL12B;TSLP
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.655718281614833,-1.5262885330081568,0.046875,0.2462466441798031,0.999,4/10,3.99%,SLCO2A1;SLCO1C1;SLCO2B1;SLC22A6
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.6369034114094898,-1.520668655793922,0.037383177570093455,0.2497166755931344,0.999,8/11,27.35%,SGMS1;SGMS2;PTDSS1;SAMD8;PIGO;GNPTAB;PIGN;AASDHPPT
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.5645722801180112,-1.5194562566873704,0.035443037974683546,0.2403335569212741,0.999,7/16,21.77%,ANO1;ANO4;TTYH2;ANO3;ANO2;ANO6;NMUR2
prerank,intracellular chloride channel activity (GO:0061778),-0.5645722801180112,-1.5194562566873704,0.035443037974683546,0.2403335569212741,0.999,7/16,21.77%,ANO1;ANO4;TTYH2;ANO3;ANO2;ANO6;NMUR2
prerank,nuclear export signal receptor activity (GO:0005049),0.7003861469740722,1.512037452868511,0.06440071556350627,0.44092271763508967,1.0,5/11,14.43%,RANBP17;NUP42;XPO7;CSE1L;NUP214
prerank,transcription coactivator binding (GO:0001223),0.6270778623197322,1.5117589286800763,0.049766718506998445,0.43142529206864266,1.0,4/20,3.07%,RORA;SMAD3;AR;THRB
prerank,monocarboxylic acid binding (GO:0033293),0.6500417607688452,1.5103037686562286,0.048465266558966075,0.42572697493471084,1.0,4/18,15.03%,CYP26B1;NR2F2;NAPEPLD;RXRA
prerank,insulin-like growth factor binding (GO:0005520),0.6490889061224446,1.5040575842451918,0.07079646017699115,0.43509399220656875,1.0,8/15,12.56%,IGFBP2;IGFBP4;IGFBP5;IGF2R;ITGB3;ITGAV;IGFBP3;INSR
prerank,amino acid:sodium symporter activity (GO:0005283),0.7002786435736151,1.4987121709108502,0.06228373702422145,0.44144568889819324,1.0,2/11,3.80%,SLC1A3;SLC6A13
prerank,ion channel activity (GO:0005216),-0.38722958662642554,-1.4952051292461217,0.01990049751243781,0.28069675901299773,1.0,18/80,9.66%,TRPM3;PIEZO2;GRID2;GRIA4;PIEZO1;GRIK1;GRIK2;GRIN2A;ABCC9;MCUB;GABRB1;TRPC1;UNC80;GRIN2B;GRIN3A;TRPM7;GRIA2;GRID1
prerank,endopeptidase activity (GO:0004175),0.43447035745529367,1.4947882012248723,0.0010638297872340426,0.4436677354001075,1.0,47/257,14.57%,ADAMTS6;ADAMTS12;ADAMTSL3;TRABD2B;THSD4;ADAMTS10;ADAMTS5;ADAM33;ADAMTS2;ADAMTSL2;MMP2;MMP19;USP11;RHBDL3;SFRP1;CTSH;MMP11;CTSF;USP47;USP20;MMEL1;ADAMTS9;SPRTN;PRSS48;USP35;USP24;USP48;PMPCB;EEF1AKMT4-ECE2;ECE2;APEH;MASP1;CAPN7;CLPP;CASP7;ADAMTSL4;F2;USP30;USP9Y;CTSZ;USP10;USP9X;CTSL;USP38;JMJD7;HPN;THOP1
prerank,inward rectifier potassium channel activity (GO:0005242),-0.5002350408660565,-1.4853657789382466,0.03283582089552239,0.29284474120985443,1.0,12/24,26.86%,KCNJ2;KCNJ3;ABCC9;KCNN2;KCNJ15;KCNJ10;KCNJ8;KCNJ6;ABCC8;KCNJ13;KCNJ16;KCNN1
prerank,calcium-release channel activity (GO:0015278),0.6392085250859356,1.4818774525999399,0.056105610561056105,0.4765310103200082,1.0,3/17,4.72%,ITPR1;TRPA1;RASA3
prerank,nucleotidase activity (GO:0008252),-0.5623962081885009,-1.4790622313400257,0.05489260143198091,0.2992493737298763,1.0,6/15,22.12%,NT5E;NT5C2;NT5C1A;NT5C;ACP3;BPNT2
prerank,protein kinase C binding (GO:0005080),0.5370345358069682,1.4760978858745124,0.05153203342618384,0.4850488822450178,1.0,9/43,9.62%,NELL1;PDLIM5;PRKCSH;GRK5;DACT1;TOP2B;PARD6G;PARD6B;ITGAV
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6455463616045689,1.474313139254447,0.0706896551724138,0.4810238011570358,1.0,8/15,20.55%,SETD1A;WDR82;SETD4;KMT2A;WDR5;SETD1B;CXXC1;RBBP5
prerank,organic cation transmembrane transporter activity (GO:0015101),0.6493594450996233,1.4733595845491545,0.07109004739336493,0.47480234120130493,1.0,3/16,7.63%,SLC44A1;SLC22A2;SLC22A4
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.6503996824812173,1.4724768916238267,0.07119741100323625,0.4683590450887007,1.0,2/15,1.08%,SLC1A3;SLC1A5
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.44221113570699555,-1.4722601799791226,0.03728813559322034,0.3060537312033792,1.0,14/37,22.19%,WARS1;WARS2;LARS1;TARS3;YARS1;YARS2;QARS1;TARS2;KARS1;FARS2;NARS2;MARS2;AARS2;TARS1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.5952599134213983,-1.4706546820706465,0.06265060240963856,0.3025300589706523,1.0,9/13,23.06%,GABRG3;GABRA2;GLRA1;GABRG2;GLRA2;GABRA3;GABRA4;GABRG1;GLRA3
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.6808226625655057,1.4700518461573775,0.09507042253521127,0.46676728088645186,1.0,3/11,15.80%,SLC25A24;SLC35B3;LRRC8A
prerank,actin binding (GO:0003779),0.43993369010784444,1.4673401753976476,0.013407821229050279,0.4661837770279456,1.0,31/170,10.13%,PHACTR1;PLEKHH2;MTSS1;PDLIM5;MICAL3;NCALD;CALD1;GSN;SYNE2;DAG1;TLN2;TPM1;PDLIM2;PARVA;SHROOM2;MACF1;VASH2;MYH10;PHACTR2;SYNPO2;IQGAP2;LIMA1;SMTN;LRRK2;VCL;MYL4;CAPZB;ACTN4;PRKN;SYNPO2L;TNNT3
prerank,"DNA binding, bending (GO:0008301)",-0.562276931718433,-1.4664379791271953,0.07672634271099744,0.3046909133309825,1.0,6/14,20.17%,LEF1;FOXD1;HHEX;TOP2A;HMGB2;HMGA2
prerank,insulin-like growth factor I binding (GO:0031994),0.6535386599282296,1.4650253006021383,0.08514492753623189,0.4649450592407798,1.0,7/13,12.56%,IGFBP2;IGFBP4;IGFBP5;ITGB3;ITGAV;IGFBP3;INSR
prerank,endopeptidase regulator activity (GO:0061135),0.5309939062694358,1.4638205615883584,0.05517241379310345,0.46009652975032156,1.0,12/40,15.32%,AHSG;RECK;FETUB;CAST;SERPIND1;TFPI;CST3;RENBP;APH1B;ITIH2;ADRM1;NLRC4
prerank,neuropeptide receptor activity (GO:0008188),-0.46946963199538966,-1.4600355008417645,0.045714285714285714,0.3118207475734839,1.0,18/29,40.37%,SORCS2;HCRTR2;NPY1R;SORCS1;GPR37;NPSR1;SORCS3;NPY5R;NMUR2;TACR1;SSTR2;GPR143;NPY2R;SSTR1;NMUR1;NTSR1;NPFFR1;GAL
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.6508277625428116,1.455938873288798,0.07692307692307693,0.47539233938197667,1.0,5/14,7.13%,COL4A3;TIMP3;RECK;FETUB;TIMP2
prerank,carboxypeptidase activity (GO:0004180),0.5490007627197252,1.4535635279400363,0.04881656804733728,0.47431374466416737,1.0,9/35,12.71%,CPXM2;AEBP1;VASH2;CPXM1;AGBL2;NAALADL1;PEPD;CPA2;CTSZ
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.5139160766023418,1.4517375223769684,0.0428380187416332,0.4722483530438686,1.0,8/53,6.39%,SLC7A11;SLC1A3;SLC7A2;SLC1A5;SLC6A9;SLC22A2;SLC7A13;SLC38A6
prerank,leak channel activity (GO:0022840),0.6156290885032524,1.4481279432209726,0.0718954248366013,0.47500738481681665,1.0,4/18,7.00%,KCNK2;NALCN;KCNK7;PANX1
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.5759893282665275,-1.4453851118585492,0.05,0.3353066703379913,1.0,8/13,13.99%,KCNQ1;PRKAR1A;GSK3A;PRKAR2B;PRKAR1B;CSK;PRKAR2A;RYR2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.43184323403207725,1.4440919830360213,0.014192139737991267,0.4788622770596,1.0,42/188,15.07%,TCF7L2;ZBTB20;TBL1XR1;PBX1;SMAD3;AR;SOX5;RUNX1;ARID5B;NKX2-1;ARID4A;PRDM5;YAP1;IRF1;CREB3L2;KLF15;BCOR;TCF7;CEBPA;NFE2L2;RNF10;NR1D1;FOXC2;NCOR1;NONO;MZF1;GLIS2;FOXA1;TFAM;CEBPB;REST;PER3;GLI1;ZNF513;HDAC4;TAF9;ETS1;TCF12;GATA6;NR1H3;RXRA;FOXK2
prerank,nucleotide diphosphatase activity (GO:0004551),0.633729310351423,1.4429431097513297,0.0766721044045677,0.47462199502885816,1.0,3/14,6.81%,CILP;ENPP1;NUDT13
prerank,growth factor receptor binding (GO:0070851),0.46153619030842397,1.4419164808353935,0.046341463414634146,0.4702090125163834,1.0,21/95,13.94%,ESM1;PDGFD;AREG;TGFA;IL6R;EPGN;KL;PDGFRA;PDGFRB;FRS2;PIBF1;SRC;IL12B;TSLP;ITGB3;FGF2;TRIP6;HBEGF;EGF;GLMN;ARF4
prerank,phospholipase binding (GO:0043274),0.6596717383234139,1.4416035755040602,0.08471760797342193,0.46360107780660453,1.0,4/13,9.32%,PDPK1;ARHGAP6;SRC;PRKN
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5332639184227972,1.4306013717477162,0.08309859154929577,0.4893223987500218,1.0,7/38,6.32%,SERPINE1;SERPING1;SERPIND1;WFDC3;TFPI;SERPINF1;SERPINH1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.4488815020852701,-1.4302803518918716,0.05448717948717949,0.3598246765968939,1.0,16/31,28.98%,SLC12A2;SLC12A7;KCNK5;ABCC9;SLC12A6;KCNK10;KCNA2;SLC12A5;SLC12A8;HCN1;TMEM38B;KCNC4;ABCC8;KCNK4;SLC12A9;AQP1
prerank,cadherin binding (GO:0045296),-0.306703217322481,-1.429828920318791,0.0,0.3540512071860985,1.0,88/315,15.10%,PKP4;PTPRB;DOCK9;COBLL1;MRTFB;STXBP6;MPP7;FNBP1L;PTPRJ;CTNND2;ESYT2;CDH2;BAIAP2L1;ITGA6;NOTCH3;PROM1;F11R;CDH1;ANK3;KDR;BSG;TJP2;EPN2;CTNNA3;CEMIP2;TJP1;STK38;HSPA8;IQGAP1;RPL34;CBL;TRPC4;SPTBN1;CDH12;CDH6;RDX;PAICS;UBAP2;EEF2;CDH8;DIAPH3;LRRFIP1;TES;PTPRT;TMOD3;CDH9;FMNL2;HSP90AB1;TAGLN2;CLIC1;HNRNPK;EHD4;EPS8L2;CDH13;ANLN;WASF2;SNX1;PACSIN2;PFKP;LASP1;TRIM25;PCBP1;CLINT1;ABCF3;ALDOA;JUP;CDH10;SH3GLB2;SCRIB;RANGAP1;RPL6;RPL29;BZW2;GLOD4;CCT8;RPL7A;GAPVD1;PAK2;SLC3A2;PPME1;RPL14;PLEC;RUVBL1;EMD;NUMB;GIPC1;MB21D2;PDLIM1
prerank,transforming growth factor beta receptor binding (GO:0005160),0.5921179497043795,1.4197709090704875,0.10906040268456375,0.5139570945270427,1.0,4/18,5.69%,TGFBR3;SMAD3;TGFBR1;ENG
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.6096606245158382,-1.4179802855514303,0.09615384615384616,0.371527857450622,1.0,6/10,20.74%,GABRG3;GABRA2;GABRG2;GABRA3;GABRA4;GABRG1
prerank,rRNA binding (GO:0019843),-0.4217910857143843,-1.4119878389995009,0.051194539249146756,0.37811348147962726,1.0,16/42,21.54%,RPS14;RPS13;RPS3;RPL11;RPS9;CAVIN1;RPS5;MRPS18A;PPAN;RPL5;FASTKD2;RPLP0;MRPS7;RPL23;RRS1;RPF2
prerank,metalloexopeptidase activity (GO:0008235),0.49807030483004544,1.4103142817396295,0.058663028649386086,0.5361286095899065,1.0,8/51,8.29%,CPXM2;CPQ;AEBP1;VASH2;CPXM1;AGBL2;DPEP1;PEPD
prerank,poly-purine tract binding (GO:0070717),0.5478059724730318,1.4099661910085772,0.09647779479326186,0.5291767792637796,1.0,6/27,10.99%,RBMS1;ATXN1;RBMS3;RBMS2;RBPMS;DDX3X
prerank,actinin binding (GO:0042805),0.5780212510698011,1.4083553347917745,0.08156606851549755,0.5264470687264805,1.0,6/21,9.66%,PDLIM5;DAG1;SYNPO2;CSRP2;CACNA1C;CSRP3
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.6388249010843648,1.4048366821610476,0.136986301369863,0.529186068590589,1.0,3/12,15.80%,SLC25A24;SLC35B3;LRRC8A
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.5571893859869101,-1.402344332025834,0.0948905109489051,0.3916524894531366,1.0,4/12,16.69%,ENTPD1;ENTPD2;ENTPD6;ENTPD3
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.47805530291213627,-1.4017596516726387,0.08539944903581267,0.38582844527854365,1.0,12/21,15.16%,PDE5A;PDE4D;PDE3B;PDE4B;PDE8A;PDE2A;PDE1C;PDE8B;PDE9A;PDE7A;PDE4C;PDE6A
prerank,nuclease activity (GO:0004518),0.4928092033370387,1.4014261197814704,0.06702412868632708,0.5321209255147079,1.0,10/52,11.57%,ENPP1;REXO5;SND1;OGG1;REXO4;RNASE12;RNASEL;PARN;DNASE1L1;RNASE7
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.3997822525009051,-1.4000119690447188,0.03435114503816794,0.3831308170517206,1.0,10/48,7.91%,TRPM3;PIEZO2;SLC12A2;SLC12A7;PIEZO1;ABCC9;TRPC1;UNC80;SLC12A6;TRPM7
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.4495672914569594,-1.3983058902459893,0.06567164179104477,0.38030645449210293,1.0,10/27,15.86%,SLC26A7;SLC26A2;ANO1;SLC22A8;SLC22A6;SLC39A8;SLC25A30;SLC26A6;SLC25A11;XPR1
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.44459630316132365,-1.3980289952865734,0.06375838926174497,0.3745726348638168,1.0,9/32,22.20%,KCNB2;KCNQ5;KCNQ1;KCNC2;KCNQ3;KCNA2;KCNS3;KCNC1;KCNC4
prerank,store-operated calcium channel activity (GO:0015279),-0.6012087165296246,-1.3968987515536686,0.08735632183908046,0.37096441109657874,1.0,5/10,13.40%,TRPC3;TRPC4;TRPC5;TRPC1;TRPC6
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.45868890311148613,-1.3903639733250033,0.06406685236768803,0.37960904833491366,1.0,12/26,28.28%,PPP1R1A;PPP1R14C;PTN;PPP1R14B;MGAT5;PPP1R14A;PPME1;LMTK2;CABIN1;PPP1R11;PPP1R1B;SET
prerank,hormone activity (GO:0005179),0.4902129484177492,1.388459449857412,0.08322147651006712,0.5638516203903347,1.0,3/54,8.44%,IGF1;VIP;NPFF
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.4640395250465066,-1.3883770485536355,0.08797653958944282,0.377521440645279,1.0,12/23,15.16%,PDE5A;PDE4D;PDE3B;PDE4B;PDE8A;PDE2A;PDE1C;PDE8B;PDE9A;PDE7A;PDE4C;PDE6A
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.47643051325187596,1.386325699021959,0.07297297297297298,0.5628732028595299,1.0,16/60,17.46%,LRRK1;PPM1H;PPM1E;CTDSPL;PPP3CA;LRRK2;MTMR3;RPAP2;CTDSP2;PPP1R3C;PHLPP2;PTEN;PPP1R3D;PPM1G;UBLCP1;DUSP4
prerank,LRR domain binding (GO:0030275),0.6156957291289569,1.3854634846803373,0.11186440677966102,0.5576784536877517,1.0,2/14,7.36%,ROBO1;PMF1
prerank,cell adhesion mediator activity (GO:0098631),-0.46521709253368454,-1.3853866020225398,0.09855072463768116,0.3784063726165072,1.0,9/24,10.50%,ESAM;BSG;CNTN4;NTNG1;SIRPA;CNTN6;LRRC4C;ROBO4;EMB
prerank,growth factor activity (GO:0008083),0.4558769557516991,1.3852813674182276,0.06483790523690773,0.5505620729066325,1.0,16/74,14.21%,IGF2;GDNF;AREG;TGFA;EPGN;CSF1;ENDOU;NTF3;IL12B;CSPG5;FGF2;HBEGF;F2;EGF;NRTN;MDK
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.458467661857117,1.380591345416889,0.07006369426751592,0.5583888976116955,1.0,16/72,12.45%,FRMPD4;SVIL;ACTN2;GSN;MARK1;TULP1;PLCD1;MYO1B;ADAP2;TULP3;SNX18;PICALM;COMMD1;GSDME;SNX21;SYTL2
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.41794598472477623,-1.3780486147736377,0.08417508417508418,0.3879958273983193,1.0,18/35,28.13%,TAF1B;RRN3;TAF1;BAZ2A;TBP;FOXP1;TAF1C;UBTF;H3-3A;AGO1;NPM1;GTF2B;TAF4;SMARCA4;RUVBL2;PIH1D1;FOS;TBPL1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.4482829967884308,-1.3749270907662492,0.0963855421686747,0.38897893368878433,1.0,8/26,9.96%,SLC6A6;ABCG2;SLC16A6;SLC5A6;SLC16A9;SLC16A1;SLC16A4;SLC26A6
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.5964481829016026,1.3749036023478411,0.11700468018720749,0.560830531273301,1.0,1/16,0.20%,ATP6V0A4
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.5964481829016026,1.3749036023478411,0.11700468018720749,0.560830531273301,1.0,1/16,0.20%,ATP6V0A4
prerank,lipoprotein particle receptor binding (GO:0070325),0.5377251720068519,1.372223244584894,0.10232558139534884,0.5620981078666744,1.0,5/27,9.04%,LRP1;HSPG2;APOE;APOA1;PICALM
prerank,copper ion binding (GO:0005507),0.49720722938540707,1.3702906079287214,0.09251700680272108,0.5610319599219055,1.0,4/42,4.99%,PAM;MOXD1;MT3;HEPH
prerank,fatty acid synthase activity (GO:0004312),-0.576156471603759,-1.3677746125250454,0.12471131639722864,0.3982640661906959,1.0,2/10,5.34%,ELOVL7;ELOVL5
prerank,CoA hydrolase activity (GO:0016289),0.5890566032794897,1.3676161938462188,0.1426086956521739,0.5622310649674639,1.0,4/16,5.14%,ACOT11;ACOT6;ACOT2;NUDT7
prerank,heme binding (GO:0020037),0.4614109448160367,1.364139626646083,0.07569721115537849,0.5658371331386748,1.0,16/65,13.13%,PTGIS;CYP26B1;CYB5B;TDO2;FLVCR2;CYP1B1;SRC;HEBP1;CYP27A1;NR1D1;CYB5A;SDHC;PGRMC2;SLC48A1;CYB5R4;NOX4
prerank,cytokine receptor activity (GO:0004896),0.4407978122335254,1.362455432241947,0.0779537149817296,0.5639286787160539,1.0,14/83,10.11%,GHR;IL31RA;IL6R;LEPR;GFRA2;OSMR;XCR1;ACKR2;CCR9;IL12B;IL13RA1;IL15RA;CNTFR;GFRA4
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6314562672833426,1.3622074622121056,0.14310344827586208,0.557849916439716,1.0,3/12,4.23%,SULF2;SULF1;GALNS
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.6122919807847529,1.3609490165611176,0.1500815660685155,0.5547658040641633,1.0,4/14,8.24%,PYCR1;MTHFR;PYCR3;ALDH1L1
prerank,O-methyltransferase activity (GO:0008171),0.6494763673924964,1.3607924938905767,0.16483516483516483,0.5487228784851461,1.0,5/10,15.39%,COMT;FTSJ3;LRTOMT;BCDIN3D;CMTR2
prerank,pseudouridine synthase activity (GO:0009982),0.6195609729060307,1.3586841612291474,0.12666666666666668,0.5480159063422108,1.0,6/13,18.89%,PUS3;RPUSD4;RPUSD2;TRUB2;PUSL1;TRUB1
prerank,GDP binding (GO:0019003),-0.35881132004966576,-1.3523086794530692,0.0390625,0.426395677015213,1.0,16/63,14.30%,RAP1A;RIT2;RAB27A;KRAS;RAB21;RAP1B;RAB5B;RAB12;RAB8B;RAB27B;ARL3;RASL12;DIRAS2;RALB;RIT1;RAB4A
prerank,P-type ion transporter activity (GO:0015662),-0.5580848056314729,-1.3502874171569876,0.10440835266821345,0.42506656770052365,1.0,5/12,11.81%,ATP2C1;ATP2A3;ATP2B2;ATP2B4;ATP7A
prerank,protein heterodimerization activity (GO:0046982),0.4072653318794286,1.3430563770115185,0.0352035203520352,0.5884633211996084,1.0,39/178,13.51%,TCF4;BMP6;ADRA1B;ARNT2;ATP1A2;BCL2;TPM1;ITGA3;IRAK2;ZHX2;NEUROD1;MIGA2;EPAS1;ADRA2C;BDKRB2;BUD23;IL12B;AGTR1;ATP1B2;TLR6;TOP2B;IRAK3;ZBTB1;KATNB1;KRT10;ARNT;MICU2;EXT1;BHLHE41;ADRA2A;KATNA1;RRAGD;NR4A1;YWHAE;MTTP;TUBB2B;TPM2;TRMT112;P4HB
prerank,peptidase inhibitor activity (GO:0030414),0.5100892188293508,1.3416700393029521,0.11634756995581738,0.5858879509889283,1.0,10/33,12.58%,AHSG;RECK;FETUB;CAST;SERPIND1;TFPI;CST3;TIMP2;RENBP;ITIH2
prerank,lipid phosphatase activity (GO:0042577),0.598069119960789,1.3394476771245938,0.15736040609137056,0.5864195897379806,1.0,3/14,3.03%,PLPP3;EPHX2;PLPP7
prerank,tRNA methyltransferase activity (GO:0008175),0.5752219054004425,1.3353559405467372,0.14403973509933773,0.5918227079856325,1.0,6/16,15.14%,TRMT44;BCDIN3D;TRMT9B;TRMT13;THUMPD3;THUMPD2
prerank,fibroblast growth factor binding (GO:0017134),0.5438721100093413,1.3314979171302057,0.14748784440842788,0.5972777702052312,1.0,9/21,15.81%,FGFR1;KL;FGFR2;FGFR4;GLG1;ITGB3;ITGAV;CXCL13;FIBP
prerank,metal ion:proton antiporter activity (GO:0051139),-0.5181574810723871,-1.330338624148668,0.13551401869158877,0.4657367070184583,1.0,5/13,8.53%,SLC9A2;SLC9B2;SLC9A6;LETM1;SLC9A7
prerank,pyridoxal phosphate binding (GO:0030170),0.5525853041217237,1.3292170019031189,0.15041322314049588,0.5982741026317845,1.0,5/20,15.79%,ABAT;ACCS;PDXK;PYGM;PYGB
prerank,ligand-gated calcium channel activity (GO:0099604),0.5564451977511866,1.3275545667696698,0.14123376623376624,0.5965766407364825,1.0,4/19,9.41%,ITPR1;TRPA1;RASA3;TRPM4
prerank,protein kinase activator activity (GO:0030295),0.4479173844372631,1.326429774685747,0.11081081081081082,0.5935933258651261,1.0,19/60,14.25%,IGF2;PRKAG2;GAS6;MT3;GPRC5D;PARP16;MAP2K1;ALS2;STK4;SPRY2;STK11;FGF13;DDX3X;RGCC;STRADA;DUSP19;WNK1;MARK2;GPRC5A
prerank,poly(A) binding (GO:0008143),0.5507350221885209,1.3252682916164624,0.15384615384615385,0.5908074702116154,1.0,5/21,10.99%,RBMS1;RBMS3;RBMS2;RBPMS;DDX3X
prerank,cyclic nucleotide binding (GO:0030551),-0.46023530575058447,-1.3184168816746533,0.12895377128953772,0.4880373311667347,1.0,4/21,4.96%,PDE5A;PDE4D;PDE4B;PDE2A
prerank,DNA-binding transcription factor binding (GO:0140297),0.3986901050517102,1.3148065379766711,0.04540420819490587,0.6160526265097724,1.0,28/189,10.63%,TCF7L2;LDB2;FHL2;RUNX1T1;SMAD3;AR;BCL2;DACT1;PRRX1;PRDM5;ASCL1;YAP1;TLE1;CRTC3;NEUROD1;TBX3;SKI;SIK1;NFE2L2;MTA2;RERE;RBPJ;NCOR1;MTA3;IFI27;CXXC5;RBL2;NEK6
prerank,kinase activator activity (GO:0019209),0.4993419039408038,1.308584229946235,0.15813253012048192,0.6280983049518384,1.0,12/30,16.25%,PRKAG2;MT3;GPRC5D;STK11;FGF13;RGCC;STRADA;DUSP19;WNK1;MARK2;GPRC5A;AGAP2
prerank,mechanosensitive ion channel activity (GO:0008381),-0.5339750737853889,-1.307988511523027,0.17592592592592593,0.5074430371033248,1.0,2/12,1.56%,PIEZO2;PIEZO1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.6150896213042167,1.3076135861581935,0.18772563176895307,0.6246447236454639,1.0,5/10,18.26%,CASP12;CFLAR;CASP7;CASP9;CASP1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.5021234639113684,1.3072313261662163,0.15671641791044777,0.6195442368768899,1.0,16/34,21.72%,IGF2;PARP16;MAP2K1;CKS1B;ALS2;STK4;SPRY2;CCNK;DDX3X;STRADA;CCNT2;RICTOR;ETAA1;MLST8;TAOK1;CCNT1
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.4549416298310753,-1.3058485318843576,0.14066496163682865,0.5060223240428073,1.0,5/20,10.53%,DLG2;TJP2;MAGI3;AK6;MPP1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.5133362973417558,1.3031892174936228,0.15256797583081572,0.6252818993039201,1.0,11/27,22.64%,POLR2D;POLR3A;POLR2C;POLRMT;PRIMPOL;POLR2L;POLR1F;MED21;POLR1H;POLR1D;POLR1C
prerank,calcium channel inhibitor activity (GO:0019855),0.6209344432035875,1.3028388430963533,0.18890814558058924,0.6202308702372827,1.0,1/11,0.27%,ITPR1
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.524880109318153,-1.301103881949646,0.1650943396226415,0.5106176941724544,1.0,5/12,8.53%,SLC9A2;SLC9B2;SLC9A6;LETM1;SLC9A7
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.4870514865108699,-1.3007206826633464,0.1491442542787286,0.5044959959615428,1.0,9/17,17.76%,PITPNC1;ATP8B1;PLTP;PITPNA;ABCG1;PCTP;PITPNB;ATP10A;ABCB4
prerank,bHLH transcription factor binding (GO:0043425),0.5488468566912305,1.2991410698886843,0.1642512077294686,0.6251774492529344,1.0,3/19,3.20%,FHL2;SMAD3;ASCL1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.6037214803737265,1.297999508354239,0.19718309859154928,0.6223545548209767,1.0,5/11,18.26%,CASP12;CFLAR;CASP7;CASP9;CASP1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.6060107973918691,1.2964413912785393,0.19081272084805653,0.6213870176791161,1.0,2/11,9.92%,AKR1B1;AKR1B10
prerank,transcription cis-regulatory region binding (GO:0000976),0.37271010401649385,1.2962988162749745,0.023638232271325797,0.6157997235285664,1.0,78/406,15.85%,TCF7L2;ZBTB20;RORA;TBL1XR1;TRPS1;TEAD1;PBX1;SMAD3;AR;SOX5;RUNX1;GLI3;AEBP1;ARID5B;NKX2-1;ARID4A;PRDM5;ASCL1;YAP1;MLXIP;MXI1;MSC;IRF1;RFX5;CREB3L2;KLF15;ETV6;EPAS1;CUX2;ZBTB8B;BCOR;TCF7;NR5A1;CEBPA;NFE2L2;RNF10;SREBF1;DR1;NR1D1;OSR1;BBX;FOXC2;NCOR1;ZBTB4;NONO;MZF1;ACTN4;GLIS2;ARNT;CREB3;FOXA1;TFAM;RBL2;ZBTB8A;ZNF177;CEBPB;POLRMT;NFE2;REST;PER3;GLI1;STAT6;ZNF513;HOXC8;HDAC4;TAF9;ETS1;TWIST2;TCF12;GATA6;NR1H3;ZNF25;RXRA;FOXK2;PSPC1;MTF1;TFCP2;ZBTB17
prerank,pre-mRNA binding (GO:0036002),0.5006089501945167,1.2943971112635446,0.15304606240713226,0.6153605168904808,1.0,11/28,23.08%,CELF2;U2AF1L4;RBM22;HNRNPA1;ERI1;RNPC3;RBM41;HNRNPU;RBM4;ZRSR2;PRPF8
prerank,calcium channel activity (GO:0005262),0.4220701872031995,1.2943138833721386,0.11518987341772152,0.6098656655167236,1.0,13/84,10.48%,CACNA2D3;SLC24A3;SLC24A1;MCU;CACNB1;SLC24A5;CACNA1C;PANX1;CUL5;ORAI2;TRPM4;ITGAV;ANXA6
prerank,active ion transmembrane transporter activity (GO:0022853),-0.39958174016580533,-1.2942648337012839,0.13953488372093023,0.5121162771318741,1.0,18/37,25.88%,SLCO2A1;SLCO1C1;SLC22A8;SLCO2B1;SLC22A6;COX4I1;UQCRH;COX6A1;COX5B;SLCO4A1;COX5A;SLCO1B1;UQCR10;COX8A;UQCR11;UQCRQ;UQCRC1;UQCRFS1
prerank,protein tyrosine kinase activity (GO:0004713),0.4068466773610893,1.2935905911170476,0.10628019323671498,0.6062746176987686,1.0,22/108,10.44%,EPHA3;EPHA7;DDR2;LYN;FGFR1;EPHA4;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;AXL;MUSK;ROR1;SRC;NTRK3;EGFR;EPHB2;RYK;BAZ1B;TTBK1
prerank,neuropeptide binding (GO:0042923),-0.469021486152775,-1.292452720268558,0.1447721179624665,0.5097816068422525,1.0,11/18,44.51%,SORL1;GPR37;NMUR2;SSTR2;MC4R;SSTR1;OPRD1;NMUR1;GPR149;OPRM1;SSTR3
prerank,sulfotransferase activity (GO:0008146),0.488356804087223,1.2917303835891427,0.15532544378698224,0.6058175278477602,1.0,5/33,4.60%,UST;GAL3ST2;GAL3ST3;TPST1;HS6ST1
prerank,amino acid transmembrane transporter activity (GO:0015171),0.4674441390835614,1.2914754476748735,0.12044817927170869,0.6009496955740479,1.0,11/47,9.72%,SLC7A11;SLC7A2;SLC1A5;SLC6A13;SLC22A2;SLC7A13;PDPN;SLC38A6;SLC22A4;SLC38A9;SLC43A1
prerank,potassium channel activity (GO:0005267),-0.3333688414900491,-1.289308213929525,0.06179775280898876,0.5116326274858664,1.0,18/89,9.58%,KCNB2;KCNK5;KCNQ5;KCND2;GRIK1;GRIK2;KCNMA1;KCND3;ABCC9;KCNK13;KCNN2;KCNQ1;KCNH7;KCNH5;KCNC2;KCNMB2;KCNK10;KCNQ3
prerank,tau-protein kinase activity (GO:0050321),0.5341131345651683,1.285089334046322,0.20516962843295639,0.6136865394205636,1.0,6/20,15.27%,ROCK2;MARK1;BRSK1;TTBK1;MARK2;DYRK1A
prerank,FAD binding (GO:0071949),0.5187884210322523,1.283133615504007,0.16825396825396827,0.613607897691447,1.0,5/24,8.94%,MICAL3;MTHFR;DDO;SQOR;AIFM1
prerank,voltage-gated calcium channel activity (GO:0005245),0.47886506153479,1.2814662612785819,0.14896755162241887,0.6129646303313138,1.0,5/37,11.33%,CACNA2D3;CACNB1;CACNA1C;ITGAV;CACNA1G
prerank,steroid hydroxylase activity (GO:0008395),0.5578773342179448,1.2812432273942471,0.19382504288164665,0.6082129203436358,1.0,5/16,18.28%,CYP7B1;CYP1B1;CYP27A1;CYP2R1;CYP1A1
prerank,glutathione transferase activity (GO:0004364),0.5207828735788093,1.2810138384553786,0.1633281972265023,0.6037027555725462,1.0,6/23,13.89%,PTGES;GSTM4;GSTM2;MGST1;GSTT1;GSTK1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5855283369290251,1.280917999776706,0.20071047957371227,0.5987268499719366,1.0,2/12,5.04%,PIK3R1;FRS2
prerank,FMN binding (GO:0010181),-0.5277985412757007,-1.2807195362399524,0.19480519480519481,0.5260723593692409,1.0,8/11,37.61%,NOS3;NOS1;MTRR;NOS2;PPCDC;NDOR1;HAO1;DUS2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.41159171858526516,1.2804239302607214,0.11070110701107011,0.5948746689247552,1.0,22/91,15.77%,FRMPD4;SVIL;ACTN2;GSN;MARK1;TULP1;PLCD1;MYO1B;SH3PXD2B;ADAP2;TULP3;SNX18;PICALM;COMMD1;GSDME;SNX21;SYTL2;WIPI1;PIRT;PARD3;GSDMD;LAPTM4B
prerank,histone demethylase activity (GO:0032452),0.49074574096996737,1.2790824633647289,0.1633281972265023,0.5933488340564391,1.0,13/27,23.23%,FBXL19;KDM5B;PHF2;KDM5C;KDM7A;PHF8;RIOX1;KDM3B;KDM4A;KDM5A;KDM4C;JARID2;KDM3A
prerank,receptor tyrosine kinase binding (GO:0030971),0.44207828407992444,1.2785520800547137,0.1584553928095872,0.5896526585721953,1.0,7/56,5.04%,ANGPT1;CBLB;PIK3R1;DOCK4;GAS6;ANGPT2;FRS2
prerank,mRNA 3'-UTR binding (GO:0003730),0.42088742951303487,1.2782304043999704,0.1218274111675127,0.585683057547263,1.0,13/79,12.76%,CELF2;RBMS1;RBMS3;CSDC2;IGF2BP2;CPEB1;ZFP36L1;CPEB3;RBMS2;PARN;SERBP1;LARP1;UTP23
prerank,calcium activated cation channel activity (GO:0005227),-0.4647460530508357,-1.2772430042934917,0.15609756097560976,0.527966028774007,1.0,7/17,16.55%,ANO1;KCNMA1;KCNN2;KCNMB2;TMEM63C;TMEM63B;ANO6
prerank,glycine binding (GO:0016594),-0.5393018600513635,-1.2741226041047524,0.16009280742459397,0.5284548907228516,1.0,4/11,7.48%,GLRA1;GLRA2;GRIN2B;GRIN3A
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.617403506983192,1.2716083596048078,0.21699819168173598,0.5989735058805413,1.0,3/10,11.22%,DSE;RENBP;GALM
prerank,ATPase binding (GO:0051117),0.42229050699523246,1.2700329254546634,0.1432225063938619,0.5983253891444242,1.0,17/71,13.84%,ATP6V0A4;AR;ABCA1;TMTC4;PPP3CA;ANK1;DERL1;SRC;ATP1B2;SLC2A13;EGFR;ATP6V1E1;CLPP;TOR1AIP1;SELENOS;PTPN3;TAF9
prerank,ligand-gated cation channel activity (GO:0099094),-0.330150638301004,-1.2687690816865194,0.07575757575757576,0.5357534414471288,1.0,12/75,8.47%,KCNJ2;GRIA4;PTK2B;GRIK1;GRIK2;GRIN2A;KCNJ3;P2RX7;KCNN2;GRIN2B;GRIN3A;GRIA2
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.5621378024480207,1.2660495163267578,0.2119205298013245,0.6042695230950844,1.0,2/14,7.28%,DHRS3;ADH1A
prerank,dynactin binding (GO:0034452),-0.5051260520470303,-1.2658487052984515,0.19220779220779222,0.5363199891187245,1.0,6/12,26.85%,BICD1;PAFAH1B1;BICDL1;BICD2;GSK3B;SPTBN5
prerank,kinase inhibitor activity (GO:0019210),0.484714369034091,1.2566124056332555,0.17941176470588235,0.6250761662814563,1.0,7/33,12.36%,RHOH;AHSG;PARVA;ITPRIP;DNAJC3;TAOK3;DUSP19
prerank,ubiquitin protein ligase activity (GO:0061630),0.37059933460402206,1.2535638013367802,0.07857911733046287,0.6288325918947681,1.0,60/228,18.74%,MYCBP2;RNF220;PDZRN3;HECW2;CBLB;SH3RF3;PELI2;SH3RF1;DCST1;MGRN1;UBR2;NEDD4;RFFL;SMURF2;BFAR;CDC42;ZNRF3;KCMF1;UBE4B;RNF10;TRIP12;DTX4;RNF185;RNF139;RNF145;UBR4;UBOX5;PRKN;ITCH;RNF181;ASB12;RNF6;RNF38;RNF152;RNFT1;RNF217;MUL1;RNF19A;RC3H2;AMFR;UBE2D1;ASB1;HACE1;HUWE1;RNF13;HLTF;RNF2;NHLRC3;UBR5;MSL2;UBR3;UBE3B;RNF138;UBE3A;RNF135;DTX3;RC3H1;RNF34;TRIM41;TRIM32
prerank,carboxylic acid binding (GO:0031406),-0.36940303096088906,-1.25349482725864,0.13190184049079753,0.5607653400728364,1.0,15/38,25.35%,GRM7;NOS3;GLRA1;GLRA2;NOS1;GRIN2B;GRIN3A;GLUD1;MAG;GCLC;RTN4R;GRIN1;GLRA3;EPDR1;SHMT1
prerank,MHC class II protein complex binding (GO:0023026),-0.5185807674424873,-1.2499610807583963,0.21497584541062803,0.5626901631444896,1.0,4/11,12.70%,HSPA8;ATP1B1;HSP90AB1;CD81
prerank,GTPase regulator activity (GO:0030695),0.36975921521116006,1.2457862079007307,0.0877005347593583,0.6458797684330211,1.0,36/212,9.81%,ALDH1A1;NRP1;ASAP1;RIN2;ERRFI1;RHOH;RABGAP1L;TBC1D4;SYDE2;DLC1;ARHGAP28;USP6NL;ARHGEF10L;ARHGAP18;NPRL3;ARHGAP29;ASAP3;RAPGEF2;IQGAP2;ARHGAP19;SMAP2;ARHGAP32;ARHGAP10;ACAP2;ARFGAP3;LRRK2;ADPRH;ARHGAP35;ALS2;ARHGAP9;ARRB1;ARL2;RUNDC3A;SYDE1;SEC23B;TBC1D2B
prerank,transcription coregulator binding (GO:0001221),0.42797968985726853,1.2417130505939828,0.17355371900826447,0.6521399826395542,1.0,11/50,12.01%,RORA;SMAD3;AR;THRB;CHD6;USP11;NR1D1;FAM89B;PHF1;NEK6;PER3
prerank,SH3 domain binding (GO:0017124),-0.3383327639777078,-1.240698735997619,0.1078838174273859,0.5797560596867741,1.0,14/62,10.26%,AFAP1L1;SHANK3;SGIP1;ELMO1;AFAP1L2;ENAH;ADAM12;ADAM15;CBL;ARHGAP27;PTPN12;WASF2;SHANK1;SKAP1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.488537376625249,1.2400818550901207,0.19672131147540983,0.6515780170552676,1.0,10/27,22.64%,POLR2D;POLR3A;POLR2C;POLRMT;POLR2L;POLR1F;MED21;POLR1H;POLR1D;POLR1C
prerank,magnesium ion binding (GO:0000287),0.3835710597861448,1.2391454056654179,0.13317757009345793,0.6494523260750116,1.0,42/135,22.17%,EYA2;ADCY2;MARK1;CIB4;EPHX2;MVK;MAP3K20;PDXK;LRRK2;ADPRH;SIK1;BRSK1;DXO;OXSR1;MAST2;STK4;IRAK3;CLYBL;IDH2;STK11;NEK6;TDP2;RAP2A;MARK2;PSPH;CERK;FOXK2;NLRC4;RP2;DYRK3;GNAI1;ENDOV;RHEB;FAN1;EXD2;OPA1;NUDT5;NUDT12;PGM1;PPA1;PAPOLA;PPA2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.5040500587134491,1.2387415663296921,0.21100917431192662,0.6454616243476347,1.0,4/22,6.70%,RBMS3;CPEB1;ZFP36L1;CPEB3
prerank,channel activity (GO:0015267),0.4499193135988073,1.238408828958753,0.20476858345021037,0.6413365517160557,1.0,8/41,13.14%,TRPA1;BCL2;PDPN;PANX1;AQP6;P2RX5;KCNK3;TMEM120B
prerank,lipase activity (GO:0016298),-0.36052219581225026,-1.2375128289016617,0.1262135922330097,0.5813779968967812,1.0,16/43,27.50%,MGLL;ABHD2;LIPE;PLA1A;PNPLA8;PNPLA3;PNPLA2;ABHD6;PITPNM3;DAGLB;LYPLA1;LIPH;LIPC;LIPA;FAAH;LPL
prerank,protein serine/threonine kinase activity (GO:0004674),0.3539139437649948,1.2348709675309348,0.07700205338809035,0.6463142110908637,1.0,71/335,16.01%,STK17B;DAPK2;PDPK1;NRK;ROCK2;CDK14;CAMK1D;CDK8;DAPK1;GRK3;GRK5;BMPR1A;DMPK;MARK1;MYLK;TGFBR1;IRAK2;MAPK4;ACVR1;CDK16;SBK3;PRKAA2;MAP3K20;CASK;NUAK1;ULK2;LRRK2;AKT3;SIK1;EIF2AK3;BRSK1;MAP2K1;ARAF;OXSR1;MAST2;STK4;IRAK3;EGFR;MAP3K8;MAP4K4;CCNK;CAMK2B;VRK3;STK11;TTBK1;NEK6;BRAF;TAOK3;IKBKE;TBK1;TLK1;WNK1;MAP3K13;RIPK2;MAP3K15;MAP4K5;ACVR1B;STK16;MARK2;MOK;PIK3R4;CDK12;RIOK3;CLK4;PLK2;CLK3;DYRK1A;PIKFYVE;DYRK1B;MAPKAPK2;TRIO
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.34904699511868087,1.2345990839931231,0.034170854271356785,0.6421210986591407,1.0,150/731,17.26%,TCF7L2;TCF4;ZBTB20;NFIA;RORA;ZFHX4;TEAD1;PBX1;SMAD3;ARNT2;PKNOX2;AR;ZKSCAN2;ZEB2;SOX5;MITF;GLIS3;NKX6-1;NR2F2;GLI2;RUNX1;PRRX1;SALL1;KCNIP3;ZIC1;SP7;IKZF2;MAF;GLI3;ZEB1;NKX2-1;THRB;PRDM5;FOXP2;NFIB;ASCL1;DNMT3A;JDP2;RUNX2;SIX5;MLXIP;RARB;ZIC4;NFIX;MXI1;MEOX2;IKZF4;MSC;IRF1;ZIC2;NEUROD4;RFX5;ZNF83;NEUROD1;CREB3L2;KLF15;RARG;TBX3;SP4;HLF;BCL6;SKI;TCF7;ATOH8;HES7;ZNF483;ZNF23;NR5A1;BATF;CEBPA;NFE2L2;ZNF697;SREBF1;ZBTB38;ZBTB24;MED8;NR1D1;RBPJ;TCF7L1;FOXC2;CHD2;HIVEP2;STAT5B;ZBTB4;HOXC5;ZBTB1;MZF1;SMAD1;GMEB1;GTF2IRD1;STAT2;GLIS2;NSD1;ARNT;CREB3L4;CREB3;FOXA1;ZKSCAN3;ZSCAN21;NR1D2;SP5;CEBPB;KLF9;BHLHE41;NFE2;NKX2-8;ZBTB37;ZFP30;REST;NR4A1;GLI1;STAT6;TEAD3;MYCN;NPAS2;EBF1;STAT4;ZNF182;HDAC4;HIVEP1;ETS1;ZNF148;ZNF383;ZNF219;TCF12;HOXD1;GATA6;NR1H3;HOXC4;RXRA;FOXK2;MYT1;MTF1;TFCP2;ZBTB17;ZNF585B;ZNF585A;MAFA;MXD4;EBF4;CREB5;PLAG1;ZNF423;FOXO6;SP1;ZFAT;MYBL1;IRF2;ZSCAN20;FOXJ3
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5700893185183938,1.23397387055546,0.2255772646536412,0.6390270216927089,1.0,7/12,24.06%,TENT5A;TENT5D;TENT4A;TENT4B;PAPOLG;PAPOLA;PAPOLB
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3638569238648911,1.2327653451916274,0.0962566844919786,0.6374745665572763,1.0,59/232,18.74%,MYCBP2;RNF220;PDZRN3;HECW2;CBLB;SH3RF3;PELI2;SH3RF1;DCST1;MGRN1;UBR2;NEDD4;RFFL;SMURF2;BFAR;CDC42;ZNRF3;KCMF1;RNF10;TRIP12;DTX4;RNF185;RNF139;RNF145;UBR4;PRKN;ITCH;RNF181;ASB12;RNF6;RNF38;RNF152;UFL1;RNFT1;RNF217;MUL1;RNF19A;RC3H2;AMFR;UBE2D1;ASB1;HACE1;HUWE1;RNF13;HLTF;RNF2;NHLRC3;UBR5;MSL2;UBR3;UBE3B;RNF138;UBE3A;RNF135;DTX3;RC3H1;RNF34;TRIM41;TRIM32
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.5909824923327228,1.2311507891772278,0.24955752212389382,0.6369392774642698,1.0,6/10,23.03%,KAT2B;HEXIM2;INCA1;CDKN2C;CDKN1B;HEXIM1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3481112400590697,1.2306450928257182,0.035211267605633804,0.6336439830398077,1.0,149/732,17.26%,TCF7L2;TCF4;ZBTB20;NFIA;RORA;ZFHX4;TEAD1;PBX1;SMAD3;ARNT2;PKNOX2;AR;ZKSCAN2;ZEB2;SOX5;MITF;GLIS3;NKX6-1;NR2F2;GLI2;RUNX1;PRRX1;SALL1;KCNIP3;ZIC1;SP7;IKZF2;MAF;GLI3;ZEB1;NKX2-1;THRB;PRDM5;FOXP2;NFIB;ASCL1;DNMT3A;JDP2;RUNX2;SIX5;MLXIP;RARB;ZIC4;NFIX;MXI1;MEOX2;IKZF4;MSC;IRF1;ZIC2;NEUROD4;RFX5;ZNF83;NEUROD1;KLF15;RARG;TBX3;SP4;HLF;BCL6;SKI;TCF7;ATOH8;HES7;ZNF483;ZNF23;NR5A1;BATF;CEBPA;NFE2L2;ZNF697;SREBF1;ZBTB38;ZBTB24;MED8;NR1D1;RBPJ;TCF7L1;FOXC2;CHD2;HIVEP2;STAT5B;ZBTB4;HOXC5;ZBTB1;MZF1;SMAD1;GMEB1;GTF2IRD1;STAT2;GLIS2;NSD1;ARNT;CREB3L4;CREB3;FOXA1;ZKSCAN3;ZSCAN21;NR1D2;SP5;CEBPB;KLF9;BHLHE41;NFE2;NKX2-8;ZBTB37;ZFP30;REST;NR4A1;GLI1;STAT6;TEAD3;MYCN;NPAS2;EBF1;STAT4;ZNF182;HDAC4;HIVEP1;ETS1;ZNF148;ZNF383;ZNF219;TCF12;HOXD1;GATA6;NR1H3;HOXC4;RXRA;FOXK2;MYT1;MTF1;TFCP2;ZBTB17;ZNF585B;ZNF585A;MAFA;MXD4;EBF4;CREB5;PLAG1;ZNF423;FOXO6;SP1;ZFAT;MYBL1;IRF2;ZSCAN20;FOXJ3
prerank,cGMP binding (GO:0030553),-0.5060147038025828,-1.2300716508276144,0.2210065645514223,0.5931361352215624,1.0,2/11,4.96%,PDE5A;PDE2A
prerank,pentosyltransferase activity (GO:0016763),0.46305281239776186,1.2283063359670794,0.19640179910044978,0.6351901344298281,1.0,12/36,19.43%,ART4;PARP11;LARGE1;LARGE2;PARP16;SIRT2;PARP14;TNKS2;UPP2;LACC1;SIRT5;PPAT
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.5859367568230429,1.2269908892143218,0.2333931777378815,0.634051778831292,1.0,5/10,21.12%,KDM7A;PHF8;RIOX1;KDM4A;KDM4C
prerank,MAP-kinase scaffold activity (GO:0005078),0.5767801003554921,1.2266649717783702,0.25380710659898476,0.6303451801508796,1.0,6/11,16.85%,KSR1;SH3RF1;MAP2K1;DUSP19;AKAP13;MAPK8IP3
prerank,disordered domain specific binding (GO:0097718),-0.4129609944152528,-1.2221917330320113,0.195906432748538,0.6074701659753284,1.0,4/23,10.38%,FN1;HSP90AB1;CALM1;CALM3
prerank,gated channel activity (GO:0022836),-0.48284445436975887,-1.221813482006107,0.21980676328502416,0.6017737087262798,1.0,2/14,1.56%,PIEZO2;PIEZO1
prerank,solute:anion antiporter activity (GO:0140323),0.5442424938663689,1.2215409371042456,0.23905723905723905,0.6393794694331203,1.0,1/14,0.10%,SLC7A11
prerank,cysteine-type endopeptidase activity (GO:0004197),0.40425199742991574,1.2185738167852884,0.19041450777202074,0.6431388307163686,1.0,27/78,21.19%,CASP12;CFLAR;USP11;SFRP1;CTSH;CTSF;USP47;USP20;USP35;USP24;USP48;CASP7;USP30;USP9Y;CTSZ;USP10;USP9X;CTSL;USP38;CASP9;CASP1;USP49;CAPN15;USP46;USP37;PIGK;UCHL1
prerank,outward rectifier potassium channel activity (GO:0015271),0.574059606860194,1.2177356121250418,0.2621527777777778,0.6410310699053045,1.0,2/11,2.60%,KCNK2;KCNT2
prerank,DNA binding (GO:0003677),0.3455456338053465,1.216880104316207,0.03229061553985873,0.6391048692160524,1.0,136/694,15.70%,TCF7L2;TCF4;POLR2D;RBMS1;RORA;TEAD1;PBX1;SMAD3;ZEB2;C1D;BCL2;NR2F2;GLI2;SP7;ARID5B;NKX2-1;ARID4A;THRB;PRDM5;FOXP2;NFIB;DNMT3A;PDS5B;NUPR1;RARB;ZIC4;OGG1;MEOX2;RLF;APLP2;IRF1;ZIC2;RFX5;NEUROD1;RARG;LIG4;DENND4A;TBX3;SP4;EPAS1;HLF;BCL6;CUX2;COLEC11;GTF3C1;HES7;SHOC1;INO80;SMARCA1;RAD51B;DMC1;CUL4B;NR5A1;SPRTN;BATF;CEBPA;NFE2L2;POLG;DDX60;SREBF1;SNAPC1;REXO4;DCLRE1C;TSHZ2;TET1;POLL;RBPJ;LIN9;TCF7L1;FOXC2;SAFB2;CHD2;KDM5B;HIVEP2;NHEJ1;EGFR;MLH1;ZBTB4;AIFM1;HNRNPA1;SPATA24;SMC6;ARNT;FOXA1;ZKSCAN3;PHF1;TFAM;CXXC5;DNASE1L1;MBD1;CENPC;DNASE2;DDX3X;CEBPB;POLRMT;NFE2;TDP2;CCDC25;SPDEF;NKX2-8;DCLRE1A;RAD18;NR4A1;MBD4;MCM2;GLI1;CAMTA1;ZNF513;MYCN;NPAS2;HDAC4;TAF9;RC3H2;ETS1;HMCES;ZNF148;RAD51D;ZNF219;POGK;YAF2;SNAPC4;NR1H3;FUBP3;RBM5;RXRA;FOXK2;HUWE1;RBM6;SAP30L;SMARCB1;TSHZ1;HDGFL3;CAMTA2;MTF1;TFCP2;RTF2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.34353920586824205,1.2167471020403167,0.03406813627254509,0.635050132075324,1.0,166/831,17.26%,TCF7L2;TCF4;ZBTB20;NFIA;RORA;ZFHX4;TRPS1;TEAD1;PBX1;SMAD3;ARNT2;PKNOX2;AR;ZKSCAN2;ZEB2;SOX5;MITF;GLIS3;NKX6-1;NR2F2;GLI2;RUNX1;PRRX1;SALL1;KCNIP3;ZIC1;SP7;IKZF2;MAF;GLI3;AEBP1;ZEB1;NKX2-1;THRB;PRDM5;FOXP2;NFIB;ASCL1;DNMT3A;JDP2;RUNX2;SIX5;MLXIP;RARB;ZIC4;NFIX;MXI1;MEOX2;IKZF4;MSC;IRF1;ZIC2;NEUROD4;RFX5;ZNF83;NEUROD1;KLF15;RARG;ETV6;TBX3;SP4;EPAS1;HLF;BCL6;CUX2;ZBTB8B;SKI;TCF7;ATOH8;HES7;ZNF483;ZNF23;NR5A1;BATF;CEBPA;NFE2L2;ZNF697;SREBF1;ZBTB38;ZBTB24;MED8;NR1D1;OSR1;BBX;RBPJ;TCF7L1;FOXC2;CHD2;HIVEP2;STAT5B;ZBTB4;HOXC5;ZBTB1;MZF1;SMAD1;GMEB1;ACTN4;GTF2IRD1;STAT2;GLIS2;NSD1;ARNT;CREB3L4;CREB3;FOXA1;ZKSCAN3;ZSCAN21;NR1D2;RBL2;SP5;ZBTB8A;ZNF177;CEBPB;KLF9;BHLHE41;NFE2;NKX2-8;ZBTB37;ZFP30;REST;NR4A1;GLI1;STAT6;TEAD3;MYCN;NPAS2;HOXC8;EBF1;STAT4;ZNF182;HDAC4;HIVEP1;ETS1;ZNF148;ZNF383;ZNF219;TWIST2;TCF12;HOXD1;GATA6;NR1H3;ZNF25;HOXC4;RXRA;FOXK2;MYT1;MTF1;TFCP2;ZBTB17;ZNF585B;ZNF585A;MAFA;MXD4;EBF4;CREB5;PLAG1;ZNF423;ATF5;TFDP1;FOXO6;SP1;ZFAT;MYBL1;IRF2;ZSCAN20;FOXJ3
prerank,calcium-activated potassium channel activity (GO:0015269),-0.5039650923936673,-1.2164280193736685,0.21300448430493274,0.6085735012560923,1.0,3/11,7.52%,KCNMA1;KCNN2;KCNMB2
prerank,potassium channel regulator activity (GO:0015459),-0.34875270052533847,-1.2157825217168041,0.1413427561837456,0.6036630442264928,1.0,10/49,11.81%,DPP10;KCNIP4;KCNAB1;NEDD4L;ABCC9;KCNMB2;SGK1;WNK2;ADRB2;DPP6
prerank,sequence-specific mRNA binding (GO:1990825),-0.5151086988138912,-1.2131200030900724,0.24367816091954023,0.6040676204708918,1.0,5/10,25.42%,DHFR;TYMS;DHX9;RBM24;FMR1
prerank,cation transmembrane transporter activity (GO:0008324),0.4288095179289545,1.2131000995549814,0.2078272604588394,0.6405886114080449,1.0,7/48,6.39%,SLC7A2;SLC1A5;SLC41A1;SLC6A9;SLC22A2;SFXN2;SLC38A6
prerank,RNA cap binding (GO:0000339),-0.4498723457010808,-1.2113780033419563,0.23291139240506328,0.6018865824312469,1.0,7/16,21.58%,EIF4E;EIF4A1;CYFIP2;EIF4E2;SNUPN;EIF3D;DCPS
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.4973485095908922,-1.210688656209116,0.23178807947019867,0.5975711288961028,1.0,5/12,14.26%,PIK3R6;IPMK;PIK3R3;PIK3C2B;PIK3CA
prerank,phosphotyrosine residue binding (GO:0001784),-0.367104820579026,-1.2075849002345231,0.17391304347826086,0.5987091565131594,1.0,12/37,19.03%,YES1;PLCG2;SHE;SHC3;BCAR3;SHB;PIK3R3;PTPN6;RASA1;NCK2;PTPN5;FGR
prerank,cytokine receptor binding (GO:0005126),0.3918301389188399,1.2037278091592143,0.19454770755885997,0.6609011436608279,1.0,11/83,7.34%,TGFBR3;SMAD3;IL6R;IL34;OSMR;CCL19;CSF1;PIBF1;IL12B;TSLP;IL13RA1
prerank,ATP binding (GO:0005524),0.3530952145172635,1.2033575235131242,0.11205073995771671,0.6574357417945501,1.0,48/266,14.37%,STK17B;DAPK2;ENPP1;DAPK1;KSR1;ABCA1;ATP1A2;BMPR1A;DMPK;MARK1;MLKL;PRKAG2;TGFBR1;MYO18A;MYH10;MYO1B;ACVR1;LIG4;MVK;OAS2;RHOBTB3;MAP3K20;PDXK;AKT3;SIK1;BRSK1;OXSR1;CLPX;MAST2;STK4;IRAK3;MAP4K4;ABCB9;STK11;NEK6;PEX6;ABCE1;P2RX5;TLK1;WNK1;INSR;MAP4K5;ACVR1B;MTREX;MARK2;HSPA9;ABCD2;RTEL1
prerank,calcium ion binding (GO:0005509),0.3491401510870301,1.203177899581669,0.11248710010319918,0.6535446676195016,1.0,46/323,10.64%,ITPR1;FBN1;PAM;CLEC3B;ENPP1;CDH11;SLC8A1;GSN;PLSCR2;ADGRV1;SPARC;LRP1;GJB2;MAN1C1;PPP3CA;CIB4;ASPH;MCTP2;STIM1;FBLN1;RAPGEF2;SLC25A24;PLA2G4A;BAIAP3;SMOC2;CDH5;COLEC11;TNNC1;CABCOCO1;DCHS1;SCUBE1;RCN1;SYT9;NAALADL1;FKBP9;PLSCR4;ANXA3;TRPM4;S100A11;MICU2;MASP1;SLIT3;SLIT1;ANXA6;PCDHB8;BRAF
prerank,chemokine binding (GO:0019956),0.4648579110104488,1.2029242419078743,0.2510822510822511,0.6497724801265389,1.0,8/30,12.79%,XCR1;ACKR2;CCR9;PDPN;ITGB3;ITGAV;FGF2;CXCR6
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.341474228844467,1.20289798295708,0.06464646464646465,0.6455177598076408,1.0,101/597,15.07%,TCF7L2;TCF4;ZBTB20;TBL1XR1;TEAD1;PBX1;SMAD3;ARNT2;PKNOX2;AR;SOX5;GLI2;RUNX1;ZIC1;MAF;GLI3;ARID5B;NKX2-1;ARID4A;THRB;PRDM5;NFIB;ASCL1;YAP1;JDP2;RUNX2;RARB;ZIC4;NFIX;LBX2;MEOX2;MSC;TSPYL2;IRF1;RFX5;NEUROD1;CREB3L2;KLF15;RARG;TBX3;HLF;BCL6;CUX2;BCOR;TCF7;HES7;ZNF23;ZW10;NR5A1;BATF;CEBPA;NFE2L2;MBD2;RNF10;SREBF1;NR1D1;OSR1;BBX;TCF7L1;FOXC2;NCOR1;KDM5B;NONO;MZF1;GMEB1;GLIS2;ARNT;CREB3L4;CREB3;FOXA1;TFAM;NR1D2;CENPC;ZNF177;CEBPB;BHLHE41;NFE2;SPDEF;NKX2-8;ZBTB37;REST;NR4A1;PER3;MBD4;MCM2;GLI1;ZNF513;MYCN;NPAS2;HOXC8;HDAC4;TAF9;HIVEP1;ETS1;TCF12;HOXD1;GATA6;NR1H3;HOXC4;RXRA;FOXK2
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.33841934634877885,-1.1987529088117,0.16549295774647887,0.6149040641705916,1.0,11/51,9.35%,SLCO2A1;SLCO1C1;SLC7A5;SLC22A8;SLCO2B1;CLCN3;SLC5A6;SLC22A6;MFSD2A;SLC35E4;SLC25A30
prerank,voltage-gated potassium channel activity (GO:0005249),-0.3091423876144422,-1.1968018391624287,0.12121212121212122,0.6140627656032469,1.0,12/80,6.21%,KCNB2;KCNJ2;KCNQ5;KCND2;KCNJ3;KCNMA1;KCND3;KCNN2;KCNQ1;KCNH7;KCNH5;KCNC2
prerank,cytokine activity (GO:0005125),0.3764389758168191,1.1963635836370328,0.18277066356228172,0.658829870493867,1.0,19/131,11.12%,BMP6;IL34;IL17D;WNT8B;INHBE;WNT4;WNT6;CCL19;CSF1;CXCL16;FAM3B;CCL4;WNT5B;IL12B;TSLP;BMP2;FGF2;BMP15;IFNK
prerank,protein tyrosine kinase binding (GO:1990782),0.39950094892071925,1.1959210368073587,0.21052631578947367,0.6557241622770426,1.0,10/71,6.47%,ANGPT1;CBLB;DOCK4;NEDD9;EPHA4;GAS6;ANGPT2;ACVR1;CDH5;CD247
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.46595093869952314,1.194674344264388,0.24071322436849926,0.6546642121595019,1.0,4/27,3.89%,SLC8A1;SLC8A3;SLC41A1;SLC9A9
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5098113306033356,-1.1944319665076162,0.23271889400921658,0.6133684890482578,1.0,3/10,10.35%,MECOM;PRDM16;SUV39H1
prerank,TBP-class protein binding (GO:0017025),-0.40915509355226704,-1.1906538959481154,0.21508379888268156,0.61707647828182,1.0,10/21,26.08%,ESR1;TAF1B;TAF1;HHEX;GTF2A2;RUVBL1;YEATS2;GTF2B;THRA;RUVBL2
prerank,sodium:proton antiporter activity (GO:0015385),-0.4843843560389834,-1.1899257723769614,0.22453703703703703,0.6130523770350463,1.0,4/11,8.53%,SLC9A2;SLC9B2;SLC9A6;SLC9A7
prerank,R-SMAD binding (GO:0070412),0.49902742211778006,1.189099466869181,0.280672268907563,0.6652486337552358,1.0,3/18,3.16%,SMAD3;LDLRAD4;PMEPA1
prerank,GTPase activator activity (GO:0005096),0.3461415105708544,1.1869605766512763,0.13236814891416754,0.6664957891210049,1.0,53/313,9.81%,ALDH1A1;NRP1;ASAP1;RIN2;MYCBP2;ERRFI1;RABGAP1L;TBC1D4;FARP1;RAPGEF4;SYDE2;DLC1;DOCK4;ARHGAP28;DOCK10;RCBTB2;USP6NL;ARHGEF10L;DOCK11;ARHGAP18;IQSEC2;DENND2A;NPRL3;ARHGAP29;ASAP3;FGD1;RAPGEF2;IQGAP2;FGD4;ARHGAP19;DENND4A;SMAP2;ARHGAP32;ARHGAP10;ARFGEF2;ACAP2;ARFGAP3;LRRK2;ADPRH;ARHGEF17;DOCK5;DENND5A;ARHGEF18;ARHGAP35;ALS2;ARHGAP9;RGL1;ARRB1;ARHGEF11;SYDE1;RAPGEF1;SEC23B;TBC1D2B
prerank,adenyl ribonucleotide binding (GO:0032559),0.3444888647058403,1.182235972445124,0.1518324607329843,0.6746992187365443,1.0,52/291,14.37%,STK17B;DAPK2;ENPP1;DAPK1;KSR1;RAPGEF4;ABCA1;ATP1A2;BMPR1A;MPPED2;DMPK;MARK1;MLKL;PRKAG2;TGFBR1;MYO18A;MYH10;MYO1B;RAPGEF2;ACVR1;LIG4;MVK;OAS2;RHOBTB3;MAP3K20;PDXK;AKT3;SIK1;BRSK1;OXSR1;CLPX;MAST2;STK4;IRAK3;MAP4K4;ABCB9;STK11;NEK6;PEX6;ABCE1;P2RX5;TLK1;WNK1;INSR;MAP4K5;ACVR1B;MTREX;MARK2;HSPA9;ABCD2;ACSS2;RTEL1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5171091630605464,1.181470767725313,0.304,0.6724992845090242,1.0,3/15,5.27%,XCR1;ACKR2;CCR9
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.406301380250994,1.1801151938858694,0.22116689280868385,0.6716832268328017,1.0,7/55,7.31%,ITPR1;SLC24A3;SLC24A1;MCU;SLC24A5;PANX1;CUL5
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.4582429009794543,-1.176690587959171,0.2918781725888325,0.6416328216424588,1.0,5/14,15.80%,OTUD7B;MINDY2;MINDY1;YOD1;USP15
prerank,semaphorin receptor binding (GO:0030215),-0.3985953244977964,-1.1742530677052536,0.24216524216524216,0.6417658180515559,1.0,8/23,12.61%,SEMA6D;SEMA6A;SEMA7A;RIT2;SEMA5B;SEMA3G;SEMA3C;SEMA4B
prerank,metal ion binding (GO:0046872),0.33449334823478544,1.173281261121033,0.11246200607902736,0.685970782959125,1.0,69/477,10.64%,ITPR1;FBN1;PAM;CLEC3B;ENPP1;EYA2;ADCY2;CDH11;SLC8A1;GSN;PLSCR2;ADGRV1;SPARC;LRP1;GJB2;MARK1;MAN1C1;PPP3CA;CIB4;EPHX2;ASPH;HMGCLL1;APOE;MCTP2;STIM1;FBLN1;RAPGEF2;MT3;SLC25A24;MVK;PLA2G4A;BAIAP3;SMOC2;MAP3K20;CDH5;COLEC11;PDXK;TNNC1;LRRK2;ADPRH;SIK1;CABCOCO1;DCHS1;BRSK1;SCUBE1;RCN1;DXO;SYT9;OXSR1;NAALADL1;FKBP9;MAST2;STK4;IRAK3;PLSCR4;ANXA3;CLYBL;TRPM4;IDH2;S100A11;STK11;MICU2;MASP1;SLIT3;SLIT1;ANXA6;PCDHB8;NEK6;BRAF
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.49049023915636175,-1.1732549268022177,0.2835820895522388,0.638250525546595,1.0,10/11,50.98%,DDAH1;DDAH2;PADI2;ARG2;ARG1;PADI1;PADI4;AGMAT;PADI3;PADI6
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5232456232447819,1.1694116711977194,0.298932384341637,0.6918404022199922,1.0,3/13,9.33%,HSD3B2;ECI1;IDI1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.3610979225169483,-1.1691538303594669,0.21785714285714286,0.6422582580220082,1.0,9/35,11.94%,TEC;YES1;PTK2B;BMX;CLK1;PKDCC;CSK;PEAK1;FES
prerank,adrenergic receptor binding (GO:0031690),0.5037623000814132,1.1674774271726263,0.2786885245901639,0.692865939507659,1.0,6/16,13.99%,GNAS;NEDD4;RAPGEF2;ADRA2C;ADRA2A;DLG4
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.46833497901341103,1.1670766211756827,0.28391167192429023,0.6897195328685523,1.0,6/25,13.39%,ART4;PARP11;PARP16;SIRT2;PARP14;TNKS2
prerank,myosin V binding (GO:0031489),-0.45491148696524997,-1.162965339158146,0.2746987951807229,0.6524058649411442,1.0,8/15,25.56%,RAB6A;RAB3C;RAB11A;RAB27B;RAB6B;RAB3A;RAB14;RAB39B
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.3688752424048384,-1.1622834810070362,0.2411764705882353,0.6480256872636129,1.0,12/31,21.28%,UBE2G1;UBE2J1;UBE2H;TAF1;UBE2D3;UBE2K;UBE2B;UBE2G2;AKTIP;UBE2S;UBE2QL1;UBE2O
prerank,alkali metal ion binding (GO:0031420),0.5340470128540743,1.1621158738268444,0.2996575342465753,0.6985064932785456,1.0,4/13,13.78%,ATP1A2;PDXK;ADPRH;HDAC4
prerank,sequence-specific DNA binding (GO:0043565),0.3296305931408083,1.1613299903353278,0.1202020202020202,0.6963663562933464,1.0,80/590,11.68%,TCF7L2;TCF4;ZBTB20;RORA;TEAD1;PBX1;SMAD3;ARNT2;PKNOX2;ZEB2;BCL2;NR2F2;GLI2;ZIC1;MAF;GLI3;THRB;PRDM5;FOXP2;NFIB;ASCL1;JDP2;RUNX2;RARB;ZIC4;NFIX;LBX2;FBXL19;MEOX2;MSC;RFX5;NEUROD1;KLF15;RARG;TBX3;SP4;EPAS1;HLF;BCL6;CUX2;TCF7;HES7;ZNF23;NR5A1;BATF;NFE2L2;MBD2;SREBF1;SNAPC1;ZBTB38;NR1D1;OSR1;BBX;TET1;RBPJ;TCF7L1;FOXC2;SAFB2;KDM5B;ZBTB4;GMEB1;GLIS2;ARNT;TELO2;CREB3L4;CREB3;FOXA1;ZKSCAN3;TFAM;CXXC5;NR1D2;MBD1;ZNF177;CEBPB;POLRMT;BHLHE41;NFE2;SPDEF;NKX2-8;ZBTB37
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.4575133821207722,-1.1597111935077469,0.28883495145631066,0.6486892861058209,1.0,4/14,6.54%,NOD1;MAL;BCL2L13;ATP2A3
prerank,SH2 domain binding (GO:0042169),0.4337330598746778,1.15514528460532,0.28245363766048504,0.7093833280471024,1.0,5/31,6.31%,DAG1;AFAP1;DLC1;SH3PXD2B;SRC
prerank,MAP kinase kinase kinase activity (GO:0004709),0.5323346963463489,1.1534927279280571,0.31464737793851716,0.7095837241620804,1.0,4/11,12.70%,MAP3K20;EGFR;MAP3K13;MAP3K15
prerank,transition metal ion binding (GO:0046914),0.33069250341959094,1.1533939608231987,0.15730337078651685,0.7056700216242531,1.0,96/397,19.72%,PAPPA;MYCBP2;PAM;MOXD1;AGMO;ENPP1;ADAM33;ADCY2;CBLB;SEC24D;SMAD3;GLI2;MSRB3;MPPED2;ZEB1;SLC30A8;FBXL19;IKZF4;LARGE1;MT3;ENDOU;HPF1;HEPH;SKI;LARGE2;PDXK;SLC11A2;RBSN;B4GALT1;DPEP1;TIMP2;ADH1A;SIRT2;TRAF7;NAALADL1;TET1;KDM5B;COMMD1;BBOX1;PRKN;NSD1;TIMM9;BAZ1B;PHF2;CXXC5;MBD1;KDM5C;ABCE1;TDP2;CPA2;NAPEPLD;MNAT1;CDA;KMT2A;SEC23A;HDAC4;NFU1;KDM7A;PHF8;CXXC4;RXRA;SAP30L;CYP2R1;RASSF1;DPP3;MYT1;MELTF;RNF2;RIOX1;COA6;SORD;AOX1;ZDHHC20;SHH;PIM1;PRIMPOL;GLO1;LACC1;DUSP12;SEC24A;HHIP;DHX58;RC3H1;POLR2L;KPNB1;SOD3;RABIF;SMPDL3B;FDX1;SIRT5;KDM4A;SCD;TET3;MDM4;CDADC1;IDE
prerank,death receptor activity (GO:0005035),-0.477934187415748,-1.1526131795667578,0.2905405405405405,0.6614402918197876,1.0,2/11,3.04%,TNFRSF11A;TNFRSF19
prerank,frizzled binding (GO:0005109),0.43840174303095647,1.1502373315577112,0.2855093256814921,0.7097341051107492,1.0,8/34,10.17%,WNT8B;WNT4;WNT6;FZD1;SFRP1;ZNRF3;WNT5B;RYK
prerank,RNA methyltransferase activity (GO:0008173),0.4721436205311026,1.1500442280755687,0.3085808580858086,0.7061934236195132,1.0,9/19,28.00%,FTSJ3;BCDIN3D;TRMT9B;TRMT13;METTL4;METTL3;TRMT12;TYW3;MEPCE
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.30383409687361446,-1.14906983164292,0.17674418604651163,0.664916738111479,1.0,25/71,18.02%,PTPRB;PTPRG;PTPRJ;UBASH3B;PTPN14;PTPRE;PTPRD;PTPRK;PTPN12;DUSP22;PTPN2;ACP1;PTPRT;PTP4A2;CDC14A;PTPN22;MTMR6;HACD2;DUSP11;PTPN6;PTPRN;PTPRC;PALD1;DUSP23;PTPN5
prerank,potassium ion leak channel activity (GO:0022841),0.509121743690973,1.1470495622611354,0.32554257095158595,0.7099183718733456,1.0,2/15,6.18%,KCNK2;KCNK7
prerank,I-SMAD binding (GO:0070411),0.513663355343738,1.1465657317922668,0.3064798598949212,0.7069012082304347,1.0,3/13,9.23%,SMAD3;TGFBR1;SMAD1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.4984768871128936,1.146422168436616,0.30066445182724255,0.7032481639500419,1.0,3/16,10.38%,TDO2;ALOXE3;CDO1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.43206005275710024,1.1439359768649686,0.2922173274596182,0.7053399443184148,1.0,15/32,21.12%,PHYHD1;TET1;BBOX1;P4HTM;JMJD7;KDM7A;PHF8;EGLN1;RIOX1;PHYH;ALKBH1;KDM4A;TET3;FTO;KDM4C
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.3281675994207994,-1.1417286161012772,0.2664359861591695,0.6790524261440486,1.0,12/42,10.50%,STXBP6;BAIAP2L1;ESAM;BSG;CNTN4;NTNG1;TMOD3;SIRPA;CNTN6;LRRC4C;ROBO4;EMB
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.4674248244387745,1.1405786200162595,0.32098765432098764,0.7105509947737927,1.0,1/22,0.20%,ATP6V0A4
prerank,metalloaminopeptidase activity (GO:0070006),-0.42483977503100795,-1.1389749357786685,0.3283208020050125,0.6805646382597921,1.0,7/16,25.66%,XPNPEP3;MMP15;RNPEPL1;MMP16;TRHDE;LNPEP;NPEPPS
prerank,iron ion binding (GO:0005506),0.4047869778886012,1.1378746864118974,0.29298486932599727,0.7133562450735967,1.0,19/48,20.14%,AGMO;HEPH;TET1;PHF2;CDO1;ABCE1;NFU1;KDM7A;PHF8;EGLN1;CYP2R1;MELTF;RIOX1;AOX1;PHYH;ALKBH1;FDX1;SCD;FTO
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.310840205945979,-1.1372397058698958,0.23790322580645162,0.6790157600951783,1.0,27/57,28.83%,COX4I1;NDUFC1;UQCRH;COX6A1;COX5B;NDUFA6;NDUFA5;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;COX5A;NDUFS7;NDUFS1;NDUFS5;UQCR10;NDUFB3;COX8A;UQCR11;UQCRQ;UQCRC1;CYB561D2;UQCRFS1;NDUFB4;NDUFV2;NDUFV3
prerank,Notch binding (GO:0005112),-0.3907064073479599,-1.1352497420058665,0.2878338278931751,0.6779457247786639,1.0,12/22,21.91%,CCN3;DNER;JAG2;NOTCH4;SNW1;GALNT11;KCTD10;DLL4;CUL3;DLL1;MEGF10;DTX1
prerank,epidermal growth factor receptor binding (GO:0005154),0.44867615326102195,1.1344645307644905,0.31357254290171604,0.7183443925708496,1.0,6/25,13.94%,AREG;TGFA;EPGN;HBEGF;EGF;ARF4
prerank,adenylate cyclase binding (GO:0008179),0.539138869623049,1.1322811566051874,0.3498233215547703,0.7202273579951579,1.0,2/10,2.63%,ADCY2;ADCY5
prerank,zinc ion binding (GO:0008270),0.32875266781366524,1.1307442692851504,0.2156448202959831,0.7200015247855871,1.0,72/293,19.72%,PAPPA;MYCBP2;PAM;ENPP1;ADAM33;CBLB;SEC24D;SMAD3;GLI2;MSRB3;ZEB1;SLC30A8;FBXL19;IKZF4;MT3;HPF1;SKI;PDXK;RBSN;DPEP1;TIMP2;ADH1A;SIRT2;TRAF7;NAALADL1;TET1;KDM5B;BBOX1;PRKN;NSD1;TIMM9;BAZ1B;PHF2;CXXC5;MBD1;KDM5C;CPA2;NAPEPLD;MNAT1;CDA;KMT2A;SEC23A;HDAC4;KDM7A;PHF8;CXXC4;RXRA;SAP30L;RASSF1;DPP3;MYT1;RNF2;SORD;ZDHHC20;SHH;PRIMPOL;GLO1;DUSP12;SEC24A;HHIP;DHX58;RC3H1;POLR2L;KPNB1;RABIF;SMPDL3B;SIRT5;KDM4A;TET3;MDM4;CDADC1;IDE
prerank,potassium ion antiporter activity (GO:0022821),0.4922984218844166,1.128937587818059,0.32948929159802304,0.7206868386416457,1.0,5/15,9.12%,SLC24A3;SLC9A9;SLC24A1;SLC24A5;SLC9A5
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.4475365812874278,-1.1262416628642038,0.2985781990521327,0.6962286117903395,1.0,5/13,17.20%,LPCAT1;AGPAT1;PNPLA3;AGPAT5;LPCAT2
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.47406909352575693,-1.1243074117281202,0.3147751605995717,0.6954019032336933,1.0,3/10,11.50%,OTUD4;YOD1;TNFAIP3
prerank,organic anion transmembrane transporter activity (GO:0008514),0.3497928489304936,1.1241986896046043,0.26765375854214124,0.7293608394752013,1.0,15/134,6.39%,SLC1A3;SLC7A2;GJA1;SLC1A5;SLC16A12;SLC13A3;SLC6A9;SLC6A13;SLC2A10;SLC25A24;SFXN2;PDPN;SLCO3A1;SLC35A3;SLC38A6
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.36437730567831106,-1.1224729580125552,0.28415300546448086,0.6943792843152656,1.0,6/27,10.96%,RNF144B;RNF144A;RNF125;SIAH1;SIAH3;DCUN1D4
prerank,galactosyltransferase activity (GO:0008378),-0.46027610006272174,-1.1181367641059103,0.31533477321814257,0.6997011992864252,1.0,3/11,6.20%,B4GALT4;B4GALT5;B4GALT7
prerank,N-methyltransferase activity (GO:0008170),0.4628515145959554,1.1178135511165566,0.3392568659127625,0.7421164998885206,1.0,4/20,9.50%,NNMT;HNMT;TRMO;DIMT1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3366076245545252,1.1162127259798542,0.2595078299776286,0.7422303506387145,1.0,27/173,11.94%,ZBTB20;TRPS1;ZEB2;MITF;KCNIP3;AEBP1;ZEB1;PRDM5;FOXP2;ASCL1;JDP2;MXI1;ETV6;TBX3;BCL6;SKI;NR1D1;ZBTB4;ZBTB1;MZF1;GTF2IRD1;ZKSCAN3;ZNF177;CEBPB;BHLHE41;ZBTB37;REST
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.4063613979977411,1.1155169104634652,0.3445378151260504,0.7399146696180092,1.0,19/42,24.01%,CCNA2;CKS1B;KAT2B;CCNK;HEXIM2;INCA1;CCNL2;CCNL1;CNPPD1;CCNQ;CDKN2C;CCNT2;CDKN1B;CCND2;CCNT1;CCNG2;HEXIM1;CCNY;CCNE2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.35431625056781985,-1.1153906583042366,0.2822822822822823,0.7009411047409257,1.0,9/29,13.96%,SLC26A7;SLC26A2;SLC25A13;SLC25A12;SLC1A1;SLC25A30;SLC26A6;SLC25A11;SLC1A4
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.33321751474022554,1.114848445396979,0.2813186813186813,0.7376487179595987,1.0,32/181,15.36%,TCF7L2;LDB2;SMAD3;ARNT2;AR;DACT1;PRRX1;CDK5RAP3;NEUROD1;NCOA2;TBX3;TACC1;NFE2L2;MTA2;RERE;RBPJ;NCOR1;MTA3;ACTN4;ARNT;IFI27;RBL2;NCOR2;BHLHE41;TEAD3;TRIP4;NCOA3;HDAC4;TCERG1;TADA3;RXRA;SMARCB1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.46649795048019654,-1.1139884237654378,0.3473451327433628,0.6986788967669397,1.0,2/11,4.78%,LEF1;GATA2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.44418554669022015,1.1134967726990808,0.3416536661466459,0.73744088188138,1.0,2/24,1.22%,CAMK1D;DAPK1
prerank,ubiquitin-specific protease binding (GO:1990381),0.4690370650247518,1.1134893305233302,0.344391785150079,0.7335120062669868,1.0,9/19,25.34%,DERL1;DERL3;PRKN;SELENOS;PTEN;AMFR;SUMO1;BAG6;LCOR
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.44771801928714966,-1.113309499064747,0.2978723404255319,0.6949163341899126,1.0,7/12,28.13%,TAF1;TBP;H3-3A;GTF2B;RUVBL2;FOS;TBPL1
prerank,estrogen receptor binding (GO:0030331),-0.3477251768459942,-1.1132669735897698,0.3009118541033435,0.6893641799836822,1.0,12/32,23.07%,LEF1;ESR1;MED1;NRIP1;STRN;TAF10;PPARGC1B;ARID5A;SRARP;PPID;PADI2;DCAF1
prerank,small GTPase binding (GO:0031267),0.3400885267662058,1.1119885477599036,0.2887402452619844,0.7336588772931237,1.0,40/170,15.15%,MYCBP2;RHOH;RABGAP1L;RAPGEF4;ABCA1;DOCK4;USP6NL;OPTN;CDC42EP4;FGD1;IQGAP2;GOLGA4;FGD4;RHOBTB3;STRN3;NDRG1;RANBP9;LRRK2;SPHK2;AFDN;MYO1C;ALS2;TRIP11;PICALM;ARFIP2;FMNL1;GGA2;BRAF;RNF152;FGD3;GOLGA5;WASF1;TNFAIP1;RAB3GAP1;TSC2;FLNA;AKAP13;RAPGEF6;TBC1D20;HACE1
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.2856171879072197,-1.1119373736636669,0.23711340206185566,0.687384466602978,1.0,33/85,28.63%,ENPP2;MGLL;ABHD2;NDST3;PLA2G7;LIPE;PNPLA7;BCHE;PAFAH1B2;PLAAT3;PNPLA3;PLA2G4C;TARS2;PNPLA2;ABHD6;PNPLA6;LYPLA2;DAGLB;AARS2;PLA2G4F;LYPLA1;PLA2G4E;AOAH;GDPD1;ABHD4;PLAAT1;LIPC;PLA2G4B;LIPA;FAAH;LPL;PGAP1;PON3
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.4542361524420945,1.1089958929676738,0.35403726708074534,0.7336209678826259,1.0,2/21,1.12%,CDK14;CDK8
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.4542361524420945,1.1089958929676738,0.35403726708074534,0.7336209678826259,1.0,2/21,1.12%,CDK14;CDK8
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.37382369526494735,-1.108148288597079,0.3240223463687151,0.6919673488964931,1.0,4/23,5.85%,PLCE1;EDNRA;PLCG2;CHRM3
prerank,carbohydrate:cation symporter activity (GO:0005402),0.5243961435545617,1.1073663442019397,0.37094017094017095,0.7339945860142262,1.0,2/11,9.29%,SLC2A10;SLC5A3
prerank,sialyltransferase activity (GO:0008373),-0.38562480445666214,-1.106426228723712,0.2962962962962963,0.6909065877331865,1.0,4/20,0.97%,ST6GALNAC3;ST3GAL6;ST8SIA4;ST6GAL1
prerank,single-stranded DNA binding (GO:0003697),0.3534253439634462,1.1028657815811493,0.32019704433497537,0.7420071491578131,1.0,15/93,14.99%,POLR2D;RBMS1;SHOC1;RAD51B;DMC1;SPRTN;REXO4;MLH1;HNRNPA1;SMC6;TDP2;MCM2;HMCES;RAD51D;FUBP3
prerank,phosphatase inhibitor activity (GO:0019212),-0.39172733274234595,-1.1012792342728057,0.3157894736842105,0.6987137251816813,1.0,12/20,34.54%,PTN;MGAT5;PPME1;LMTK2;URI1;ANP32E;STYX;CABIN1;PPP1R1B;SET;SAG;ENSA
prerank,ATP hydrolysis activity (GO:0140603),0.4056598099014691,1.1007092893277148,0.32474964234620884,0.7440709207568721,1.0,14/41,17.81%,MYO18A;RNF213;RHOBTB3;SHOC1;CLPX;DDX3X;MYO1E;ABCA3;ABCD2;TOR1B;SMCHD1;ABCB6;DDX4;TOR3A
prerank,microtubule binding (GO:0008017),-0.24109675930456273,-1.1003444202548491,0.1780821917808219,0.6955340828834063,1.0,58/222,20.44%,DNM3;MTUS1;SGIP1;MAP2;REEP1;NAV3;STARD9;CCDC88A;KIF26B;EML5;MID1;FMN1;KIF6;KIF13A;RPS3;KIF2A;ARHGEF2;FNTA;CDK5;KRIT1;SUN2;SYBU;RP1;RAB11A;PAFAH1B1;ARL3;CCDC61;KIF16B;NEFH;KIF20B;KIF1A;KIF15;POLB;DCTN1;GAS2L1;TRPV4;CCDC88C;CDK5RAP2;MAP1B;CEP57;KIF21A;CAPN6;DNM1;PRC1;GAS8;IRAG2;KIF23;KIF18A;REEP2;MTCL1;MAST1;CLASP1;KNSTRN;KIF5A;SPAG5;KIF18B;CCDC170;CLIP2
prerank,NADPH binding (GO:0070402),-0.4308811000646406,-1.0993492473021362,0.3438320209973753,0.6925046895436084,1.0,10/13,37.61%,KCNAB1;DHFR;CBR3;HMGCR;GRHPR;MTRR;CBR4;LBR;NDOR1;DUS2
prerank,chemorepellent activity (GO:0045499),0.44123249193134023,1.098859121287511,0.3543913713405239,0.7448134933545703,1.0,4/25,4.30%,EPHA7;SEMA3D;SEMA5A;APOA1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.47141812332386157,1.0976194139452835,0.37251655629139074,0.7440537074388542,1.0,2/16,1.82%,SLC1A5;SLC13A3
prerank,sterol binding (GO:0032934),0.3874599184829826,1.097199639614514,0.33203125,0.7413297304581539,1.0,19/56,18.96%,RORA;ABCA1;INSIG2;APOA1;OSBPL8;STAR;SIDT1;ANXA6;TSPO;VDAC1;GRAMD1A;OSBPL9;NR1H3;OSBPL5;GRAMD1C;NPC1;INSIG1;ERLIN1;OSBP2
prerank,microtubule motor activity (GO:0003777),-0.3058337415877849,-1.0968023576292203,0.2768595041322314,0.6936044777353905,1.0,19/51,22.51%,STARD9;KIF26B;KIF6;KIF13A;KIF2A;KIF16B;KIF20B;KIF1A;DYNLRB1;KIF15;KIFC3;KIF21A;KIF23;KIF18A;KIF5A;KIF18B;KIF22;KIF4A;KIF14
prerank,single-stranded RNA binding (GO:0003727),0.39379026258495753,1.0935631615723367,0.34642356241234223,0.746671308351038,1.0,5/43,10.99%,POLR2D;A1CF;DDX60;HNRNPA1;DDX3X
prerank,acyl-CoA hydrolase activity (GO:0047617),0.46649062664916274,1.0933039279824779,0.3633217993079585,0.7435693751245643,1.0,3/17,4.50%,ACOT11;ACOT6;ACOT2
prerank,protein kinase regulator activity (GO:0019887),0.35172672108332964,1.092793279666506,0.33209876543209876,0.7412470361086498,1.0,37/95,24.19%,PARVA;CCNA2;PRKAG2;MT3;ITPRIP;GPRC5D;DNAJC3;CCNK;STK11;FGF13;TAOK3;CCNL2;RGCC;STRADA;CCNL1;DUSP19;WNK1;CNPPD1;MARK2;GPRC5A;CDKN1C;AGAP2;CCNQ;CCNT2;CDKN1B;PRKAG1;ELP4;MADD;CCND2;TRIB1;CCNT1;CCNG2;NCKAP1L;HEXIM1;CCNY;CCNE2;MBIP
prerank,cardiolipin binding (GO:1901612),0.5228390550100931,1.0919604158669438,0.3925399644760213,0.7397063031000856,1.0,5/10,21.45%,GSDME;PLEKHN1;GSDMD;OPA1;STOML2
prerank,protein kinase C activity (GO:0004697),-0.4262939740688585,-1.0908371895722428,0.3382352941176471,0.7036891517651482,1.0,4/14,17.55%,PRKCH;PKN1;PRKCZ;PRKCE
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3150896816230108,1.0870167838781002,0.2949117341640706,0.7486499720826789,1.0,83/346,18.74%,MYCBP2;RNF220;PDZRN3;HECW2;CBLB;SH3RF3;PELI2;SH3RF1;DCST1;MGRN1;UBR2;NEDD4;RFFL;SMURF2;RNF213;BFAR;BCOR;CDC42;ZNRF3;PML;CUL4B;RNF31;KCMF1;RNF10;TRIP12;CUL5;UBE2U;DTX4;FBXL3;TRAF7;RNF185;RNF139;RNF145;UBA7;UBR4;PRKN;ITCH;RNF181;ASB12;RNF6;RNF38;RNF152;MIB1;FBXO9;RSPRY1;FBXO11;ERCC8;FBXO4;BTRC;RNFT1;RNF217;MUL1;TNFAIP1;RNF19A;RC3H2;UBE2E2;AMFR;UBE2D1;ASB1;HACE1;HUWE1;RNF13;HLTF;DZIP3;RNF2;NHLRC3;UBR5;UBE2R2;MSL2;RNF214;UBR3;UBE3B;RNF138;UBE3A;RNF135;PJA2;DTX3;TRIM45;RC3H1;RNF34;TRIM47;TRIM41;TRIM32
prerank,solute:sodium symporter activity (GO:0015370),-0.3562992024294024,-1.0848181069915839,0.3667621776504298,0.7129677457663723,1.0,3/27,8.29%,SLC4A10;SLC5A6;SLC4A8
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.3973926778727243,1.0839578611476013,0.3748251748251748,0.7528098664788758,1.0,17/40,26.34%,NNMT;DNMT3A;COMT;HNMT;LRTOMT;TPMT;THUMPD3;THUMPD2;METTL4;DNMT3B;PEMT;N6AMT1;DNMT1;CARNMT1;ARMT1;SETD3;RRP8
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.43644797565440346,-1.081770669726886,0.37468354430379747,0.7152705203059715,1.0,5/12,17.95%,CISD2;CISD1;ISCU;SDHB;CIAPIN1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.49543263499532986,1.0805141903170339,0.40134907251264756,0.7574599010859507,1.0,2/12,7.99%,B3GALT1;B3GALNT1
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.43906645385663573,-1.0783967117832964,0.3878048780487805,0.7185769200311994,1.0,5/12,27.10%,TRAF5;TRAF1;TRAF2;BABAM2;TRAF6
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.376474669671135,-1.077109810155102,0.34908136482939633,0.7165155156276167,1.0,9/21,20.66%,REV3L;POLM;POLH;POLE4;POLB;POLN;POLD4;POLQ;POLK
prerank,beta-tubulin binding (GO:0048487),0.4129595919366244,1.0759550462846035,0.36617647058823527,0.7652936990378573,1.0,9/31,21.34%,GJB6;DLEC1;PDCD5;FGF13;EML4;IFT74;APPL1;HTT;TAOK1
prerank,phospholipase C activity (GO:0004629),-0.355250406436994,-1.0759262366685485,0.3628571428571429,0.7143026140341484,1.0,4/25,5.85%,PLCE1;EDNRA;PLCG2;CHRM3
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.31847639465857575,-1.075119208271045,0.36774193548387096,0.7111929510566531,1.0,6/42,3.46%,YES1;PLCG2;SHE;SHC3;BCAR3;SHB
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.33270610596030703,-1.0743174401377595,0.3333333333333333,0.7079407637125735,1.0,12/34,21.28%,UBE2G1;UBE2J1;UBE2H;TAF1;UBE2D3;UBE2K;UBE2B;UBE2G2;AKTIP;UBE2S;UBE2QL1;UBE2O
prerank,low-density lipoprotein particle binding (GO:0030169),-0.396610691252746,-1.0740749203428135,0.3669950738916256,0.7033958755460846,1.0,7/16,11.57%,PLTP;THBS1;SORL1;SCARF1;CDH13;SCARB1;STAB1
prerank,ion gated channel activity (GO:0022839),-0.35942163625981915,-1.0732471301070243,0.3430232558139535,0.7006085913949367,1.0,8/24,16.55%,ANO1;ANO4;TTYH2;ANO3;TMEM63C;ANO2;TMEM63B;ANO6
prerank,clathrin adaptor activity (GO:0035615),0.4732426226430501,1.0732460436437778,0.3993174061433447,0.7685448996898511,1.0,4/15,9.97%,STON1;DAB2;AP1G2;AP1M1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.2798219531124028,-1.0709044401803625,0.3173913043478261,0.7012380886821584,1.0,26/74,24.14%,NADK2;DGKB;DGKH;HK2;PANK3;DGKK;RFK;IPMK;ETNK1;FAM20C;DGKG;DGKQ;PIK3C2B;PIK3CA;CLP1;NOL9;NADK;TKFC;DGKZ;DGKI;KHK;PIK3CG;CHKA;PGM2L1;PKM;IDNK
prerank,UDP-glycosyltransferase activity (GO:0008194),0.35631270172437196,1.070573510041785,0.36671001300390116,0.7716846961998881,1.0,8/70,10.09%,GXYLT2;B3GALT1;OGT;LARGE1;LARGE2;B4GALT1;B3GALNT1;EXT1
prerank,metal ion transmembrane transporter activity (GO:0046873),0.41774523490556326,1.0673902489911973,0.36418816388467373,0.7762110753181065,1.0,3/27,6.47%,ITPR1;SLC41A1;SLC11A2
prerank,RNA stem-loop binding (GO:0035613),0.47979636590143787,1.0646896933726897,0.4006849315068493,0.7793145748537588,1.0,7/12,23.61%,MYH10;CPEB3;DDX3X;RC3H2;RC3H1;LARP6;METTL16
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.43890260294353817,-1.0604416385422966,0.39,0.7172137942267772,1.0,6/11,28.52%,BAG4;GRPEL1;HSPBP1;HSPH1;GRPEL2;BAG2
prerank,adenyl nucleotide binding (GO:0030554),-0.43890260294353817,-1.0604416385422966,0.39,0.7172137942267772,1.0,6/11,28.52%,BAG4;GRPEL1;HSPBP1;HSPH1;GRPEL2;BAG2
prerank,androgen receptor binding (GO:0050681),-0.34455236869640615,-1.0591948217657525,0.3390804597701149,0.7151361751761008,1.0,10/25,19.13%,KDM1A;SNW1;FOXP1;PKN1;TMF1;TRIM68;ARID5A;EP300;RNF14;DDX5
prerank,glutamate receptor binding (GO:0035254),-0.39101588028759726,-1.0589655165341834,0.39195979899497485,0.7106250430233358,1.0,6/17,16.80%,SHANK3;SHANK1;NSF;HOMER1;IGSF11;HOMER3
prerank,transcription corepressor binding (GO:0001222),0.40288869605668354,1.0588431198974844,0.3875968992248062,0.7903363760486254,1.0,7/27,12.01%,RORA;USP11;NR1D1;FAM89B;PHF1;NEK6;PER3
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.4059824291933944,-1.0577823487158007,0.39588688946015427,0.7086376616193865,1.0,5/15,17.20%,LPCAT1;AGPAT1;PNPLA3;AGPAT5;LPCAT2
prerank,lipoprotein particle binding (GO:0071813),-0.3731265595864672,-1.0577181231028427,0.3854166666666667,0.7040324535041506,1.0,7/20,11.57%,PLTP;THBS1;SORL1;SCARF1;CDH13;SCARB1;STAB1
prerank,DNA polymerase activity (GO:0034061),-0.3623995311190533,-1.0560344563061226,0.3611859838274933,0.7032314681224593,1.0,9/22,20.66%,REV3L;POLM;POLH;POLE4;POLB;POLN;POLD4;POLQ;POLK
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.48134451894897834,1.0521244647617,0.40932642487046633,0.8035505457569361,1.0,4/13,9.58%,PDGFD;PDGFRA;PDGFRB;ITGB3
prerank,GTPase activity (GO:0003924),-0.23676023063863585,-1.0516054643056414,0.25,0.7091938775700048,1.0,50/192,19.08%,DNM3;RAP1A;RIT2;RAB27A;KRAS;MFN1;GBP5;EEF2;RAB6A;GNA14;GBP4;RAB21;GBP7;GCH1;RAB3C;RAP1B;RAB5B;GNB2;RAB8B;GTPBP10;RHOB;RAB11A;EFTUD2;RAB27B;GTPBP1;ATL2;RASL12;ARHGDIB;GFM2;DIRAS2;GPN3;RALB;GNB1;RAB24;GNG5;RIT1;RAB6B;EEF1A1;RAB4A;GPN2;GNG11;GNA12;DNM1;GNA11;RAB3A;NKIRAS2;TBCC;RAB5C;GNAZ;GNA13
prerank,phosphatidylinositol binding (GO:0035091),-0.26573473319215657,-1.0502358336695818,0.3711340206185567,0.7074736558585886,1.0,22/91,16.15%,PITPNC1;ESYT2;MCF2L;EPB41;DENND1B;CCDC88A;SNX13;PITPNA;WDFY3;TNFAIP8L3;SNX27;HIP1R;SNX1;ITPR3;SCARB1;EXOC8;FES;PHF12;PLEKHF2;GAP43;PIGU;PITPNB
prerank,exonuclease activity (GO:0004527),0.3761667399312344,1.0492618483252085,0.4068965517241379,0.8071948644413836,1.0,10/46,11.80%,ENPP1;REXO5;POLG;REXO4;DCLRE1C;DXO;EXOSC1;REXO2;ERI1;EXOSC7
prerank,mannosyltransferase activity (GO:0000030),0.43686927832525246,1.047942872586596,0.4292237442922374,0.8064086316450917,1.0,2/21,2.04%,TMTC1;TMTC4
prerank,chloride channel regulator activity (GO:0017081),-0.41001794866927954,-1.0445109417444238,0.40420560747663553,0.7165737362612148,1.0,5/14,16.85%,VAMP8;SGK1;WNK2;CFTR;STX1A
prerank,3'-5' DNA helicase activity (GO:0043138),0.4608505759162493,1.0434998057988145,0.4228295819935691,0.8137373843849312,1.0,4/16,12.24%,NAV2;RECQL5;ASCC3;MCM2
prerank,cysteine-type peptidase activity (GO:0008234),0.3494019552190889,1.0422717503776864,0.4276401564537158,0.8129108482693056,1.0,26/73,21.19%,USP11;SFRP1;CTSH;CTSF;USP47;USP20;USP35;USP24;USP48;ATG4A;CASP7;OTULINL;USP30;USP9Y;CTSZ;USP10;USP9X;CTSL;USP38;CASP9;CASP1;USP49;USP46;ATG4B;USP37;UCHL1
prerank,C-C chemokine receptor activity (GO:0016493),0.4288759639335947,1.0399741517007282,0.4270516717325228,0.8149266391675116,1.0,3/21,5.27%,XCR1;ACKR2;CCR9
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.325805507676819,-1.0394621770605905,0.3567251461988304,0.7244218005568074,1.0,7/33,10.96%,RNF144B;RNF144A;RNF125;SIAH1;RPS3;SIAH3;DCUN1D4
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.41563397501357113,-1.0374311366033648,0.40654205607476634,0.7244368924652099,1.0,5/12,21.43%,CNOT6L;PAN3;PNLDC1;CNOT7;CNOT8
prerank,ATPase activator activity (GO:0001671),0.4320784026223485,1.0349009508737272,0.43527508090614886,0.8245126676959578,1.0,4/20,16.37%,DNAJC1;ATP1B2;TOR1AIP1;TOR1AIP2
prerank,GTPase binding (GO:0051020),0.3125940137908139,1.0348101700047272,0.4078516902944384,0.8209488673093888,1.0,43/195,15.15%,MYCBP2;RHOH;RABGAP1L;RAPGEF4;ABCA1;DOCK4;USP6NL;OPTN;CDC42EP4;FGD1;IQGAP2;GOLGA4;FGD4;GNB3;RHOBTB3;STRN3;NDRG1;RANBP9;LRRK2;SPHK2;AFDN;MYO1C;ALS2;TRIP11;PICALM;ARFIP2;FMNL1;GGA2;BRAF;RNF152;RRAGD;FGD3;GOLGA5;WASF1;TNFAIP1;RAB3GAP1;TSC2;FLNA;AKAP13;RADIL;RAPGEF6;TBC1D20;HACE1
prerank,microtubule minus-end binding (GO:0051011),0.4673831429109017,1.034116086436386,0.436241610738255,0.8189769440215082,1.0,4/13,19.34%,MACF1;HAUS7;CAMSAP1;NUMA1
prerank,triglyceride lipase activity (GO:0004806),-0.37022988377308674,-1.0338159693962783,0.4051948051948052,0.7284902442195758,1.0,7/20,27.50%,LIPE;PNPLA3;PNPLA2;DAGLB;LIPH;LIPC;LPL
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2964978107900273,1.0333189765300803,0.4136874361593463,0.8171398510463266,1.0,83/431,17.43%,STK17B;DAPK2;ENPP1;RHOH;DAPK1;KSR1;ABCA1;ATP1A2;RHOD;BMPR1A;DMPK;RANBP17;MARK1;MLKL;PRKAG2;RHOBTB1;RRAS2;TGFBR1;MYO18A;MYH10;MYO1B;ACVR1;LIG4;MVK;OAS2;MRAS;RHOBTB3;MAP3K20;PDXK;CDC42;LRRK2;AKT3;RHOBTB2;SIK1;BRSK1;RAB22A;OXSR1;CLPX;MAST2;STK4;IRAK3;ARL2;MAP4K4;ARFIP2;ABCB9;STK11;RHOT1;ARL1;ANXA6;NEK6;PEX6;ABCE1;P2RX5;RRAGD;RHOQ;TLK1;WNK1;TUBB2B;INSR;RAP2A;MAP4K5;ACVR1B;MTREX;MARK2;HSPA9;ARF4;ABCD2;RTEL1;GNL2;NLRC4;RND3;ARF6;TUBB2A;ARL5A;AGAP2;AKT1;RHOG;LONP1;PIM1;PTPA;ABCB6;RHOU;GCK
prerank,WW domain binding (GO:0050699),0.40503705895109166,1.03325974986389,0.41626794258373206,0.81355432960473,1.0,5/26,11.35%,PMEPA1;RAPGEF2;TCEAL8;TCEAL1;NFE2
prerank,G protein-coupled receptor binding (GO:0001664),0.323169640119844,1.0313310531800475,0.4122401847575058,0.8145863641139472,1.0,25/132,14.68%,GRK3;WNT8B;WNT4;GNAS;WNT6;CCL19;INSL3;FZD1;SFRP1;USP20;ZNRF3;WNT5B;AGTR1;TULP3;NPFF;ARRB1;ARHGEF11;PRKN;RYK;ADM;PTCH2;GNAO1;GPRASP2;FLNA;RSPO1
prerank,methyl-CpG binding (GO:0008327),0.42090468790393254,1.0313125235844007,0.4218009478672986,0.8109705619420645,1.0,7/22,14.94%,MBD2;ZBTB38;TET1;ZBTB4;CXXC5;MBD1;CXXC4
prerank,Hsp70 protein binding (GO:0030544),-0.3296955108010262,-1.02952547986578,0.35802469135802467,0.7346946438293585,1.0,11/31,23.49%,RPS3;DNAJB14;SACS;ERN1;NOD2;GPR37;DNAJC8;HIKESHI;PPID;DNAJB1;PPEF2
prerank,ubiquitin binding (GO:0043130),0.34323721315073624,1.0291961476489693,0.43522012578616354,0.8124597352506924,1.0,16/73,14.11%,SMAD3;NEDD4;FAF2;SPRTN;RNF31;SIRT2;UBXN2B;RNF185;CKS1B;UBXN11;PRKN;USPL1;OTULINL;RAE1;RNFT1;ADRM1
prerank,protein phosphatase 2A binding (GO:0051721),-0.35196539810015004,-1.0281066971799584,0.4182825484764543,0.733563531310996,1.0,8/23,15.79%,CTTNBP2NL;GRIN3A;ADCY8;STRN;PPME1;FOXO1;SMG7;STRN4
prerank,chloride channel inhibitor activity (GO:0019869),-0.4371586772936982,-1.0229009736973351,0.44298245614035087,0.7420413447638615,1.0,5/10,23.73%,VAMP8;WNK2;CFTR;STX1A;WNK4
prerank,ankyrin binding (GO:0030506),-0.3579940838340924,-1.0221532955026154,0.42592592592592593,0.7391783978789331,1.0,8/19,15.93%,CDH1;NRCAM;SPTBN1;SPTB;PLEC;CACNA1D;KCTD6;PTPRC
prerank,hyaluronic acid binding (GO:0005540),0.4952332490893296,1.021177067320446,0.4737762237762238,0.8285101664311509,1.0,3/10,14.28%,CEMIP;LYVE1;CHODL
prerank,manganese ion binding (GO:0030145),0.3567711549729536,1.0162929793056947,0.435723951285521,0.8367589733450412,1.0,6/48,6.86%,ADCY2;MPPED2;LARGE1;ENDOU;LARGE2;B4GALT1
prerank,Hsp90 protein binding (GO:0051879),-0.31767255742685957,-1.015287659074286,0.416403785488959,0.7512981066246787,1.0,9/33,20.49%,SLC12A2;KDR;RPS3;UNC45B;ERN1;NOD2;HIF1A;PPID;USP19
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.4123965112522438,1.0151192571157648,0.46021840873634945,0.8360483069032292,1.0,2/25,1.42%,MICAL3;CYP26B1
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.44507046546429085,-1.0145154438592856,0.441747572815534,0.7484865526910853,1.0,6/10,27.29%,USP22;NAA60;EP300;BRCA2;ATF2;HAT1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.48820964533697764,1.0119552621515804,0.4678260869565217,0.8398883207920892,1.0,3/10,11.92%,ECHDC2;ECI1;ECHS1
prerank,double-stranded RNA binding (GO:0003725),-0.27033191460858785,-1.0098618195779268,0.4085106382978723,0.7551012769326082,1.0,17/70,15.52%,STRBP;IFIH1;MBNL1;TFRC;LRRFIP1;VIM;HSP90AB1;TUBB4B;ELAVL1;EIF4A1;MSN;ADAR;SLC3A2;SUPV3L1;APTX;ADARB2;MRPL44
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.4485679622038214,1.0096538300280635,0.4395973154362416,0.8420034779513464,1.0,1/13,0.60%,SLC7A2
prerank,serine-type peptidase activity (GO:0008236),0.32104571002593285,1.0075867508033622,0.4623921085080148,0.8433181187016289,1.0,11/96,11.76%,GZMK;MMP2;ENDOU;RHBDL3;CTSH;PRSS48;APEH;HTRA1;MASP1;CLPP;F2
prerank,NAD+ binding (GO:0070403),0.4548333692211738,1.0073570464689199,0.46397188049209137,0.8401798832357518,1.0,2/12,7.38%,CRYL1;SIRT2
prerank,phosphatase activity (GO:0016791),0.337656027960984,1.0065319214891204,0.4580152671755725,0.8385165213356451,1.0,5/73,3.00%,CILP;PLPP3;ATP1A2;PXYLP1;EPHX2
prerank,double-stranded DNA binding (GO:0003690),0.28636571993392884,1.0056568296795232,0.4862944162436548,0.8371904493989987,1.0,65/531,12.18%,TCF4;ZBTB20;RBMS1;TEAD1;PBX1;ARNT2;PKNOX2;GLI2;ZIC1;MAF;GLI3;THRB;NFIB;ASCL1;JDP2;RUNX2;RARB;ZIC4;NFIX;LBX2;MEOX2;MSC;RFX5;NEUROD1;KLF15;RARG;TBX3;HLF;BCL6;CUX2;TCF7;HES7;ZNF23;RAD51B;DMC1;NR5A1;SPRTN;BATF;DDX60;SREBF1;REXO4;NR1D1;OSR1;BBX;TCF7L1;FOXC2;KDM5B;EGFR;GMEB1;GLIS2;ARNT;CREB3L4;CREB3;FOXA1;NR1D2;MBD1;ZNF177;CEBPB;BHLHE41;NFE2;SPDEF;NKX2-8;ZBTB37;NR4A1;TERF2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.4754498115614009,1.0052867289339866,0.4675090252707581,0.8344169548749371,1.0,1/11,0.27%,ITPR1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.48589430020673685,1.003778560893322,0.48300536672629696,0.8344746883535024,1.0,3/10,10.79%,ASH1L;NSD1;SETD5
prerank,AMP binding (GO:0016208),0.4691550783450216,1.0037768257553794,0.47333333333333333,0.8309315085221821,1.0,2/11,3.24%,MPPED2;PRKAG2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.40732432479267855,1.0037308718237659,0.49216300940438873,0.8275151473755145,1.0,3/22,9.04%,HSPG2;APOE;PICALM
prerank,mRNA binding (GO:0003729),0.2955345587125997,1.0036281990574347,0.47103004291845496,0.8242625529468843,1.0,30/249,11.34%,CELF2;SAMD4A;RBMS1;RBMS3;A1CF;CSDC2;RBFOX1;RBMXL2;HNRNPLL;RBFOX2;MYH10;IGF2BP2;SNRNP70;CPEB1;ZFP36L1;THOC2;ACO1;SF1;CPEB3;DXO;RBMS2;HNRNPR;RBPMS;METTL14;PARN;EIF3A;NUP98;DDX3X;EIF2S2;SERBP1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.31193797454611105,1.0033491676523922,0.46794150731158607,0.8214020090163034,1.0,41/147,16.64%,RIN2;MYCBP2;FARP1;RAPGEF4;DOCK4;DOCK10;RCBTB2;DOCK11;IQSEC2;DENND2A;FGD1;RAPGEF2;FGD4;DENND4A;ARFGEF2;ARHGEF17;DOCK5;DENND5A;ARHGEF18;ALS2;RGL1;ARHGEF11;RAPGEF1;EIF2B4;SBF2;LAMTOR2;ARHGEF10;FGD3;DENND1A;EGF;RAB3GAP1;EPS8L1;SERGEF;CCZ1;AKAP13;RAPGEF6;EIF2B3;RAB3IL1;ARFGEF1;FNIP1;DENND6A
prerank,peptidoglycan binding (GO:0042834),-0.43357416075592803,-1.0031420281389154,0.4786516853932584,0.7661693988533667,1.0,6/10,32.00%,NOD1;PGLYRP1;NOD2;JCHAIN;NLRP3;TLR2
prerank,C-C chemokine binding (GO:0019957),0.4077206273897176,1.0027699454144978,0.4624624624624625,0.8193109015593678,1.0,3/22,5.27%,XCR1;ACKR2;CCR9
prerank,voltage-gated cation channel activity (GO:0022843),-0.2527603836609855,-1.0014162425829247,0.42857142857142855,0.7655357796933254,1.0,28/97,21.31%,KCNB2;PTK2B;KCNQ5;KCND2;GRIN2A;KCNMA1;KCND3;KCNQ1;KCNH7;KCNH5;KCNC2;GRIN2B;GRIN3A;CACNA2D2;KCNQ3;KCNA2;CACNA2D1;CACNA1D;KCNS3;CACNG3;CACHD1;CACNG4;CACNA1A;GRIN1;HCN1;CACNB3;HVCN1;KCNC1
prerank,filamin binding (GO:0031005),-0.41553269508653,-1.0005004293936723,0.46153846153846156,0.7630289441999476,1.0,1/11,0.02%,NEBL
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3506568529125144,0.9990018974615813,0.46184738955823296,0.8246344962288399,1.0,4/49,3.00%,ATP1A2;PXYLP1;MPPED2;EPHX2
prerank,proton transmembrane transporter activity (GO:0015078),-0.2987003296723107,-0.9987608554131919,0.39666666666666667,0.762693353167441,1.0,15/39,25.88%,CLCN3;COX4I1;CLCN5;UQCRH;COX6A1;COX5B;COX5A;CLCN4;UQCR10;COX8A;UQCR11;ATP6V1F;UQCRQ;UQCRC1;UQCRFS1
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.28213444833427,-0.9971006398283704,0.4448669201520912,0.7619575669964602,1.0,19/49,25.31%,CPNE8;ESYT2;MCTP1;DYSF;CPNE3;SYT1;PCLO;PLA2G4C;SYT6;CPNE5;SYT4;ANXA1;SYT15;PLA2G4F;PLA2G4E;SYT5;ANXA8;ESYT3;CPNE9
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.4348837091220414,-0.9955668405852433,0.47380410022779046,0.7610755543686413,1.0,4/10,12.93%,SHANK3;SHANK1;NSF;IGSF11
prerank,potassium:proton antiporter activity (GO:0015386),-0.4165177473206667,-0.9944323694900135,0.4697986577181208,0.7591880326907278,1.0,3/10,8.53%,SLC9A2;SLC9A6;SLC9A7
prerank,tubulin binding (GO:0015631),-0.21186028101270754,-0.9938514871819285,0.45652173913043476,0.7562572320178845,1.0,73/295,19.71%,DNM3;MTUS1;SGIP1;TTLL7;MAP2;UNC5C;TTLL5;REEP1;NAV3;STARD9;DIP2B;RABGAP1;CCDC88A;KIF26B;EML5;MID1;DIXDC1;FMN1;KIF6;KIF13A;RPS3;KIF2A;ARHGEF2;TBCE;FNTA;CDK5;KRIT1;SUN2;PAK1;SYBU;RP1;EFHC2;RAB11A;PAFAH1B1;ARL3;AGBL4;CCDC61;ALDOA;KIF16B;NEFH;KIF20B;KIF1A;PHF6;GIT1;KIF15;POLB;DCTN1;GAS2L1;TPPP3;TRPV4;CCDC88C;CDK5RAP2;EMD;MAP1B;CEP57;KIF21A;CAPN6;DNM1;PRC1;GAS8;CDK5R1;IRAG2;KIF23;BRCA2;KIF18A;REEP2;MTCL1;RAB11FIP5;MAST1;CLASP1;KIF5A;SPAG5;KIF18B
prerank,motor activity (GO:0003774),-0.2659810896455402,-0.9918114211758352,0.43829787234042555,0.7565394452199394,1.0,19/60,22.51%,STARD9;KIF26B;KIF6;KIF13A;KIF2A;KIF16B;KIF20B;KIF1A;DYNLRB1;KIF15;KIFC3;KIF21A;KIF23;KIF18A;KIF5A;KIF18B;KIF22;KIF4A;KIF14
prerank,cAMP binding (GO:0030552),-0.4091952217220736,-0.9909781907339212,0.4923747276688453,0.7541199146417017,1.0,3/11,4.96%,PDE4D;PDE4B;PDE2A
prerank,protein phosphatase binding (GO:0019903),-0.24117898101308513,-0.9909443859985805,0.4819277108433735,0.7497646044852154,1.0,31/117,17.28%,PPP1R16B;CTTNBP2NL;ITGA1;IQGAP1;MET;KIFAP3;PXN;KCNQ1;ERBB2;PTPRT;FLT4;SIRPA;AP3B1;GRIN3A;ATP2B4;AKAP11;ANAPC7;GTF2F1;JUP;MTMR9;SKAP1;ADCY8;STRN;PPP1R3B;PPME1;CEACAM1;FOXO1;SMG7;STRN4;JAK3;RACK1
prerank,hexosaminidase activity (GO:0015929),0.4581793789257559,0.9908284393194484,0.515358361774744,0.8400898800168898,1.0,1/12,0.72%,CEMIP
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.37439091863631246,0.9886027911447939,0.4885386819484241,0.8419761208482144,1.0,12/33,21.26%,AR;RECQL5;WDR43;PAF1;NCOA3;PCF11;ELOF1;WAC;CDC73;ELP4;HNRNPU;SCAF8
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.336647766196439,-0.988480183316414,0.4766355140186916,0.7427358806313097,1.0,11/22,36.14%,CHRM3;HTR2A;HRH1;CHRM2;CHRM1;HTR6;HTR5A;HRH3;CHRM5;HTR2B;HTR1D
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.336647766196439,-0.988480183316414,0.4766355140186916,0.7427358806313097,1.0,11/22,36.14%,CHRM3;HTR2A;HRH1;CHRM2;CHRM1;HTR6;HTR5A;HRH3;CHRM5;HTR2B;HTR1D
prerank,serotonin receptor activity (GO:0099589),-0.336647766196439,-0.988480183316414,0.4766355140186916,0.7427358806313097,1.0,11/22,36.14%,CHRM3;HTR2A;HRH1;CHRM2;CHRM1;HTR6;HTR5A;HRH3;CHRM5;HTR2B;HTR1D
prerank,titin binding (GO:0031432),0.44692339968885897,0.9882739821628622,0.4726027397260274,0.8391692230233564,1.0,1/13,0.87%,ACTN2
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.30338843981842456,-0.9824492550354311,0.5144694533762058,0.7527417911475184,1.0,4/35,2.95%,PLCE1;GPCPD1;ENPP2;APEX2
prerank,transaminase activity (GO:0008483),0.46698429630717864,0.9824321173431876,0.494077834179357,0.8493570755260639,1.0,1/11,2.21%,ABAT
prerank,nuclear receptor coactivator activity (GO:0030374),0.3433878993394083,0.979694931869595,0.5080213903743316,0.8524317582792785,1.0,21/52,21.36%,NCOA2;BRD8;ATXN7L3;TACC1;MED14;ZMIZ1;ACTN4;FGF2;PSMC3IP;HELZ2;NCOA3;ETS1;SS18;NCOA7;CARM1;NCOA6;MED30;DCAF6;ACTN1;MED12;PRKCB
prerank,fibroblast growth factor receptor binding (GO:0005104),0.4071503897576862,0.9790884675992879,0.5,0.850411445215881,1.0,3/21,10.16%,KL;FRS2;FGF2
prerank,methyltransferase activity (GO:0008168),0.3486350339870054,0.9783959637265988,0.4979253112033195,0.8485036713834095,1.0,13/46,21.25%,NNMT;COMT;BUD23;NSUN2;FTSJ3;LRTOMT;BCDIN3D;NSUN4;METTL4;DNMT3B;METTL3;N6AMT1;DNMT1
prerank,sodium channel regulator activity (GO:0017080),-0.2925713814219398,-0.9781847963311084,0.46325878594249204,0.7579397610718599,1.0,8/37,10.27%,NEDD4L;YWHAH;CAMK2D;FGF12;NOS1;ATP2B4;SGK1;GPLD1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.2848215614267059,0.9775755143615269,0.5221987315010571,0.8470128748626159,1.0,53/254,18.20%,TCF4;NFIA;SMAD3;AR;MITF;RUNX1;PRRX1;SP7;NFIB;MLXIP;MEOX2;RLF;IRF1;RFX5;NEUROD1;KLF15;HLF;CEBPA;RBPJ;FOXC2;MZF1;SMAD1;GMEB1;GLIS2;CREB3;FOXA1;ZSCAN21;NKX2-8;NR4A1;STAT6;MYCN;SMARCD2;ETS1;TCF12;HOXC4;FOXK2;MTF1;TFCP2;ZBTB17;ZNF585B;ZNF585A;PLAG1;ATF5;TFDP1;SP1;MYBL1;GTF2I;IRF2;FOXJ3;ELF1;FOXO3;RFXANK;SOX11
prerank,phosphatidic acid binding (GO:0070300),-0.3429133633923294,-0.9766591221647513,0.4699738903394256,0.757267492170239,1.0,2/19,0.74%,PITPNC1;PLTP
prerank,exopeptidase activity (GO:0008238),-0.2757869864891677,-0.9744041881396229,0.48363636363636364,0.7582660880205243,1.0,19/50,26.91%,DPP10;FAP;PRCP;XPNPEP3;ACE2;DPP6;MME;METAP2;BLMH;GGH;DPEP3;CPE;DPP4;NUDT16;RCE1;TRHDE;LNPEP;NPEPPS;CPB1
prerank,histone deacetylase activity (GO:0004407),0.41092748556813474,0.9735564894524757,0.5147286821705427,0.8532327352010229,1.0,10/19,28.88%,SIRT2;HDAC8;HDAC4;SUDS3;MIER3;HDAC6;HDAC5;HDAC1;MIER1;SIRT7
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.36703479251479465,0.9732186165630683,0.5007541478129713,0.8505617400254706,1.0,5/30,6.97%,GAS6;CAST;MT3;CST3;DPEP1
prerank,histone acetyltransferase binding (GO:0035035),0.40171873615993287,0.9714542527768905,0.49842767295597484,0.8512647391974644,1.0,5/21,12.95%,GLI3;EPAS1;SIRT2;KANSL1L;TRIP4
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.3157243275223541,-0.9711439864794373,0.5175438596491229,0.7615809205974774,1.0,6/29,14.91%,PTPRJ;GCH1;NFATC1;SIRT1;DUSP7;DUSP8
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.2894523682029028,-0.9681245708608143,0.5179153094462541,0.7599543163482592,1.0,15/34,28.83%,NDUFC1;NDUFA6;NDUFA5;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;NDUFS7;NDUFS1;NDUFS5;NDUFB3;NDUFB4;NDUFV2;NDUFV3
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.2894523682029028,-0.9681245708608143,0.5179153094462541,0.7599543163482592,1.0,15/34,28.83%,NDUFC1;NDUFA6;NDUFA5;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;NDUFS7;NDUFS1;NDUFS5;NDUFB3;NDUFB4;NDUFV2;NDUFV3
prerank,GTPase inhibitor activity (GO:0005095),0.44354221478177164,0.9680616497327149,0.5008375209380235,0.8556133891482192,1.0,4/13,12.61%,RHOH;IQGAP2;ARL2;GPS1
prerank,pyrophosphatase activity (GO:0016462),0.34249746579827955,0.9668140058872144,0.5202156334231806,0.8550015521768989,1.0,7/50,10.99%,CILP;ENPP1;NUDT7;DXO;DOLPP1;PLPP5;DDX3X
prerank,high voltage-gated calcium channel activity (GO:0008331),0.4649711963450144,0.9666566934679156,0.4963898916967509,0.852088664032791,1.0,2/10,6.66%,CACNB1;CACNA1C
prerank,glucuronosyltransferase activity (GO:0015020),0.4026732054626939,0.9654568675901947,0.5325542570951586,0.8514811154656731,1.0,7/19,23.81%,LARGE1;LARGE2;EXT1;CHSY1;EXT2;B3GAT3;B4GAT1
prerank,ephrin receptor binding (GO:0046875),0.39393479389667946,0.9645353760889921,0.5104,0.8503215189050478,1.0,5/21,9.03%,LYN;EFNB2;SRC;EFNA2;EFNB1
prerank,phosphate ion binding (GO:0042301),-0.40945830753354684,-0.9642143546081648,0.5044843049327354,0.7650506030075108,1.0,5/10,31.95%,PDE2A;PNP;MTHFD2;CHST14;ADSS2
prerank,phospholipase A2 activity (GO:0004623),-0.3153195963431768,-0.9627621480348654,0.515850144092219,0.7643743081001232,1.0,14/26,37.22%,PLA2G7;PLAAT3;PNPLA8;PNPLA3;PLA2G4C;PLA2G4F;PLA2G4E;PLAAT1;PLA2G4B;PLA2G5;PLB1;PLA2G6;PLA2G3;PLAAT5
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.33325434335033577,0.9618832858574066,0.5304010349288486,0.8528115811991137,1.0,14/55,16.48%,SLC7A2;SLC16A12;SLC13A3;SLC6A13;PDPN;SLC38A6;SLC22A4;SLC38A9;SLC16A3;SLC38A3;SLC7A6;SLC38A10;SLC38A2;SLC16A2
prerank,N-acetyltransferase activity (GO:0008080),0.4111977017356603,0.9574595241400337,0.5278219395866455,0.8592984324372644,1.0,9/19,24.13%,KAT2B;SAT2;NAA80;NAT2;NAA50;SAT1;SMARCE1;NAT14;ESCO1
prerank,chemoattractant activity (GO:0042056),0.38574907499860694,0.9555600290892684,0.5372907153729072,0.8600482926907799,1.0,6/26,20.02%,GDNF;NTF3;FGF2;BMP4;CX3CL1;PGF
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.45378822532710616,0.954543243906385,0.5150943396226415,0.8588946711032203,1.0,2/10,6.97%,DPYSL3;DPEP1
prerank,actin monomer binding (GO:0003785),0.38798893230232007,0.9526955147372003,0.514820592823713,0.859671839658638,1.0,3/22,7.31%,MTSS1;LIMA1;MYL4
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.20835562546662342,-0.9490788309995348,0.6557377049180327,0.791829157700354,1.0,62/248,19.71%,DNM3;RAP1A;RIT2;RAB27A;KRAS;MFN1;VWA8;GBP5;EEF2;RAB6A;KIF2A;GNA14;GBP4;RAB21;GBP7;GCH1;RAB3C;RAP1B;RAB5B;GNB2;RAB8B;GTPBP10;RHOB;RAB11A;EFTUD2;RAB27B;GTPBP1;ATL2;RASL12;ARHGDIB;GFM2;KIF20B;DIRAS2;KIF1A;GPN3;RALB;GNB1;RAB24;GNG5;RIT1;KIF15;CFTR;RAB6B;EEF1A1;RAB4A;RUVBL1;GPN2;GNG11;GNA12;DNM1;GNA11;RAB3A;NKIRAS2;TBCC;CHD3;RAB5C;GNAZ;GNA13;KIF5A;CLU;DHX9;KIF18B
prerank,voltage-gated anion channel activity (GO:0008308),-0.3602657120464736,-0.9445161007247191,0.5157894736842106,0.7980937638953746,1.0,3/15,8.88%,ANO1;CLCN3;CLCN5
prerank,protein phosphatase 1 binding (GO:0008157),-0.3258605144500405,-0.9419602209392046,0.5589041095890411,0.7995534455307914,1.0,9/21,31.21%,PPP1R16B;KCNQ1;AKAP11;PPP1R3B;PPP1R11;PPP1R16A;LILRB1;PPP1R3F;PHACTR4
prerank,tropomyosin binding (GO:0005523),0.42120871648346536,0.9412761297318168,0.5482815057283142,0.8815456840018798,1.0,3/16,2.82%,CALD1;TMOD4;TNNT1
prerank,vinculin binding (GO:0017166),-0.386609499777797,-0.9365651904895576,0.5290023201856149,0.8075746102868013,1.0,3/11,9.00%,UTRN;PXN;SORBS3
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.4259831436830228,0.9358162129977504,0.5524956970740104,0.8904611913708823,1.0,5/14,14.62%,ACO1;EXO5;NUBPL;NFU1;ETFDH
prerank,UDP-galactosyltransferase activity (GO:0035250),0.44630910846492966,0.9339946809589548,0.5417439703153989,0.891013049252667,1.0,2/10,6.86%,B3GALT1;B4GALT1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.38965511752881093,0.9338761727568473,0.5466893039049237,0.8878920942734609,1.0,7/18,22.80%,GAS6;MT3;DPEP1;NOL3;BIRC2;BIRC3;XIAP
prerank,retinoid X receptor binding (GO:0046965),0.44324280112153724,0.9323995143361339,0.5472370766488414,0.8878036782829529,1.0,3/11,9.67%,RARG;TACC1;NSD1
prerank,protein kinase binding (GO:0019901),0.26389519136861955,0.9314250876699639,0.687246963562753,0.886692701794291,1.0,93/479,17.04%,TCF7L2;NELL1;PDLIM5;ERRFI1;RHOH;GHR;SMAD3;SASH1;PRKCSH;IL31RA;GRK5;DACT1;RHOD;KIF13B;NEDD9;EPHA4;NBEAL1;CCNA2;CEP152;PRKAG2;RHOBTB1;PDGFRB;KIF20A;RFFL;CDK5RAP3;MAPK4;ACVR1;TOM1L2;PKIA;RHOBTB3;CDH5;SKI;CDC42;CD247;RHOBTB2;SIK1;NISCH;ERCC6L2;IL15RA;CKS1B;TOP2B;PARD6G;OXSR1;PARD6B;IRAK3;DNAJC3;KAT2B;ZBTB4;SPRY2;CCNK;SMAD1;PRKN;ITGAV;TELO2;PARN;SPRED3;KIZ;NEK6;ADRA2A;UFL1;RGCC;TNIP2;DUSP19;WNK1;MAP3K13;MAP2K6;TRIP4;DACT2;VDAC1;NOX4;MVP;FAM83F;LLGL1;PTPN23;IBTK;GATA6;CEP192;SUFU;BAG5;RNF13;SPRED1;RND3;TPCN2;MAPKAPK2;STX1B;CASP9;TBL2;AGAP2;RHOG;MAPK8IP3;CDKN2C;RNF138;ZC3HC1
prerank,tau protein binding (GO:0048156),0.3411432309907324,0.9313398544424358,0.5427350427350427,0.8835989379136662,1.0,6/40,10.44%,ROCK2;MARK1;APOE;BRSK1;PICALM;TTBK1
prerank,endopeptidase activator activity (GO:0061133),0.4424589526801561,0.9306580786981704,0.5542570951585977,0.8819004453430556,1.0,4/10,19.70%,APH1B;ADRM1;NLRC4;PSME3
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.3303289372238275,0.929797110522984,0.5783633841886269,0.8805021849015324,1.0,6/46,11.82%,B3GALT1;OGT;LARGE1;B3GALNT1;EXT1;MGAT3
prerank,thioesterase binding (GO:0031996),0.4233037362071263,0.929228728638403,0.5472027972027972,0.8785815248637648,1.0,4/11,15.37%,CDC42;ADRA2A;HAUS7;ARF6
prerank,death domain binding (GO:0070513),-0.39221678478329236,-0.9280458259964282,0.5465116279069767,0.8228679831685387,1.0,6/11,17.28%,CRADD;DAPL1;BCL2L1;MCL1;DAP;RACK1
prerank,sodium channel activity (GO:0005272),0.332372198425676,0.926631427330465,0.5589519650655022,0.8810184880528334,1.0,3/37,5.57%,SCN7A;SHROOM2;GRIK5
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.3792815166983483,-0.9251196774612093,0.5202863961813843,0.8250464469917902,1.0,3/12,6.54%,NOD1;BCL2L13;ATP2A3
prerank,flavin adenine dinucleotide binding (GO:0050660),0.3205528543561025,0.9235080416471144,0.570281124497992,0.8845253527896014,1.0,16/53,23.13%,MICAL3;DPYD;MTHFR;DDO;SQOR;AIFM1;FOXRED2;NOX4;ETFDH;AOX1;CYB5R3;ETFA;PRODH;SDHA;LDHD;DLD
prerank,phosphatase binding (GO:0019902),0.2919951507986496,0.9224097746380147,0.6053268765133172,0.8835514305593917,1.0,25/105,15.74%,PIK3R1;SMAD3;ANK1;CDH5;EIF2AK3;MAST2;MTMR3;EGFR;ANAPC5;VRK3;PPP1R3C;IKBKE;TBK1;CD33;RCAN3;WNK1;SYTL2;STAT6;TSC2;MVP;DLG4;CEP192;SPRED1;DZIP3;PIK3R2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.39186481483437224,0.9188256970486336,0.5702341137123745,0.8878641970022094,1.0,7/18,21.94%,PIK3R1;WDR81;WDR91;PIK3R2;AGAP2;SOCS4;SOCS7
prerank,MAP kinase activity (GO:0004707),-0.35888894063890603,-0.9182874799502204,0.5792079207920792,0.8361573549071963,1.0,7/14,24.26%,NLK;MAPK10;MAPK8;MAPK3;MAPK1;MAPK11;MAPK7
prerank,calcium channel regulator activity (GO:0005246),0.337329428510592,0.912659932226138,0.5820029027576198,0.8975617843348,1.0,2/37,4.12%,ITPR1;STIM1
prerank,symporter activity (GO:0015293),-0.39085281024653806,-0.9113762834254868,0.5870535714285714,0.8473969935743411,1.0,2/10,7.78%,SLC5A6;MFSD2A
prerank,leucine zipper domain binding (GO:0043522),0.43448102558162816,0.9112743571538753,0.5654545454545454,0.8971780823013497,1.0,4/10,20.99%,PMF1;PAWR;AATF;DDIT3
prerank,syntaxin binding (GO:0019905),0.3066320710129865,0.9095252164431962,0.5903141361256544,0.8976779873008487,1.0,8/61,7.85%,DAPK1;ABCA1;UNC13C;BAIAP3;STXBP3;STX16;LRRK2;SYT9
prerank,hormone receptor binding (GO:0051427),-0.3496420981444027,-0.9068400869671419,0.5773955773955773,0.8530706471857,1.0,3/14,12.82%,SOCS2;JAK2;TYK2
prerank,ribosomal small subunit binding (GO:0043024),0.3887764636074043,0.9066585900762409,0.5907643312101911,0.9002768334323482,1.0,6/17,20.06%,ERAL1;DDX3X;ABCE1;LARP1;PIM1;PTCD3
prerank,chemokine receptor activity (GO:0004950),0.36350581422227757,0.9064358159247217,0.6027190332326284,0.8974662037971624,1.0,3/24,5.27%,XCR1;ACKR2;CCR9
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.40645362543690833,0.906356859793232,0.5652951699463328,0.8944317048008527,1.0,7/12,23.23%,PHF2;KDM7A;PHF8;KDM3B;KDM4A;KDM4C;KDM3A
prerank,histone deacetylase binding (GO:0042826),0.2900831084087936,0.9049920238419769,0.6180048661800487,0.8941274678583134,1.0,23/88,17.75%,DACT1;GLI3;BCOR;BEX4;SIRT2;TOP2B;MTA2;NCOR1;ZMYND15;MTA3;KAT2B;BRMS1L;PRKN;NCOR2;BHLHE41;YWHAE;HDAC4;AKAP8L;SUDS3;CAMTA2;SP1;KPNA2;NIPBL
prerank,cation channel activity (GO:0005261),0.2867456495142265,0.9045487484042538,0.6151035322777101,0.891939836922352,1.0,13/94,10.48%,SLC24A3;NALCN;TRPA1;CALHM5;SLC24A1;MCU;KCNK7;SLC24A5;PANX1;CUL5;KCNQ4;TRPM4;ANXA6
prerank,hexosyltransferase activity (GO:0016758),0.2890280433594852,0.9040678090690992,0.64004914004914,0.8897418734156128,1.0,9/101,8.30%,TMTC1;TMTC4;B3GALT1;OGT;LARGE1;LARGE2;B4GALT1;B3GALNT1;ALG5
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.39384479282154644,-0.9035055628748525,0.5959821428571429,0.8561388816465035,1.0,5/10,21.89%,SIRPA;JUP;CXADR;DSG2;DSP
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.3828717723597199,0.9024533616648108,0.6055646481178396,0.8898516342407806,1.0,2/18,3.64%,PDLIM5;CNN3
prerank,regulatory RNA binding (GO:0061980),0.3322842699966766,0.9020055528966737,0.5957746478873239,0.8876443944743522,1.0,12/38,24.47%,ZC3H7B;TUT7;PIWIL4;HNRNPA1;TUT4;ZNF346;RC3H1;DICER1;AGO4;RBM4;SOX2;AGO3
prerank,adenylyltransferase activity (GO:0070566),0.37217361432299034,0.9014699764263565,0.583739837398374,0.8856149034652763,1.0,10/21,25.79%,OAS2;TENT4A;TENT4B;PAPOLG;NMNAT2;COASY;PAPOLA;NMNAT1;PAPOLB;ABL1
prerank,protein phosphatase regulator activity (GO:0019888),0.31447557708088547,0.8999692804407938,0.6063829787234043,0.8855982555113601,1.0,8/53,13.47%,RCAN2;DMPK;RCAN1;PPP4R4;RCAN3;PPP2R5D;BOD1L1;IGBP1
prerank,MAP kinase phosphatase activity (GO:0033549),-0.36925855822591036,-0.8978645916976865,0.594059405940594,0.8645199589246899,1.0,5/12,36.20%,DUSP7;DUSP8;DUSP3;DUSP5;DUSP2
prerank,kinase binding (GO:0019900),0.25535887128876117,0.894092607148965,0.7732379979570991,0.8945987204095385,1.0,89/434,17.04%,TCF7L2;ERRFI1;RHOH;GHR;GSN;SMAD3;SASH1;IL31RA;RHOD;KIF13B;WWC2;NBEAL1;CCNA2;SP100;CEP152;PRKAG2;RHOBTB1;PDGFRB;KIF20A;RFFL;CDK5RAP3;MAPK4;TOM1L2;RHOBTB3;SKI;CDC42;SRC;RHOBTB2;PARP16;SIK1;CEBPA;NISCH;ERCC6L2;IL15RA;CKS1B;OXSR1;TTC28;IRAK3;DNAJC3;EGFR;KAT2B;ZBTB4;SPRY2;CCNK;SMAD1;PRKN;TELO2;PARN;SPRED3;KIZ;NEK6;TRIP6;ADRA2A;UFL1;RGCC;TNIP2;STRADA;WNK1;MAP3K13;MAP2K6;TRIP4;VDAC1;MYCN;MVP;FAM83F;LLGL1;DLG4;PTPN23;FLNA;IBTK;GATA6;CEP192;SUFU;BAG5;SPRED1;RND3;LAPTM4B;TPCN2;STX1B;CASP9;TBL2;AGAP2;SGO1;RHOG;ATF5;TNS2;CDKN2C;RNF138;ZC3HC1
prerank,voltage-gated sodium channel activity (GO:0005248),0.3584496239449841,0.8931397879945729,0.6161137440758294,0.893284611946395,1.0,1/22,0.69%,SCN7A
prerank,hydro-lyase activity (GO:0016836),0.3247751714962539,0.892770573620277,0.597997138769671,0.8910093027683791,1.0,5/41,8.02%,GMDS;ECHDC2;ACO1;ECI1;ENO2
prerank,phospholipase activity (GO:0004620),-0.2408827444494512,-0.8924673014036303,0.6653061224489796,0.8717528633684756,1.0,25/67,27.50%,PLCE1;ENPP2;MGLL;PNPLA7;PLAAT3;GPLD1;PNPLA8;PNPLA3;PLA2G4C;SMPDL3A;ABHD6;PITPNM3;PLD3;PNPLA6;LYPLA2;PLA2G4F;LYPLA1;PLA2G4E;GDPD1;LIPH;ABHD4;PLAAT1;LIPC;PLA2G4B;LPL
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.36631573251038146,0.8923196487851225,0.6015873015873016,0.8887871277900734,1.0,8/21,18.50%,AKAP7;ARFGEF2;PRRC1;WASF1;AKAP8L;ARFGEF1;PJA2;PRKACA
prerank,syntaxin-1 binding (GO:0017075),0.35988396743265355,0.8906937713966054,0.6024844720496895,0.8888191883050325,1.0,4/22,6.60%,DAPK1;UNC13C;STXBP3;LRRK2
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3461051561717504,-0.8873812019871254,0.617948717948718,0.8782193747602985,1.0,3/15,11.16%,EPB41;WDFY3;SCARB1
prerank,PDZ domain binding (GO:0030165),0.3027783325460773,0.8848361372420349,0.6436170212765957,0.8969656812150026,1.0,10/61,9.32%,TGFBR3;DOCK4;FZD2;ARHGAP29;SYNJ2;RAPGEF2;FZD1;PLEKHA2;SLC22A4;PRKN
prerank,ferrous iron binding (GO:0008198),-0.30290480954440746,-0.8846458527959762,0.6016949152542372,0.8797907904028871,1.0,5/21,12.33%,EGLN3;FTL;FTH1;EGLN2;ISCU
prerank,DNA replication origin binding (GO:0003688),-0.2920928584683717,-0.8846433078043145,0.6027027027027027,0.8753474025725696,1.0,11/23,36.19%,ORC4;MCM8;MCM3;DHX9;MCM5;ORC5;GRWD1;CDC6;POLA1;MCM7;KAT7
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.3207209971641745,0.8838687806706377,0.6225626740947076,0.8957618395837418,1.0,17/44,20.88%,SETD7;ASH1L;KMT5B;SETD1A;NSD1;WDR82;SETD5;SETD4;SMYD3;KMT2E;KMT2A;SETDB1;WDR5;SETD1B;CXXC1;RBBP5;N6AMT1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.3761933201090968,-0.8821630652392897,0.6239495798319328,0.8761882656208004,1.0,5/10,29.65%,PIK3R3;PIK3C2B;PIK3CA;PIK3CG;PIK3CD
prerank,ribosomal large subunit binding (GO:0043023),-0.3642730731026119,-0.8802332275858666,0.6121951219512195,0.875827080608522,1.0,6/11,26.42%,MRRF;MALSU1;NPM1;CPEB2;LTN1;CPSF6
prerank,Wnt-activated receptor activity (GO:0042813),0.3761666545795573,0.8794337834067967,0.6216666666666667,0.9016134599036153,1.0,4/15,10.17%,FZD2;FZD1;ROR1;RYK
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.416937230418165,0.8784841055700047,0.6123893805309735,0.9004328406445432,1.0,1/10,3.80%,SLC6A13
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.2977905077141231,-0.8778984434795708,0.6641414141414141,0.8763427989809334,1.0,2/21,4.34%,GRIK2;P2RX7
prerank,peptidase activator activity (GO:0016504),0.3585228928638023,0.8768724473023131,0.621283255086072,0.9007073698583592,1.0,7/22,15.32%,PCOLCE;PSME4;CLPX;APH1B;ADRM1;CASP8AP2;NLRC4
prerank,nucleotidyltransferase activity (GO:0016779),0.3699914301216599,0.8768053119398562,0.6462035541195477,0.8978385979118125,1.0,8/19,21.39%,TUT7;TENT4A;TUT4;CRPPA;TENT4B;YRDC;PAPSS2;NUDT5
prerank,amyloid-beta binding (GO:0001540),0.29076783280061963,0.8761668022238794,0.6650124069478908,0.8959727165145991,1.0,12/79,9.04%,LRP1;HSPG2;EPHA4;APOE;APOA1;LDLR;CST3;APBB2;TLR6;APBA1;EPHB2;PICALM
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.34751972712771684,-0.8754445748805288,0.6344339622641509,0.8772415583955311,1.0,3/12,12.53%,EIF4E;CYFIP2;EIF4E2
prerank,lysophospholipase activity (GO:0004622),0.35954958166364626,0.8685667969172585,0.6307448494453248,0.9075304902663619,1.0,3/20,6.13%,ASPG;PLA2G4A;LYPLAL1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.40590857494393934,0.8683866732103298,0.6073298429319371,0.9048794109529106,1.0,4/11,16.25%,UBE4B;UBOX5;AMFR;UBR5
prerank,MAP kinase kinase activity (GO:0004708),0.3786391009287846,0.8670932623864667,0.627318718381113,0.9045527321874386,1.0,3/15,12.85%,LRRK2;MAP2K1;MAP2K6
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.32867003295005626,-0.8660200911691796,0.6498740554156172,0.8931946323153659,1.0,6/16,18.60%,MTMR2;INPP5F;MTMR9;SACM1L;MTMR6;SYNJ1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.33943212326920585,-0.8654620182903263,0.629976580796253,0.8898889424290402,1.0,3/13,14.26%,PIP5K1B;PIK3C2B;PIK3CA
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.3327827092656634,0.8648255746276313,0.657393850658858,0.9057280160596053,1.0,6/32,9.72%,SLC1A5;SLC6A9;SFXN2;SLC38A6;SLC38A9;SLC43A1
prerank,miRNA binding (GO:0035198),0.32801755970178004,0.8637969180216305,0.6473149492017417,0.9045349156790591,1.0,10/30,24.47%,ZC3H7B;TUT7;HNRNPA1;TUT4;ZNF346;RC3H1;AGO4;RBM4;SOX2;AGO3
prerank,general transcription initiation factor binding (GO:0140296),-0.2902748272345394,-0.8628075046667509,0.685131195335277,0.8909311005411286,1.0,11/25,23.25%,ESR1;TAF1B;TAF1;TBP;HHEX;GTF2A2;RUVBL1;YEATS2;THAP7;GTF2B;THRA
prerank,myosin binding (GO:0017022),0.29537136735582936,0.862205884496487,0.6895161290322581,0.9044693608850879,1.0,3/55,1.20%,KIRREL1;CALD1;GSN
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.3751791589897311,-0.8608865262274364,0.6361556064073226,0.890577037334565,1.0,5/10,10.68%,PRKAR1A;PKIB;PRKAR2B;PRKAR1B;PRKAR2A
prerank,cytochrome-c oxidase activity (GO:0004129),-0.33058190981017677,-0.8607492624103856,0.6666666666666666,0.8866026246645843,1.0,5/15,22.63%,COX4I1;COX6A1;COX5B;COX5A;COX8A
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.2719625334206934,0.8605829923210916,0.7053892215568862,0.9046810259975437,1.0,27/100,16.32%,MYO10;OGT;MYO1B;SH3PXD2B;IQGAP2;OSBPL8;PLA2G4A;ADAP2;PLEKHA8;ARHGAP9;ARFIP2;COMMD1;SNX12;GOLPH3L;SNX21;DENND1A;WIPI1;PLEKHN1;PIRT;PARD3;SAP30L;OSBPL5;GSDMD;LAPTM4B;GOLPH3;FCHSD2;AKT1
prerank,cholesterol transfer activity (GO:0120020),0.37671737468251965,0.8597790293163687,0.626465661641541,0.9032834173554851,1.0,5/16,15.43%,ABCA1;APOA1;MTTP;GRAMD1A;GRAMD1C
prerank,water transmembrane transporter activity (GO:0005372),0.40114787194519863,0.8596655673107937,0.6369747899159663,0.9005819452920245,1.0,2/11,8.38%,PDPN;AQP6
prerank,thyroid hormone receptor binding (GO:0046966),0.33568516965371187,0.8595146938427228,0.654490106544901,0.8979391665836592,1.0,10/28,18.82%,BRD8;TACC1;TRIP12;MED16;NCOR1;NSD1;TRIP6;NCOA3;NCOA6;MED30
prerank,hexose transmembrane transporter activity (GO:0015149),-0.34178654343295956,-0.8594827793405964,0.6420047732696897,0.8850068969716867,1.0,1/12,0.75%,SLC2A1
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.3427088300532376,-0.8594531410500419,0.6488372093023256,0.880806009466616,1.0,2/12,9.25%,SPPL3;BACE2
prerank,acetylcholine receptor activity (GO:0015464),-0.2957913690542826,-0.8574009856107916,0.6601123595505618,0.8808133950902589,1.0,13/22,46.84%,CHRM3;CHRM2;CHRM1;CHRNB1;HRH3;CHRM5;CHRNA5;CHRNG;CHRNA3;CHRNE;CHRNB4;CHRNB3;HRH4
prerank,cholesterol binding (GO:0015485),0.3090707259050412,0.8561551038644564,0.6775510204081633,0.9013979545775691,1.0,13/47,15.76%,ABCA1;APOA1;OSBPL8;STAR;SIDT1;ANXA6;TSPO;VDAC1;GRAMD1A;NR1H3;OSBPL5;GRAMD1C;NPC1
prerank,ADP binding (GO:0043531),0.3412612450075932,0.851950548411536,0.654490106544901,0.9058537133882557,1.0,3/25,3.85%,PRKAG2;MYO18A;MYH10
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.27753251108957877,0.8493553773341953,0.7071611253196931,0.9075632126191646,1.0,16/75,18.12%,CRYL1;DHRS3;H6PD;MDH2;HSD3B2;MDH1B;ADH1A;DCXR;AKR1B10;KDSR;BDH1;SORD;PHGDH;PGD;DHDH;ME3
prerank,peptide hormone receptor binding (GO:0051428),0.3973006081861401,0.847747517634536,0.6654929577464789,0.9073674672314156,1.0,1/11,5.56%,VIP
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.39019735476462697,0.8452660281406547,0.6293103448275862,0.9090119953821739,1.0,2/11,19.33%,SLC22A4;SLC25A29
prerank,chemokine activity (GO:0008009),0.32110702397675783,0.8415927637881694,0.6746626686656672,0.9130489516180144,1.0,3/31,6.11%,CCL19;CXCL16;CCL4
prerank,NADP binding (GO:0050661),-0.26017563340076155,-0.8399078562033379,0.7422680412371134,0.910559092939214,1.0,18/32,28.95%,KCNAB1;NOS3;NOS1;ME1;DHFR;SPR;CBR3;HSD11B1;DHCR7;TM7SF2;HMGCR;CAT;GRHPR;NOX1;MTRR;CBR4;CRYZL1;NOS2
prerank,endoribonuclease activity (GO:0004521),0.3214786795315262,0.8391949343564419,0.6887905604719764,0.9142040009670482,1.0,11/32,24.87%,SND1;ENDOU;PIWIL4;RNASEL;TSNAX;ENDOV;DICER1;NOB1;RCL1;AGO3;LACTB2
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.3346282196656552,-0.8374322126719429,0.6790123456790124,0.9110719012482936,1.0,9/12,51.61%,RRH;OPN1MW3;OPN1MW;OPN3;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,nuclear receptor binding (GO:0016922),0.25776700773652883,0.8360625595822212,0.7399527186761229,0.9169148689181602,1.0,21/111,15.03%,TCF7L2;SMAD3;NCOA2;BRD8;TACC1;MED14;TRIP12;MED16;NCOR1;STAT5B;ACTN4;NSD1;RNF6;NCOR2;TRIP6;NR4A1;WIPI1;TRIP4;NCOA3;TADA3;RXRA
prerank,protein homodimerization activity (GO:0042803),0.23791103716191372,0.8347077113815119,0.892245720040282,0.9164751887557936,1.0,96/589,15.73%,ENPP1;FBLN5;GHR;GDNF;SMAD3;CPQ;BCL2;NR2F2;CRYL1;TPM1;FGFR1;IL6R;BMPR1A;SLC30A8;IL17D;EPHX2;FGFR2;KIT;TPST1;FOXP2;PDGFRA;APOE;NPR3;IRAK2;CSF1;APPL2;MAPK4;DPYD;ACVR1;ZHX2;GSTM4;MIGA2;GSTM2;ADRA2C;ADRB3;PDXK;HOGA1;TNNC1;PML;LRRK2;KYNU;CEBPA;GUCY2D;ZBTB38;NAALADL1;MMUT;ALS2;STK4;IRAK3;RBPMS;ZBTB4;CBY1;COMMD1;ZBTB1;MZF1;ACTN4;CAMK2B;S100A11;ARNT;ABCB9;TIMM9;MASP1;EXT1;CARD9;SMIM1;SLC39A13;CEBPB;GALM;BHLHE41;ADRA2A;FBXO4;TERF2;CIP2A;PANK1;CDA;MAP3K13;RIPK2;ZNF318;TPM2;GOLGA5;KMT2A;TSC2;PSPH;ABCD2;FLNA;SNX9;DGAT2;NUDT16L1;CRPPA;PEX11B;GLIPR2;NLRC4;PRKRA;CYP2R1;CASR;HMGCS1
prerank,CARD domain binding (GO:0050700),-0.3229277399828484,-0.832334638949417,0.654911838790932,0.9162608333971615,1.0,4/14,15.21%,NOD1;CARD14;NOD2;CARD16
prerank,antiporter activity (GO:0015297),-0.29479423860036347,-0.8319967609091276,0.7092391304347826,0.9126081051783048,1.0,10/20,31.77%,CLCN3;SLC35E4;SLC25A30;ATP1A3;SLC25A11;CLCN4;SLC35D1;SLC25A10;SLC25A14;SLC35D2
prerank,G protein-coupled receptor activity (GO:0004930),0.2439880472163197,0.8319779027336188,0.8257080610021786,0.9183453844358961,1.0,19/239,8.34%,ADRA1B;PDGFRL;ADGRV1;LGR4;PDGFRB;ADGRL1;NPR3;LTB4R;GPR63;ADRA2C;LHCGR;ADRB3;BDKRB2;MTNR1A;AGTR1;GRM2;LPAR1;DRD3;MAS1
prerank,endonuclease activity (GO:0004519),0.2984137895112474,0.8314599144172561,0.7104194857916103,0.916460831527495,1.0,17/49,26.09%,SND1;OGG1;ENDOU;REXO4;PIWIL4;RNASEL;MBD4;TSNAX;DICER1;NOB1;APLF;RCL1;MRE11;AGO3;LACTB2;ANG;N4BP2
prerank,carboxy-lyase activity (GO:0016831),-0.27793358896775766,-0.831089043420944,0.7159763313609467,0.9101595905619209,1.0,10/23,41.01%,ECHDC1;DDC;GAD1;BCKDHA;MLYCD;PPCDC;UXS1;AZIN1;PCK2;MVD
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.368261553990327,0.8308117261840829,0.6717687074829932,0.9145964967799841,1.0,1/15,1.19%,PIK3R1
prerank,snRNA binding (GO:0017069),0.30330917614322317,0.8302334880437084,0.7340876944837341,0.9126871291828221,1.0,15/42,23.68%,RBMXL2;SNRNP70;RBM22;HEXIM2;RNPC3;LSM8;RBM41;CCNT2;LSM10;HNRNPU;CCNT1;NCBP2;HEXIM1;PRPF8;TOE1
prerank,solute:proton symporter activity (GO:0015295),0.3633159435823473,0.8285403084721958,0.659468438538206,0.9127156794711008,1.0,3/16,8.00%,SLC2A10;SLC11A2;SLC2A13
prerank,chemokine receptor binding (GO:0042379),0.30795439005689984,0.8270841417674583,0.7086956521739131,0.912333585623741,1.0,5/35,13.54%,CCL19;CXCL16;CCL4;ITCH;CXCL13
prerank,acetyltransferase activity (GO:0016407),0.3110972381550814,0.8248084396136387,0.706821480406386,0.9133524349420435,1.0,11/31,24.13%,DBT;KAT2B;LCAT;SAT2;NAA80;NAA50;SAT1;PAFAH2;SMARCE1;NAT14;ESCO1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.35850541566222577,0.8237672598528861,0.6552845528455284,0.9122637899970695,1.0,6/15,22.53%,SH3PXD2B;PLA2G4A;SAP30L;SESTD1;RUBCNL;LANCL2
prerank,nuclear localization sequence binding (GO:0008139),-0.294863037720268,-0.819272336486769,0.7327823691460055,0.9279744740954902,1.0,4/18,10.31%,NUP153;NFKBIA;IPO5;CABP1
prerank,sterol transfer activity (GO:0120015),0.35442653833336885,0.81759074992513,0.6819672131147541,0.9195751376182312,1.0,5/17,15.43%,ABCA1;APOA1;MTTP;GRAMD1A;GRAMD1C
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.3049025623599454,0.8157133786606992,0.7149059334298119,0.9198989238813956,1.0,7/34,9.06%,MYO10;OGT;MYO1B;IQGAP2;ADAP2;ARHGAP9;COMMD1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.26661220684590214,-0.8153031294884692,0.7560240963855421,0.9309244283408076,1.0,13/28,30.46%,EDC3;RPP14;POP4;RPP21;MRPL44;ELAC2;RNASEH1;NUDT16;EXO1;POP7;APEX1;FEN1;RPP40
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.34783728619583176,-0.8141371800304807,0.7317073170731707,0.9286027346737458,1.0,3/10,22.95%,ANKRD13A;USP15;FAAP20
prerank,protein kinase inhibitor activity (GO:0004860),0.2962840475500497,0.8134420580068661,0.7354570637119113,0.9209295683585211,1.0,9/42,15.34%,PARVA;ITPRIP;DNAJC3;SPRY2;TAOK3;DUSP19;IBTK;CDKN1C;SPRED1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.37580147597372476,0.8084332950895162,0.6810631229235881,0.926265832091717,1.0,3/12,13.77%,CDK8;CCNK;CDK12
prerank,ion channel inhibitor activity (GO:0008200),0.30302334518595364,0.8080670613151197,0.736231884057971,0.9240675871434657,1.0,2/35,4.26%,ITPR1;NEDD4
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.31323527607137136,0.8068100225247409,0.7157434402332361,0.9233560115828395,1.0,6/30,10.81%,SLC30A8;SLC25A37;SLC30A2;SLC11A2;SLC30A10;SLC39A13
prerank,NF-kappaB binding (GO:0051059),-0.2692547484640962,-0.806530231762258,0.7642276422764228,0.9377694753871942,1.0,8/24,21.95%,FAF1;NFKBIA;EP300;NPM1;HDAC3;PSMA6;COMMD7;GSK3B
prerank,phosphatidate phosphatase activity (GO:0008195),0.37046752166102226,0.8061213705873936,0.6843003412969283,0.9217814893581237,1.0,6/13,26.43%,PLPP3;PLPP5;LPIN3;LPIN2;PLPPR2;LPIN1
prerank,myosin II binding (GO:0045159),0.3783262719850726,0.8041388986600857,0.6846011131725418,0.9222483580943871,1.0,2/10,7.31%,GSN;MYL4
prerank,Tat protein binding (GO:0030957),-0.3412326933969902,-0.8008327801777261,0.70509977827051,0.9432836661514297,1.0,5/10,31.61%,ACTB;NPM1;DLL1;SMARCA4;MDFIC
prerank,serine-type endopeptidase activity (GO:0004252),0.25933319068710375,0.7973603015109146,0.7686472819216182,0.9306476188087803,1.0,8/80,11.76%,MMP2;RHBDL3;CTSH;PRSS48;APEH;MASP1;CLPP;F2
prerank,GABA receptor binding (GO:0050811),-0.3304675177232293,-0.7925960637815872,0.7440758293838863,0.9525498938316451,1.0,5/11,25.59%,PLCL2;TRAK2;JAKMIP1;GABARAP;AKAP5
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.3580073414653507,0.7913118715163675,0.7032374100719424,0.937107243982907,1.0,1/11,1.34%,SASH1
prerank,kinesin binding (GO:0019894),-0.26001712803107074,-0.7844279184591486,0.8152492668621701,0.961679928706844,1.0,10/27,27.95%,ACTB;SPAG9;KIFAP3;NEFH;PRC1;KIF18B;KIF1B;SPTBN5;RAB29;FAM83D
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.3370127074484002,-0.7840328993707542,0.7516778523489933,0.957997185386358,1.0,4/10,22.28%,APOBEC1;GDA;ADARB2;DCTD
prerank,mRNA 5'-UTR binding (GO:0048027),-0.2678269462411056,-0.7830794978598679,0.833810888252149,0.9551309630343499,1.0,6/24,14.43%,RPL41;RPS14;RPS13;RPS7;RPL26;RPL5
prerank,histone acetyltransferase activity (GO:0004402),-0.2453665803540427,-0.7794196647659495,0.8037974683544303,0.9566694966460921,1.0,10/30,19.17%,TAF1;KAT2A;TAF10;TADA2A;USP22;KAT6A;NAA60;EP300;BRCA2;MCM3AP
prerank,histone methyltransferase binding (GO:1990226),-0.3251009939596422,-0.7791242056385644,0.7710280373831776,0.9529024684581837,1.0,2/11,6.87%,LCORL;HSP90AB1
prerank,alpha-tubulin binding (GO:0043014),0.3021043105220565,0.778735648671823,0.7688821752265861,0.9538768630289156,1.0,4/31,6.61%,DLEC1;EFHC1;INO80;BEX4
prerank,nucleosomal DNA binding (GO:0031492),0.31573571858272764,0.7779839225404792,0.7560581583198708,0.9522436178002687,1.0,6/21,16.84%,MBD2;SMARCC2;MTA2;SMARCD2;SMARCB1;HNRNPC
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.2254220825494267,0.7774834631503054,0.8927444794952681,0.95021955817445,1.0,75/269,23.80%,TXNIP;SMAD3;BCL2;MOAP1;RFFL;CDK5RAP3;AXIN2;FAF2;SKI;DERL1;PML;CUL4B;RNF31;VCL;SNCAIP;CUL5;DBT;ARRB1;EGFR;UBOX5;PRKN;LTBR;STAT2;SMC6;ITCH;CKB;NEK6;SLC22A18;IKBKE;RAD18;YWHAE;ACVR1B;TRIP4;MUL1;SYT11;GLMN;DIO2;HSPA9;SNX9;UBE2D1;BAG5;TMBIM6;HLTF;LAPTM4B;AUP1;SPART;SPOP;MAP1LC3A;BECN1;RNF34;PSMD1;PRKACA;KDM4A;SUMO1;UBE2T;PSMA3;PRDX6;UCHL1;CBS;TRIB1;SMAD2;JKAMP;TSG101;RNF20;BAG6;HDAC6;WFS1;AMBRA1;BRCA1;HSPA5;ATXN3;ERLIN2;UBXN7;CASC3;DET1
prerank,vitamin D receptor binding (GO:0042809),-0.3032015268329386,-0.7741351847622199,0.782608695652174,0.956762267677777,1.0,4/14,12.59%,MED1;MED4;SNW1;THRAP3
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.2893978517001401,0.7725633391053427,0.7733918128654971,0.954938306990713,1.0,7/34,16.47%,SETD7;KMT5B;SETD4;SMYD3;KMT2E;SETDB1;EEF2KMT
prerank,methylation-dependent protein binding (GO:0140034),0.2645123956394739,0.7723662248947182,0.8007968127490039,0.9524426460159575,1.0,18/57,21.02%,ING3;ING5;PHF1;PHF2;L3MBTL1;L3MBTL2;KMT2E;JMJD7;WDR5;KDM7A;PHF8;CBX5;SPIN4;ATRX;KDM4A;CXXC1;RBBP5;KDM5A
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.29979799245085575,-0.7713277357191548,0.7566265060240964,0.9567490178602699,1.0,6/14,25.03%,RPP14;POP4;RPP21;ELAC2;TSEN34;POP7
prerank,histone methyltransferase activity (GO:0042054),-0.23921132227237407,-0.7704049851875975,0.8354037267080745,0.953976378272291,1.0,8/32,17.17%,EED;EZH2;PRMT7;SMYD2;SUV39H1;SMYD1;PRMT6;KMT5A
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.3320696700722938,-0.766853735378406,0.7395348837209302,0.9508891787407655,1.0,2/10,14.91%,DUSP7;DUSP8
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.3320696700722938,-0.766853735378406,0.7395348837209302,0.9508891787407655,1.0,2/10,14.91%,DUSP7;DUSP8
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.2559828624102746,-0.764659740501033,0.7965616045845272,0.9500237963554191,1.0,7/23,21.94%,PLEKHA5;HIP1R;KIF16B;WDR45B;WIPI2;CLVS2;PLA2G4E
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.32183730072106875,0.7644442874061905,0.7496087636932708,0.9615281439194943,1.0,9/20,24.06%,SLC30A8;SLC30A2;SLC30A10;SLC39A13;SLC39A1;SLC39A12;SLC39A6;SLC30A5;SLC30A4
prerank,transferrin receptor binding (GO:1990459),-0.31886115267486315,-0.7624521004794457,0.7718120805369127,0.9491959769451053,1.0,3/10,21.79%,SNX1;CD81;CHUK
prerank,telomeric DNA binding (GO:0042162),-0.24415452067044519,-0.7622880537249411,0.8610271903323263,0.945389634038357,1.0,18/32,42.44%,KDM1A;HNRNPD;CTC1;HNRNPA2B1;ZBTB48;SMG7;TEN1;HMBOX1;APEX1;PIF1;TERT;STN1;PURA;TERF2IP;ACD;TINF2;UPF3A;XRCC6
prerank,deubiquitinase activity (GO:0101005),-0.19236302742047837,-0.7619599863267632,0.9117647058823529,0.9418746310977797,1.0,20/88,20.73%,USP53;OTUD7B;MINDY2;USP29;MINDY1;OTUD7A;OTUD4;USP31;YOD1;OTULIN;TNFAIP3;USP14;USP22;USP15;USP4;UFD1;EIF3F;OTUB1;USP19;TANK
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.2546430925049124,0.7597166120638413,0.8403141361256544,0.9656681994463655,1.0,11/69,16.69%,ASPG;PLA2G4A;DBT;LPGAT1;KAT2B;CERS6;CERS5;MOGAT3;DGAT2;CERS2;ZDHHC20
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.3353464360557966,0.7569584946227196,0.7566225165562914,0.9671252144988722,1.0,4/14,16.10%,AIFM1;CYB5R4;NOX4;NOX3
prerank,neurexin family protein binding (GO:0042043),0.3673863905058127,0.7561888447891527,0.7552816901408451,0.9655949942384097,1.0,2/10,12.45%,SYTL5;SYTL2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.3176162133930821,-0.7554650447446324,0.7845433255269321,0.9474289837858901,1.0,2/11,5.49%,APEX2;RPS3
prerank,ubiquitin protein ligase binding (GO:0031625),0.21954831950750053,0.7535579181317709,0.9138297872340425,0.9665856488865702,1.0,71/254,23.80%,TXNIP;SMAD3;BCL2;MOAP1;RFFL;AXIN2;FAF2;SKI;DERL1;PML;CUL4B;RNF31;VCL;SNCAIP;CUL5;DBT;ARRB1;EGFR;UBOX5;PRKN;LTBR;SMC6;CKB;NEK6;SLC22A18;IKBKE;RAD18;YWHAE;ACVR1B;MUL1;SYT11;GLMN;DIO2;HSPA9;SNX9;UBE2D1;BAG5;TMBIM6;HLTF;LAPTM4B;AUP1;SPART;SPOP;MAP1LC3A;BECN1;RNF34;PSMD1;PRKACA;KDM4A;SUMO1;UBE2T;PSMA3;PRDX6;UCHL1;CBS;TRIB1;SMAD2;JKAMP;TSG101;RNF20;BAG6;HDAC6;WFS1;AMBRA1;BRCA1;HSPA5;ATXN3;ERLIN2;UBXN7;CASC3;DET1
prerank,ribonuclease activity (GO:0004540),0.2630046950602734,0.753310456621777,0.8212824010914052,0.9641153008656432,1.0,18/56,25.49%,SND1;ENDOU;RNASE12;EXOSC1;PIWIL4;RNASEL;RNASE7;EXOSC7;TSNAX;DICER1;NOB1;EXOSC2;RCL1;AGO3;LACTB2;EXOSC8;ANG;RNASE4
prerank,lysine-acetylated histone binding (GO:0070577),0.3133136117549793,0.7530204020480782,0.771875,0.9589950516763988,1.0,4/20,6.93%,PSME4;PHIP;MLLT3;ATAD2B
prerank,acetylation-dependent protein binding (GO:0140033),0.3133136117549793,0.7530204020480782,0.771875,0.9589950516763988,1.0,4/20,6.93%,PSME4;PHIP;MLLT3;ATAD2B
prerank,5'-3' exonuclease activity (GO:0008409),0.33319382587994173,0.7510341545477363,0.739424703891709,0.9589571569038082,1.0,6/14,24.39%,DCLRE1C;DXO;DCLRE1A;FAN1;XRN1;MRE11
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.25405589289370867,-0.7493696481216063,0.839142091152815,0.9518995474453361,1.0,9/24,28.89%,AK5;IP6K1;AK7;PMVK;PPIP5K1;ITPKB;AK3;ITPKC;NME2
prerank,3'-5' exonuclease activity (GO:0008408),-0.2174498830416437,-0.7475338264586093,0.8960573476702509,0.9501076812634601,1.0,12/45,21.43%,REV3L;CNOT6L;ANGEL2;PNPT1;PNLDC1;RAD1;TATDN1;DIS3L2;EXOSC5;CNOT7;USB1;CNOT8
prerank,ribonuclease P RNA binding (GO:0033204),-0.3204883401021129,-0.7472061933210192,0.7755102040816326,0.9465534239662806,1.0,5/10,30.46%,RPP14;POP4;RPP21;POP7;RPP40
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3080905046410687,0.7449515156277748,0.7774244833068362,0.9646691265972649,1.0,5/22,11.60%,OPTN;SPRTN;WDR81;ZBTB1;IKBKE
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.2985697293356464,0.7440456822861901,0.7847328244274809,0.9632512727266797,1.0,1/24,1.26%,GLUL
prerank,retinoic acid receptor binding (GO:0042974),0.3176119111248328,0.744035881359801,0.7740384615384616,0.960561197289484,1.0,4/17,9.67%,RARG;TACC1;ACTN4;NSD1
prerank,neuropeptide hormone activity (GO:0005184),0.31153723088713736,0.7438018279929045,0.7625,0.9581333660622867,1.0,3/22,15.66%,VIP;NPFF;NPY
prerank,microtubule plus-end binding (GO:0051010),0.31024671259558834,0.7437264294301733,0.7854889589905363,0.9555420780842129,1.0,3/20,9.51%,STIM1;CLIP4;MAPRE2
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.2878196446421639,0.7418354932340304,0.8208955223880597,0.9555324083542106,1.0,6/29,9.97%,PRKAG2;PKIA;KAT2B;SPRY2;HEXIM2;INCA1
prerank,SUMO binding (GO:0032183),0.3362168185994106,0.7400610619899229,0.7759197324414716,0.9552650129979565,1.0,4/13,14.32%,PML;USPL1;SERBP1;CASP8AP2
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.27681506289515745,0.7349987749876753,0.8079178885630498,0.9591960832994504,1.0,13/35,28.27%,BCDIN3D;QRSL1;TRMT9B;TRMT13;DTWD1;ALKBH1;DUS3L;FTO;TRMT12;TYW3;PTRH2;TRIT1;QTRT2
prerank,RNA polymerase II complex binding (GO:0000993),0.2832910153294227,0.7337390367998994,0.8279411764705882,0.9582220206284685,1.0,11/32,21.26%,RECQL5;WDR43;PAF1;NCOA3;PCF11;ELOF1;WAC;CDC73;ELP4;HNRNPU;SCAF8
prerank,voltage-gated ion channel activity (GO:0005244),-0.28604684953402026,-0.7336391882549996,0.8305084745762712,0.9605871824877813,1.0,5/14,21.23%,KCND2;CACNA1H;ANO6;HCN1;HVCN1
prerank,RNA polymerase binding (GO:0070063),0.30147302941029636,0.7295259451753944,0.7784911717495987,0.9610221082796542,1.0,7/18,23.00%,NEDD4;TCERG1;CCNT2;PKN2;SCAF8;CCNT1;BRCA1
prerank,tRNA binding (GO:0000049),-0.21565632970629955,-0.7285347749168903,0.875886524822695,0.9630449182192439,1.0,20/43,35.65%,TRMT10A;PSTK;PTCD1;YARS2;EEF1A1;KARS1;FARS2;AIMP1;AARS2;EIF2AK4;NSUN6;TRMT10C;CTU1;TERT;HSD17B10;DALRD3;THG1L;TRMT10B;DARS2;ELP1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.2855132259801826,-0.7284517487462356,0.8300970873786407,0.9591911214626285,1.0,9/14,51.46%,CAPNS1;CAPN6;CAPN3;CAPN11;CAPN2;CAPN12;CAPN8;CAPNS2;CAPN9
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.2931918297039229,0.7283998692139252,0.8261538461538461,0.9597555905720822,1.0,3/26,7.99%,B3GALT1;GBGT1;B3GALNT1
prerank,signal sequence binding (GO:0005048),0.26987419856383693,0.7224098376544993,0.8395573997233748,0.9646604740026,1.0,11/35,24.73%,CEMIP;KPNA6;KDELR3;NUP214;KPNA2;KPNA1;KPNB1;SEC61A1;AP2B1;KDELR2;KPNA4
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.25686476491086546,0.7205044275770162,0.8360655737704918,0.9645079601361984,1.0,19/49,23.75%,OPTN;SPRTN;EPS15;WDR81;ZBTB1;TNIP2;IKBKE;RAD18;DZIP3;TNIP1;PSMD4;UIMC1;BRCC3;ZFAND6;ABRAXAS2;BAG6;HDAC6;PRPF8;PARP10
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.2370074390948627,-0.7172344498245778,0.910828025477707,0.9683523882448489,1.0,9/29,23.97%,ACER3;ACER2;GANC;OVGP1;CTBS;NEU1;PARG;GLA;HPSE
prerank,lysine N-methyltransferase activity (GO:0016278),0.29940147288787794,0.7149536059642612,0.8114754098360656,0.9689323619233478,1.0,3/20,16.47%,SETD7;SETD4;EEF2KMT
prerank,mRNA methyltransferase activity (GO:0008174),0.3282395021258943,0.7147610517246502,0.7971781305114638,0.9665246684308662,1.0,6/12,24.75%,NSUN2;METTL14;CMTR2;METTL3;METTL16;PCIF1
prerank,receptor antagonist activity (GO:0048019),0.30509380001073655,0.7138732926744725,0.8271812080536913,0.9649292844203972,1.0,4/17,23.24%,DKK3;IL18BP;FST;PXDN
prerank,GTP binding (GO:0005525),0.21497344140362068,0.7130533233075427,0.9370165745856354,0.9633227076274496,1.0,29/172,16.62%,RHOH;RHOD;RANBP17;RHOBTB1;RRAS2;MRAS;RHOBTB3;CDC42;LRRK2;RHOBTB2;RAB22A;ARL2;ARFIP2;RHOT1;ARL1;ANXA6;RRAGD;RHOQ;TUBB2B;INSR;RAP2A;ARF4;GNL2;RND3;ARF6;TUBB2A;ARL5A;AGAP2;RHOG
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.21751388361516485,-0.7124136455190796,0.896774193548387,0.9698704052487904,1.0,10/34,21.43%,CNOT6L;ANGEL2;PAN3;PNPT1;PNLDC1;DIS3L2;EXOSC5;CNOT7;USB1;CNOT8
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.28487189147990005,0.7117933714175251,0.8300153139356815,0.9621408384361753,1.0,11/24,22.53%,OSBPL8;PLA2G4A;PLEKHA8;ARFIP2;GOLPH3L;OSBPL5;GSDMD;GOLPH3;SESTD1;RUBCNL;LANCL2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.23473784606472425,-0.7104704184777074,0.8922651933701657,0.9678557731346136,1.0,5/25,10.69%,ARAP3;HIP1R;PLEKHA1;KIF16B;PLEK
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.33105266461615723,0.7079548428726548,0.7921146953405018,0.9641189057639834,1.0,11/11,66.92%,CHRNB2;CHRNA7;CHRNA4;CHRNA9;CHRNA2;CHRNA10;CHRNA1;CHRNB4;CHRNA3;CHRNA5;CHRNB1
prerank,RNA binding (GO:0003723),0.19677989383686884,0.7043579655169795,1.0,0.9656060556686229,1.0,276/1321,21.47%,POLR2D;CELF2;SAMD4A;RBMS1;BICC1;ROCK2;RBMS3;C1D;LRP1;DCN;TENT5A;A1CF;CSDC2;RBFOX1;RRBP1;SON;ADK;RBMXL2;MACF1;HNRNPLL;RBFOX2;FNDC3B;SPATS2L;SND1;RFTN1;MYO18A;MYH10;CDC42EP4;POLR1G;CAST;ZC3H7B;ENDOU;IGF2BP2;TNS1;GOLGB1;MDH2;NUDT7;OAS2;MAP3K20;SIDT1;SNRNP70;DYNC1H1;ZFP36L1;NPM3;TNRC6B;THOC2;ERI3;SERPINH1;RPUSD4;ACO1;SF1;CPEB3;BUD23;PNN;NPM2;DDX60;NUP42;SNTB2;DDX17;REXO4;RPP25L;TOP3B;DXO;HELZ;DNTTIP2;TUT7;EXOSC1;ERAL1;SAFB2;ZNF106;RBMS2;CHD2;TNRC6A;IBA57;RBM22;ALDH18A1;HNRNPR;NSUN2;RBPMS;METTL14;HNRNPA1;FLYWCH2;APEH;NONO;DDX39A;GFM1;ACTN4;EIF4A2;HEXIM2;DIMT1;RAVER2;ASCC3;ADAT1;PRRC2B;DDX19A;FTSJ3;RNASEL;WDR33;PARN;PPHLN1;TFAM;EIF3A;BYSL;RPUSD2;MANF;TRIP6;ERI1;NUP98;DDX3X;DDX31;EIF2S2;POLRMT;DDX23;PPP1R10;SERBP1;SUGP1;RBM19;RAE1;EIF5B;SUGP2;EXOSC7;MAGOHB;STXBP1;DDX50;WDR43;YWHAE;RCAN3;TUT4;LARP1;TRMT9B;HMGN5;SLC16A3;NMD3;GANAB;UTP23;DDX10;MTREX;TEFM;NOL3;ALDH6A1;USP10;USO1;IFIT2;RBM34;STAU1;HELZ2;ESF1;P4HB;GTF2E2;TIAL1;MARK2;SNRPD2;TEP1;HSPA9;RC3H2;NELFE;FLNA;NSUN5;TCERG1;SRP72;SRSF5;AKAP8L;NUDT16L1;RBM39;FASN;PCF11;GPKOW;GNL2;FUBP3;RBM5;RPP30;PRRC2C;HUWE1;CLK3;RRP7A;MRPL23;RBM6;HLTF;PRKRA;RBM4B;DDX52;DZIP3;PSPC1;RPP38;MRPL40;ELP5;EPPK1;COA6;EIF3I;DNAJC21;TBL2;LSM8;KTN1;TENT4B;SRRM2;DCP1A;SYNCRIP;HNRNPC;LONP1;NGDN;KPNA2;TRMT2A;TSNAX;PRPF6;PATL1;DDX4;NAF1;ZNF346;SF3B2;SF3B1;LSM10;RRP9;DARS1;SRSF10;ALKBH1;KHDC4;R3HDM2;PRRC2A;PPIE;CPSF2;DHX58;CKAP4;TRUB2;RC3H1;METTL3;EIF3C;DDX1;PARP12;TPR;ENDOV;TRIM32;KPNB1;FIP1L1;DICER1;SAP18;PSMD4;RSRC2;SUMO1;FASTKD3;DUS3L;NCOA5;ZGRF1;CCDC47;LARP6;YTHDF2;GPATCH8;PTCD3;AATF;UTP3;HNRNPU;AGO4;YRDC;HDLBP;ZFP36L2;GSPT1;FSCN1;ACTN1;DDX49;HNRNPH1;ZC3H15;MRPS28;MRPS35;DDX24;CEBPZ;PKN2;SCG3;BMS1;EIF4G2;SCAF8;UBFD1;SRSF3;RARS2;NOCT;NUDT5;SARS2;SARS1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.2590709937013518,0.7015136573877447,0.8603988603988604,0.9662795698455764,1.0,3/38,6.60%,PIK3R1;FRS2;LRRK2
prerank,phosphatase activator activity (GO:0019211),-0.2742869236693151,-0.7008875934341197,0.8870192307692307,0.9743869139662003,1.0,4/14,10.38%,PPP2R5A;GTF2F1;CALM1;CALM3
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.24455609118968827,-0.6991995042756218,0.9144385026737968,0.9721002550325807,1.0,13/21,51.68%,GRM5;GRM1;GRIA1;CHRNB1;CHRNA5;CHRNG;CHRNA3;CHRNE;CHRNB4;CHRNB3;DRD5;CHRNA1;DRD1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.32151180787795053,0.6974191677882914,0.8079584775086506,0.9681620421993952,1.0,5/13,20.57%,DNASE1L1;ENDOV;DICER1;ZGRF1;FAN1
prerank,MHC class I protein binding (GO:0042288),0.3166649196681706,0.6945989860257533,0.8341968911917098,0.9687273970855751,1.0,4/13,20.91%,DERL1;ABCB9;TAPBP;TAP1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.23086931564606666,0.6937140107198024,0.915057915057915,0.9671333717136825,1.0,6/73,8.34%,LGR4;NPR3;LTB4R;LHCGR;BDKRB2;MAS1
prerank,O-acyltransferase activity (GO:0008374),-0.21774538655407555,-0.6906554340081004,0.9298245614035088,0.9768251331780422,1.0,6/30,17.20%,LPCAT1;MBOAT1;PLA2G4C;MBOAT7;LPCAT3;LPCAT2
prerank,CCR chemokine receptor binding (GO:0048020),0.27418130108358657,0.6889501207445867,0.8703427719821163,0.969795623248247,1.0,4/28,17.52%,CCL19;CCL4;CXCL13;CX3CL1
prerank,ATPase regulator activity (GO:0060590),0.2523656883621451,0.6841547140303252,0.8925035360678925,0.9724849533899025,1.0,7/38,16.41%,DNAJC1;ATP1B2;KATNB1;TOR1AIP1;BAG5;TOR1AIP2;FNIP1
prerank,guanyl ribonucleotide binding (GO:0032561),0.20406011188901077,0.6833881053948035,0.9714912280701754,0.970717180393826,1.0,31/196,16.62%,RHOH;RHOD;MPPED2;RANBP17;RHOBTB1;RRAS2;RAPGEF2;MRAS;RHOBTB3;CDC42;LRRK2;RHOBTB2;RAB22A;ARL2;ARFIP2;RHOT1;ARL1;ANXA6;RRAGD;RHOQ;TUBB2B;INSR;RAP2A;ARF4;GNL2;RND3;ARF6;TUBB2A;ARL5A;AGAP2;RHOG
prerank,death receptor binding (GO:0005123),0.30042411198294044,0.6807911728747876,0.8563922942206655,0.9710778774479268,1.0,8/15,27.01%,NTF3;CASP8AP2;BDNF;FEM1B;MADD;MYD88;FADD;RIPK1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.20779566912980343,-0.6760210420198107,0.9371069182389937,0.986639474536129,1.0,10/33,21.43%,CNOT6L;ANGEL2;PNPT1;PNLDC1;DIS3L2;EXOSC5;CNOT7;DCP2;USB1;CNOT8
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.28199250189588143,0.674807109709146,0.8754045307443366,0.9747308555053306,1.0,4/20,16.49%,USP47;OTULINL;USP9X;COPS2
prerank,gamma-tubulin binding (GO:0043015),-0.23429860673825206,-0.672805100343105,0.9186046511627907,0.9856185034762857,1.0,6/21,18.67%,DIXDC1;PAK1;GIT1;CDK5RAP2;BRCA2;RAB11FIP5
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.25094342065527686,-0.6701049854382626,0.9021479713603818,0.9840322060008057,1.0,4/17,16.13%,AK5;CLP1;NOL9;AK7
prerank,protein phosphatase activator activity (GO:0072542),-0.26380062845872154,-0.6640810738156543,0.8844339622641509,0.985593055514581,1.0,3/13,10.38%,PPP2R5A;CALM1;CALM3
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.23047496658994437,-0.6612075176909036,0.9115853658536586,0.9839962713562398,1.0,10/22,36.20%,MTMR2;DUSP7;DUSP8;DUSP23;CDKN3;DUSP3;SBF1;PPM1F;DUSP5;DUSP2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.258042601702112,0.6597690915570222,0.8947368421052632,0.986758355956539,1.0,7/28,21.21%,PRKAA2;LRRK2;MAP2K1;MAP2K6;AKT1;PRKACA;AURKA
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.2573861328634097,-0.6568201670545074,0.8973105134474327,0.9838356923220352,1.0,5/12,22.00%,CCDC88A;VEGFA;VEGFC;DAB2IP;VEGFD
prerank,translation initiation factor activity (GO:0003743),0.24239984343829551,0.6565423515683977,0.9094827586206896,0.9871101065269337,1.0,9/36,18.43%,EIF4A2;EIF3A;EIF2B4;EIF2S2;EIF5B;EIF4E3;EIF2B3;EIF3I;EIF3C
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3003849915650252,0.6529425842772703,0.8471001757469244,0.9877439157512616,1.0,4/11,19.20%,NAA40;NAA20;NAA80;NAA50
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.26732168367030107,-0.6523804316144962,0.8921568627450981,0.9836442486404626,1.0,6/12,28.52%,DHRS4;NDUFS7;CBR1;CBR4;CRYZL1;NQO1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.26991548261203296,-0.6520430139830631,0.8907363420427553,0.9800487346836925,1.0,6/11,46.30%,HCN1;HCN4;AQP1;CNGA2;CNGA4;CNGA3
prerank,methylated histone binding (GO:0035064),0.2229783332500817,0.6519830952112398,0.9518716577540107,0.9859759246447637,1.0,18/62,21.02%,ING3;ING5;PHF1;PHF2;L3MBTL1;L3MBTL2;KMT2E;JMJD7;WDR5;KDM7A;PHF8;CBX5;SPIN4;ATRX;KDM4A;CXXC1;RBBP5;KDM5A
prerank,palmitoyltransferase activity (GO:0016409),0.25268399501341926,0.6519496116526489,0.8938053097345132,0.9834363077650878,1.0,1/28,1.26%,GLUL
prerank,DNA secondary structure binding (GO:0000217),-0.2003844185989691,-0.6451880278082737,0.9475308641975309,0.9815400760532047,1.0,9/31,25.46%,MEF2C;YY1;RAD51C;HMGB2;HMGA2;MSH2;LIN54;RAD51AP1;GEN1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.26784827231444586,0.6446393136720504,0.8883495145631068,0.9873034803636966,1.0,4/20,14.60%,AGPAT3;LPGAT1;MOGAT3;DGAT2
prerank,RNA polymerase core enzyme binding (GO:0043175),0.2452313377120504,0.6417807858932264,0.909221902017291,0.9872715148702216,1.0,12/33,21.53%,RECQL5;WDR43;PAF1;NCOA3;PCF11;ELOF1;WAC;CDC73;ELP4;HNRNPU;SCAF8;MAF1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.23391792445348408,0.6324180938531544,0.9367816091954023,0.9924723752310419,1.0,12/38,22.53%,SH3PXD2B;PLA2G4A;SNX12;SNX21;DENND1A;WIPI1;PARD3;ATG2B;WDR45;SESTD1;RUBCNL;LANCL2
prerank,neuropeptide receptor binding (GO:0071855),-0.24938825423267902,-0.6299764271183691,0.8997429305912596,0.9884718804813064,1.0,2/14,18.38%,SHANK1;PPY
prerank,aminopeptidase activity (GO:0004177),-0.2071460515937731,-0.6196681234685528,0.9764705882352941,0.9910261627064821,1.0,9/26,25.66%,XPNPEP3;MMP15;RNPEPL1;METAP2;BLMH;MMP16;TRHDE;LNPEP;NPEPPS
prerank,nuclear import signal receptor activity (GO:0061608),0.2743909090109315,0.6196423853889466,0.8938640132669984,0.9997135096183407,1.0,4/15,18.84%,KPNA6;KPNA2;KPNA1;KPNB1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.21411833709959857,0.615728649282397,0.9614855570839065,0.9999264264808306,1.0,17/54,25.22%,ASPG;ASPA;SIRT2;NGLY1;HDAC8;HDAC4;VNN1;SUDS3;AGA;DARS1;SIRT5;MIER3;HDAC6;HDAC5;ACER1;HDAC1;ACY1
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.25455325024906883,-0.6102743307797565,0.9292682926829269,0.9925525943733419,1.0,7/11,30.25%,NUDT4;DCP2;NUDT11;DCPS;NUDT16;NUDT10;NUDT1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.2950755386904838,0.6089882055676437,0.9120879120879121,1.0,1.0,4/10,23.67%,PML;IDE;FAN1;ANKRD13D
prerank,exoribonuclease activity (GO:0004532),0.27512265335234126,0.6049624216589863,0.8894472361809045,1.0,1.0,5/12,27.35%,EXOSC1;EXOSC7;EXOSC2;EXOSC8;EXOSC9
prerank,glucose transmembrane transporter activity (GO:0005355),0.259756500895688,0.6043163540740878,0.9206611570247933,1.0,1.0,4/17,17.56%,SLC2A10;SLC5A3;SLC2A4;SLC2A8
prerank,kinase activity (GO:0016301),0.18874557249508714,0.5995365708716258,0.995249406175772,1.0,1.0,24/109,21.35%,LYN;EPHA4;MVK;PDXK;LRRK2;SPHK2;MAP4K4;FN3KRP;CHKB;CKB;PI4KA;PANK1;CERK;AKT1;ITPKA;GK;CDC7;FN3K;NMRK1;COASY;BCKDK;PKN2;TAOK1;PAPSS2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.2685965332521458,0.5983839322693085,0.9174757281553398,0.9988258771002917,1.0,1/15,5.18%,PLA2G4A
prerank,thiol-dependent deubiquitinase (GO:0004843),0.19536420138093177,0.5975101397828187,0.9792682926829268,0.99687581445903,1.0,13/83,13.43%,USP11;USP47;USP20;USP35;USP24;USP48;USP30;USP9Y;USP32;USP10;USP9X;MINDY3;USP38
prerank,damaged DNA binding (GO:0003684),0.21610702345859148,0.5974223735544079,0.9567642956764296,0.9944200293745458,1.0,6/44,11.92%,OGG1;CUL4B;DCLRE1C;SMC6;DCLRE1A;RAD18
prerank,CXCR chemokine receptor binding (GO:0045236),0.2781277961098958,0.5908098126992104,0.9136690647482014,0.9959758054766777,1.0,2/11,13.54%,ITCH;CXCL13
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.18740756629435368,-0.5905544331725245,0.9716713881019831,0.9992818234878798,1.0,6/28,21.50%,TMBIM1;TRAF5;TRAF1;TRAF2;DAB2IP;BABAM2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.2555158935474349,0.5904160796994514,0.929042904290429,0.9936628263144034,1.0,2/16,6.68%,NEIL1;ADPRH
prerank,omega peptidase activity (GO:0008242),0.19024602547032285,0.5878224154301591,0.983030303030303,0.9926566016381432,1.0,14/89,13.43%,USP11;USP47;USP20;USP35;USP24;USP48;APEH;USP30;USP9Y;USP32;USP10;USP9X;MINDY3;USP38
prerank,single-stranded DNA helicase activity (GO:0017116),-0.2081337395465132,-0.5836397638154909,0.9625668449197861,0.99857648590122,1.0,9/19,29.49%,RAD51;DHX9;POLQ;WRNIP1;HELB;MCM5;DSCC1;CHTF18;PIF1
prerank,cAMP response element binding (GO:0035497),-0.251606179587258,-0.5832889498078422,0.9395348837209302,0.9949264526706662,1.0,6/10,32.86%,CREB1;JUN;HMGA2;ATF2;NR4A3;E4F1
prerank,telomerase RNA binding (GO:0070034),0.23613403282503337,0.577693658892121,0.9475357710651828,0.995570010616591,1.0,6/22,20.15%,PARN;TEP1;TENT4B;HNRNPC;NAF1;HNRNPU
prerank,ribonuclease P activity (GO:0004526),-0.23967501498986124,-0.568755837089062,0.953810623556582,0.9974743998114275,1.0,3/11,15.48%,RPP14;POP4;RPP21
prerank,ribosome binding (GO:0043022),0.1985936999365529,0.5609081039048733,0.975,1.0,1.0,11/46,22.35%,CPEB1;CPEB3;EIF6;ERI1;SERBP1;SRP72;EIF3C;CCDC47;SEC61A1;CPEB4;BAG6
prerank,carbohydrate kinase activity (GO:0019200),-0.23394409429587779,-0.5572996813297895,0.9482352941176471,0.9981616534468674,1.0,1/11,5.76%,HK2
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.23495090771721605,0.5561572954396085,0.9517684887459807,1.0,1.0,3/17,17.02%,DPYD;DECR1;DECR2
prerank,phospholipase inhibitor activity (GO:0004859),0.2661236941743021,0.5551181818629255,0.9342806394316163,0.9992910020708461,1.0,5/10,33.88%,ANXA5;ANXA2;ANXA4;ANXA9;ANGPTL3
prerank,endodeoxyribonuclease activity (GO:0004520),-0.18982289747183317,-0.547450391865864,0.9919571045576407,0.9979946596718271,1.0,8/20,32.68%,RPS3;ZRANB3;EXO1;EXOG;APEX1;ENDOG;FEN1;ERCC5
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.21479140655341086,-0.5443460644432924,0.9710467706013363,0.9953175141522604,1.0,6/13,36.37%,TRMT10A;TRMT1L;TRMT10C;TRMT10B;FTSJ1;TARBP1
prerank,single-stranded telomeric DNA binding (GO:0043047),0.2499327251133496,0.54055593068375,0.9458544839255499,1.0,1.0,2/11,12.18%,HNRNPA1;TERF2
prerank,aspartic-type peptidase activity (GO:0070001),-0.23053336480594533,-0.5399022850290981,0.9607843137254902,0.9928568419689944,1.0,2/10,24.07%,BACE2;CTSE
prerank,four-way junction DNA binding (GO:0000400),0.2304524239639772,0.533753459457205,0.9699842022116903,1.0,1.0,7/17,26.39%,RAD51B;RAD51D;XRCC2;MSH6;HMGB3;ABL1;HMGB1
prerank,MHC protein binding (GO:0042287),-0.19382722163053825,-0.5320434013138481,0.9868766404199475,0.9914063365664704,1.0,4/20,17.40%,ATP5F1A;TUBB4B;CD81;LAG3
prerank,DNA polymerase binding (GO:0070182),0.22809562788653243,0.5318153486257738,0.9634920634920635,1.0,1.0,9/18,30.29%,FANCI;RTEL1;CDK2AP1;LONP1;NABP2;HMGB1;HSP90AA1;SMG6;PCNA
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.20396843837997355,-0.5310701890852574,0.9791183294663574,0.9880075160174286,1.0,6/15,29.65%,PIK3R3;PIK3C2B;PIK3CA;PIK3CG;PI4K2B;PIK3CD
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.23541135677060426,0.527593777960591,0.9627749576988156,1.0,1.0,3/14,13.79%,MTMR3;MTMR7;PTEN
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.2440044300439388,0.5223637411783638,0.958904109589041,0.9998510884676435,1.0,3/11,18.70%,FBXO11;PRMT9;CARM1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.22887725481772847,0.5132815317899825,0.9768270944741533,1.0,1.0,2/14,11.78%,AK8;NME6
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.24482532743310984,0.512444727008345,0.9522900763358778,0.998064693597515,1.0,2/10,11.72%,DCLRE1C;DCLRE1A
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.2085928979586339,0.4970086316880894,0.9743178170144462,0.9998160165296339,1.0,1/18,5.28%,HSD3B2
prerank,snoRNA binding (GO:0030515),0.19034665508888787,0.49200865798365545,0.9880952380952381,0.9985942658507864,1.0,9/30,27.04%,NUDT7;BYSL;NUDT16L1;RRP9;BMS1;NUDT5;NOP14;HEATR1;TBL3
prerank,peptide N-acetyltransferase activity (GO:0034212),0.2254188471714019,0.48456080460085943,0.9574468085106383,0.9978750010429442,1.0,3/10,19.20%,NAA20;NAA80;NAA50
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.2038939979750358,-0.47598926752287046,0.9749430523917996,0.9957790773612286,1.0,6/10,40.77%,NCF2;NOX1;NCF1;NCF4;DUOX1;CYBA
prerank,U6 snRNA binding (GO:0017070),0.20184814415125513,0.46677667502111864,0.9749582637729549,0.9989447978757549,1.0,4/14,23.61%,RBM22;LSM8;PRPF8;METTL16
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.16931736934037378,-0.4451795500501458,1.0,0.996041853101122,1.0,9/15,45.92%,P2RX7;P2RY14;PTAFR;P2RX3;P2RX6;GPR171;P2RX1;GPR87;P2RY13
prerank,Toll-like receptor binding (GO:0035325),0.20296602267488645,0.4248518141773579,0.9911504424778761,1.0,1.0,3/11,21.73%,TLR6;TIRAP;MYD88
prerank,deoxyribonuclease activity (GO:0004536),0.18587019590884765,0.412224473022117,0.993421052631579,1.0,1.0,5/14,26.01%,DNASE1L1;MBD4;APLF;MRE11;MAP1S
prerank,SUMO transferase activity (GO:0019789),0.17361547155594598,0.4054818152506943,1.0,0.9993735908389328,1.0,16/16,82.66%,MUL1;HDAC4;NSMCE2;PIAS3;MDM2;RNF212;PIAS4;UBE2I;PIAS1;EGR2;RNF212B;PIAS2;TOPORS;TRIM28;CBX4;RANBP2
prerank,N-acyltransferase activity (GO:0016410),0.15055149800400006,0.39825350686820177,0.9985380116959064,0.9974834702813977,1.0,10/32,24.13%,CERS6;CERS5;CERS2;SAT2;NAA80;NAA50;SAT1;SMARCE1;NAT14;ESCO1
